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Summary
The pathogenesis of affective disorders is not clearly understood and 
the diagnostic validity of psychiatric disorders remains unclear. The aim of this 
thesis was to identify sub-phenotypes in affective disorders that may be 
biologically validated by future molecular genetic studies.
The dataset comprised over 1000 subjects meeting diagnostic criteria 
(DSM-IV) for bipolar I disorder (BPI) or major recurrent depression (MDDR) 
who were previously recruited as part of ongoing molecular genetic studies. 
Subjects had been assessed in detail using Schedules for Clinical 
Assessment in Neuropsychiatry (SCAN) and case-note reviews. I undertook 
hypotheses testing and exploratory analyses in this dataset using a range of 
univariate and multivariate statistical tests.
I found that a depressive episode at illness onset in BPI subjects was 
associated with a more depressive course of illness. I also found clinical 
characteristics of depression that were associated with a bipolar, rather than 
unipolar, course of illness. Using the HCL-32, I identified a substantial number 
of MDDR subjects (17%) who reported bipolar symptoms at a level similar to 
that reported by BPI subjects.
I found significant differences in the clinical course of illness of MDDR 
and BPI subjects according to the lifetime presence of recurrent panic attacks, 
as well as clinical characteristics that appeared to be associated with the 
presence of panic attacks only in BPI subjects.
In the unipolar sample, I found that within subjects psychotic episodes 
tended to be more severe than non-psychotic episodes. However, between 
subjects there was wide variation in severity in both those that did, and did 
not, experience psychotic episodes.
In MDDR subjects, I found that episodes of postpartum depression 
clustered in families (p=0.015). I found no significant evidence for the 
familiality of reporting of life events in the MDDR sample.
These studies identify sub-phenotypes that may be of use in future 
genetic studies.
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Introduction
1.1 Summary
In this introductory chapter I will begin by briefly describing the history of the 
concept and classification of affective disorders, with reference to the 
descriptions, definitions and later diagnostic systems that were developed for 
both clinical and research purposes. I will then briefly discuss what is known 
about the aetiology and pathogenesis of affective disorder before describing 
some of the ways in which these disorders may be treated. The main focus of 
this chapter will be a consideration of the family and genetic studies that have 
been conducted to date that have examined whether there are familial or 
genetic risk factors associated with susceptibility for affective disorders. The 
final section of this chapter will describe the aims and layout of this thesis.
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1.2 Background
The term “affective (mood) disorder” includes a wide range of conditions, 
ranging from common, mild episodes of mood variation, to more severe 
psychotic affective episodes, which represent some of the most severe forms 
of illness seen in psychiatric practice. The core features of affective disorder 
include a pathological disturbance in mood (ranging from severe elation to 
severe depression) and disturbances in thinking and behaviour, which may 
include psychotic features, such as delusions or hallucinations.
Historically the concept of affective disorders is very old, although by the late 
nineteenth century the writings of Falret and Baillarger began to describe a 
disorder (‘folie a double forme1 and ‘folie circulate’) resembling affective 
disorders as they are known today. The disorder they described had an acute 
onset, was bipolar in character, and alternated between periods of normality 
and episodic exacerbations (Jelliffe, 1931, Lewis, 1934). In the early twentieth 
century, Emil Kraepelin (1921) distinguished manic depressive illness from 
the other psychotic disorders (dementia praecox). Manic depressive illness 
tended to be relatively severe, episodic, and recurrent, with a good prognosis 
and periods of normality between illness episodes. Kraepelin’s description of 
manic depressive illness included syndromes featuring both mania and 
depression, as well as recurrent depression alone.
Modern diagnostic systems classify affective disorders as either unipolar or 
bipolar in nature, a distinction first described by Leonhard (1959). The 
unipolar/ bipolar distinction has received some support through the work of
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investigators who published family studies during the 1960s. These studies 
suggested that predisposition to the two forms of affective disorders was 
specific for each disorder, and that the hereditary loading was more 
pronounced in bipolar than in unipolar probands (Angst, 1966, Perris, 1966, 
Winokur et al., 1969).
By the 1970s, classification of psychiatric disorders began to rely on a 
descriptive approach and the use of operational criteria, for example, the 
Feighner criteria (Feighner et al., 1972) and the Research Diagnostic Criteria 
(Spitzer et al., 1978). In modern classification systems, such as DSM-IV 
(APA, 2000), a diagnosis of bipolar disorder requires the presence of at least 
one episode of mania during the course of the illness, which may also be 
accompanied by one or more episodes of major depression. The main clinical 
distinction between bipolar and unipolar disorders is the requirement of an 
episode of mania for a bipolar diagnosis. Bipolar disorder can also be 
classified as either bipolar I disorder (BPI) or bipolar II disorder (BPII) 
according to DSM-IV. A diagnosis of BPI requires that the patient has 
experienced a period of mania that has lasted for at least a week and that has 
caused the patient significant impairment in work, social or personal 
functioning. BPII requires that a patient has experienced a period of 
hypomania (a milder form of mania) for at least four days. These episodes 
may also cause impairment in functioning but to a lesser degree than 
episodes of mania. A diagnosis of BPII also requires the presence of a major 
depressive episode(s), which may or may not be present for a diagnosis of 
BPI.
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Patients with major depression (unipolar depression/ disorder) may be 
diagnosed according to DSM-IV as either major depressive disorder single 
episode (MDDS) or major depressive disorder recurrent episodes (MDDR) 
depending on whether the patient has experienced a depressive episode 
previously.
Prevalence estimates for affective disorders vary according to the diagnostic 
criteria, methodology and sample employed. However, the US National 
Comorbidity Survey estimated lifetime prevalence of DSMIII-R major 
depression to be 17.1%. (Kessler et al., 1994). The rate for women was 
almost twice that of men, being 21.3% and 12.7% respectively (Kessler et al., 
1994), demonstrating the consistent gender differences that have been found 
for unipolar depression.
The prevalence rate for narrowly defined bipolar disorder is substantially less 
than for unipolar disorder and has been estimated to be between 0.5% and 
1.5%, with no consistent evidence for any gender distinction (Smith and 
Weissman, 1992).
The pathogenesis of affective disorders is not clearly understood. Studies 
have suggested that imbalances in certain neurotransmitters or 
malfunctioning of neurotransmitter receptors may be implicated in mood 
disorders (Gelder et al., 2006). The monoamines, norepinephrine, serotonin 
and dopamine are the neurotransmitters traditionally associated with affective
5
disorders, however, more recently other neurotransmitters, such as glutamate 
and GABA, have also been implicated (Leonard, 2007). Neurophysiological 
abnormalities have been found in patients with affective disorders (Gelder et 
al., 2006), although it is difficult to establish whether abnormalities in brain 
structure and function in individuals with affective disorders are causes or 
correlates of the illness. Considerable experimental and clinical evidence has 
suggested that neuroendocrine abnormalities may play a role in the 
pathogenesis of mood disorders (Gelder et al., 2006). A well replicated 
example of this is the dysfunction in the hypothalamic-pituitary-adrenal (HPA) 
axis seen in patients with major depression (Young and Korszun, 1998).
Treatments for affective disorders range from biological treatments, such as 
medication or electro-convulsive therapy (ECT), to psychological treatments, 
such as cognitive-behavioural therapy (CBT) or psychodynamic therapy, to 
socio cultural based treatments, such as interpersonal therapy (Gelder et al., 
2006).
Antidepressant and mood stabilising medications that are used to treat 
affective disorders exert their effects by altering levels of neurotransmitters or 
sensitivity of receptors to neurotransmitters (these findings contributed to the 
monoamine hypothesis of mood disorders). Antidepressant medications are 
generally classified into tricyclic antidepressants, monoamine oxidase 
inhibitors, or selective serotonin reuptake inhibitors (and other second 
generation antidepressants). These drug classes vary in their effectiveness 
across individuals and in their potential to produce side effects (Healy, 2002).
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Psychological treatments, such as CBT, blend cognitive and behavioural 
theories of depression (Beck et al., 1974). They aim to change negative 
patterns of thinking and enable individuals to solve concrete problems in their 
lives though the development of new life skills.
Socio-cultural approaches to the treatment of depression focus on an 
individual’s roles and relationships in society. Interpersonal therapy is a socio­
cultural approach to treating depression because it views the individual’s 
symptoms in the context of their relationships and interpersonal roles (Nolen- 
Hoeksema, 2001).
Currently, the diagnostic validity of psychiatric disorders remains unclear. Due 
to a limited understanding of the biological systems involved in affective 
disorders, current classification systems aim to identify patients that display 
signs and symptoms that appear to consistently co-occur and are therefore 
thought to best represent an affective disorder. Such descriptive, syndromal 
approaches are based on the best available evidence (Kendell, 1987, Farmer 
and McGuffin, 1989), but their usefulness is limited by unknown biological 
validity. At present, many patients fail to respond adequately to mood 
stabilising or antidepressant medication, and many experience undesirable 
side effects from medication. There are important management differences 
between bipolar and unipolar depression. For example, in bipolar depression 
antidepressants have to be used more cautiously and with closer ongoing
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monitoring of mental state after the initial improvement because of the 
substantial risk of mood switch or mood cycling (NICE, 2006b).
The identification of genes that may make an individual susceptible to 
developing a mood disorder will lead to an increased understanding of the 
biological and neuro-chemical pathways involved in affective illness. Such 
findings will introduce new possibilities into classification and diagnosis. It is 
hoped that this will result in a classification of disorders that is biologically 
validated, enabling the development and use of more targeted, and therefore 
more efficient, treatments both pharmacological and non-pharmacological.
1.3 Measuring Genetic and Environmental Risk Factors
1.3.1 Family, Adoption and Twin Studies
Family studies compare the prevalence of mood disorders in biological 
relatives (usually first-degree relatives) of probands with mood disorders to 
the prevalence of mood disorders in relatives of suitably matched individuals 
with no history of mood disorder. Family studies provide an estimate of 
familiality (how much a disorder aggregates in families). Family studies 
cannot, however, establish whether a disorder aggregates in families as a 
result of genetic factors, or as a result of environmental risk factors that are 
also familial (or as a result of both).
Adoption and twin studies are the two main approaches used to disentangle 
genetic and environmental effects. In both adoption studies and twin studies,
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it is possible to separate the variance in liability to affective disorder into three 
components: genetic influences, shared environmental influences, and unique 
environmental influences (see Figure 1-1).
Shared
Environmental
Influences
Non-Shared
(Individual)
Environmental
Influences
Genetic
Influences
[Familial] [Non-Familial]
PHENOTYPE
Figure 1-1: Genetic and Environmental Influences on the Phenotype
Shared environmental influences and genetic influences (which are familial) and non- shared
environmental influences (which are non-familial) interact and impact on the phenotype.
Adoption studies are based on the offspring of one set of parents being reared 
from early in life by unrelated strangers. Aggregation of disease in biological 
parents of an affected individual suggests that a genetic component may 
influence liability. Aggregation of disease in unrelated parents of an adopted 
affected individual suggests that environmental factors may play an important 
role in contributing to disease susceptibility. This study design has become 
more difficult to conduct as a result of declining adoption rates.
Twin studies compare genetically identical (monozygotic) twins with fraternal 
twins who share half their genes on average (dizygotic). Higher concordance 
rates for disease in monozygotic twin pairs compared with dizygotic twin pairs
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suggests the involvement of a genetic component in disease susceptibility. 
Twin studies rely on the equal environment assumption, that monozygotic and 
dizygotic twins are equally correlated in their exposure to environmental risk 
factors for affective disorders. If this assumption is incorrect, a greater 
similarity between monozygotic than dizygotic twin pairs, could result from 
environmental and not genetic factors. However, the equal-environment 
assumption has been examined repeatedly, and there is considerable 
evidence supporting its validity for major depression (Kendler et al., 1994, 
Kendlerand Gardner, 1998).
1.3.2 Molecular Genetic Studies
Molecular genetic studies can be divided into the positional and candidate 
gene approaches. The positional approach determines the chromosomal 
locations of susceptibility genes, usually by linkage studies.
Linkage Studies
Linkage studies aim to find regions within the genome that are likely to 
harbour susceptibility genes by examining genetic marker allele sharing in 
members of families with more than one affected member (most commonly 
using an affected sibling-pair design). Linkage studies require no knowledge 
of disease pathophysiology and are therefore useful for the study of 
psychiatric illnesses where pathogenesis is poorly understood. However, the 
use of linkage analysis in studies of affective disorder is complicated by an 
unknown model of inheritance, genetic heterogeneity and the likely 
importance of non-genetic factors. It is now recognised that due to the
10
expected small or modest genetic effect sizes, large samples (hundreds to 
thousands) are required to provide adequate power to detect linkage.
Association Studies
Association studies compare allele frequencies at a marker locus for 
unrelated affected individuals (cases) and appropriate comparison individuals 
(controls). Differences indicate either that the variant itself is directly involved 
in influencing disease susceptibility or that it is very close to a DNA variant 
that influences susceptibility (called “linkage disequilibrium”). The great 
advantage of association is that it can detect genes of very small effect that 
will be overlooked by linkage studies. Association approaches usually focus 
on variants in a specific gene or genes thought to be candidates for 
involvement in illness (“candidate gene studies”).
Since the completion of the Human Genome Project in 2003 and the 
International Hapmap Project in 2005 it is now possible to conduct whole 
genome association studies, where whole genome samples can be quickly 
and accurately analysed for genetic variations that may contribute to disease 
susceptibility.
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1.4 Family, Adoption and Twin Studies and Affective 
Disorders
1.4.1 Family, Adoption and Twin Studies and Bipolar Disorder
There is consistent evidence for the increased risk of bipolar disorder in the 
relatives of bipolar probands. A meta-analysis of eight studies (Jones et al.,
2002) provided an estimate of risk (as measured by odds ratios, OR, and 95% 
confidence intervals, Cl) in first degree relatives of probands diagnosed with 
bipolar I disorder of 7% (Cl 5-10%). There is also evidence for increased rates 
of other affective disorders in the relatives of bipolar probands, compared to 
the risk for the general population. The studies used in the meta-analysis 
mentioned above also found high rates of unipolar illness in the relatives of 
bipolar probands. These rates of unipolar disorder were higher in the relatives 
of bipolar probands than the rates of bipolar disorder, although when taking 
into account the larger population prevalence for unipolar disorder, the relative 
risk is much lower, at approximately double the risk (McGuffin and Katz,
1989). Interestingly, Blacker & Tsuang (1993) estimated that two-thirds to 
three-quarters of cases of unipolar disorder in the relatives of individuals with 
bipolar disorder, can be considered to be “genetically bipolar”, meaning that 
they share a common genetic susceptibility with the bipolar form of affective 
illness.
There is also strong evidence for the increase in rates of bipolar II disorder in 
the relatives of bipolar I probands, (Gershon et al., 1982, Rice et al., 1987). 
There has been no consistent evidence for an increased risk of schizophrenia
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in bipolar relatives although schizoaffective disorder, in which manic features 
occur, has shown consistent familial aggregation with bipolar disorder (Rice et 
al., 1987, Gershon etal., 1982, Kendler et al., 1998).
Several adoption studies have considered the genetic and environmental 
factors associated with mood disorders, although only two of these have been 
based on a modern definition of bipolar disorder (Mendlewicz and Rainer, 
1977, Wender et al., 1986). The results of both of these studies are consistent 
with a role for genetic factors influencing susceptibility for affective disorders, 
including bipolar disorder.
Studies have consistently shown an increased probandwise concordance rate 
in monozygotic (MZ) twins when compared with dizygotic (DZ) twins 
(Kringlen, 1967, Allen et al., 1974, Bertelsen et al., 1977, Torgersen, 1986, 
Kendler et al., 1993d, Cardno et al., 1999). Pooling the data from these 
studies provides an estimate of MZ concordance for narrowly defined bipolar 
disorder of 50%. More recently, a Finnish twin study (Kieseppa et al., 2004) of 
bipolar I disorder reported a probandwise concordance rate of 43% in MZ 
twins compared to 6% in DZ twins. They found that genetic and specific 
environmental factors contributed to the best fitting model, with a heritability 
estimate of 0.93.
Twin studies have also suggested that familial factors may be shared across 
the functional psychoses. McGuffin et al (2003) concluded from their twin 
study that there are substantial genetic and non-shared environmental factors
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conferring susceptibility to mania and depression, but that most of the genetic 
variance in liability to mania is specific to the manic syndrome. Similarly, 
Cardo et al (2002) found that there appeared to be an overlap in genetic 
susceptibility between schizophrenia, bipolar disorder and schizoaffective 
disorder, but that there are also separate components to schizophrenia and 
bipolar disorder (but not schizoaffective disorder).
Certain proband and illness characteristics have been identified as important 
in the prediction of morbidity rates in relatives. Life time risk of affective 
disorders in family members is increased with earlier age at onset (Strober, 
1992), as well as with the number of affected relatives (Gershon et al., 1982).
Potash et al (2003) found that a history of psychotic bipolar disorder in 
probands increased the risk of bipolar disorder in relatives. They also found 
that psychotic bipolar disorder itself clustered in families of probands with 
psychotic bipolar disorder. O’ Mahony et al (2002) also found that the degree 
of psychosis appeared to be familial in bipolar families.
Risk for panic disorder in families segregating bipolar disorder appears to be a 
familial trait (MacKinnon et al., 1997, MacKinnon et al., 2002) and there is 
evidence to suggest that vulnerability to the puerperal triggering of episodes 
may be a marker for a more familial form of bipolar illness (Jones and 
Craddock, 2002).
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Another aspect of the phenotype that has been shown to cluster in the 
families of patients with bipolar disorder is response to lithium prophylaxis 
(Grof et al., 2002). The authors found a higher frequency of bipolar disorder in 
the relatives of lithium responders, and a higher frequency of schizophrenia in 
families of non-responders.
1.4.2 Family, Adoption and Twin Studies and Major Depressive 
Disorder
Family studies have provided strong evidence for the familial aggregation of 
major depression. A meta-analysis by Sullivan et al (2000) found that all five 
of the studies that met the inclusion criteria for the meta-analysis supported 
the familial aggregation of major depressive disorder. Studies have 
consistently shown increased rates of unipolar illness in the relatives of 
unipolar probands. However, there is no evidence to suggest that rates of 
bipolar disorder are increased in the relatives of unipolar probands (McGuffin 
and Katz, 1989).
Although adoption studies have been inconsistent in supporting the role of 
genetic influences on liability to major depression, Sullivan et al (2000) found 
that two of three studies included in their meta-analysis were consistent with 
genetic influences on liability to major depression.
Twin studies have consistently shown higher concordance rates for 
monozygotic twins that for dizygotic twins, consistent with a genetic 
contribution to the development of major depression. Sullivan et al (2000)
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concluded from their meta-analysis of five twin studies that familial 
aggregation was due to additive genetic effects (37%), and individual-specific 
environmental effects (63%), with a minimal contribution of shared 
environmental effects.
Some studies have shown major depression with an earlier age at illness 
onset to be more familial than later onset depression, although this was not 
supported by a meta-analysis (Sullivan et al., 2000). Recurrence of 
depressive episodes appears to be the characteristic most strongly and 
consistently associated with increased familiality and heritability (Sullivan et 
al., 2000).
Other clinical features, such as impairment during depression (Kendler et al., 
1994, Kendler et al., 1999) and duration of the longest depressive episode 
(McGuffin et al., 1996, Kendler et al., 1999) have also been found to be 
associated with increased familiality of major depression.
Major depressive disorder is often divided into reactive (triggered by an event) 
and endogenous (coming from within) depression. Family studies provide little 
support for this distinction (Rush and Weissenburger, 1994) with no difference 
in family history being found for the two types of depression. However, it has 
been suggested that reactive (neurotic) depression may be less familial than 
endogenous depression, but only when severe depression in relatives is 
taken as the relevant phenotype (McGuffin et al., 1987). Twin studies suggest 
that the genetic contribution to neurotic depression is probably small,
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compared to endogenous depression, at most accounting for about 20% of 
the variance in liability (McGuffin et al., 1994).
Atypical subtypes of major depression have been shown to be at least 
partially distinct from typical subtypes from a clinical, longitudinal and familial 
genetic perspective (Kendler et al., 1996). Melancholic depression has been 
found to identify a subset of individuals with distinct clinical features and a 
particularly high familial liability to depressive illness (Kendler, 1997). 
However, from a familial perspective, the differences between melancholic 
and non-melancholic major depression are quantitative, not qualitative (i.e. 
melancholic major depression is more severe than, but not aetiologically 
distinct from, non-melancholic major depression).
Evidence for the familiality of psychotic features in bipolar patients has been 
demonstrated (Potash et al., 2001, O'Mahony et al., 2002, Potash et al.,
2003), however, findings in unipolar disorder have not been so consistent.
Winokur et al (1985) found no evidence that psychotic probands were more 
likely than the non-psychotic to have psychotic relatives. This was supported 
by the findings of Coryell et al (1985) who found that patterns of familial 
psychopathology were similar for psychotically depressed inpatients and non- 
psychotic depressed inpatients. However, Coryell et al (1985) also found 
increased rates of schizophrenia and decreased rates of depression in the 
families of depressed patients with mood-incongruent psychosis compared to 
those with mood-congruent psychotic features. Recently, interesting findings
17
have emerged in relation to phenotypic overlap between bipolar disorder and 
schizophrenia and have pointed to the possibility of common psychosis 
susceptibility genes (Craddock et al., 2005). Further investigation of the 
relationship between major depression and psychosis is needed.
Research has consistently found that influences on anxiety and depression, 
both as symptoms and disorders, are almost entirely shared (Jardine et al., 
1984, Kendler et al., 1992, Roy et al., 1995). Familial factors may explain a 
limited proportion of cases where unipolar depression is comorbid with panic 
disorder, however, Maier et al (1995a) concluded from their study that the 
majority of comorbidity between unipolar depression and panic disorder may 
still be due to non-familial factors. Interestingly, a more recent study found 
that the temporal relationship between comorbid panic and depression may 
play an important role in determining the familial risk for depression in family 
members (Dindo and Coryell, 2004).
The literature supporting the familiality of antidepressant response is sparse, 
however, studies to date have been consistent in finding that positive 
response to antidepressant medication clusters in families in both patients 
with unipolar depression (O'Reilly et al., 1994) and also in patients with bipolar 
disorder (Franchini et al., 1998).
There has been no evidence supporting an influence of the sex of the 
proband on rates of illness among relatives, although the risk of unipolar 
illness in female relatives of unipolar probands is greater than the risk to male
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relatives (Weissman et al., 1984a, Winokur et al., 1982). Whether this 
increased risk is due to biological or social factors is an issue of much debate.
Although women are twice as likely to experience major depression compared 
with men, heritability estimates using a clinical twin sample have been 
reported to be the same for men and women (McGuffin et al., 1996).
However, a recent population-based twin study by Kendler et al (2006) 
suggests that the heritability of major depression is higher in women than in 
men and that some genetic risk factors for major depression may be sex 
specific in their effect. Some twin studies have suggested that there may be 
sex differences in the genes conferring liability to depression (Bierut et al., 
1999), though other studies show no such difference (Agrawal et al., 2004). A 
possible explanation for these findings is that males and females share most 
but not all genetic influences for major depression.
It has been suggested that when focusing on clinical samples or more severe 
or clear-cut cases in the community, the heritability of major depression 
increases and is only slightly less than the 80% figure usually quoted for 
schizophrenia or bipolar disorder (McGuffin et al., 2007). However, 
contrasting with this suggestion, Sullivan et al (2000) found that estimates of 
heritability were similar in subjects ascertained from community and clinical 
sources.
These studies have also demonstrated a graduation in risk of major 
depression between various classes of relatives, with monozygotic co-twin
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showing the highest risk, through first degree relative to unrelated member of 
the general population showing the lowest risk. The majority of studies 
suggest a relative risk to siblings (As) of affective disorder in the region of 
three (Jones et al., 2002). However, one study comparing the siblings of 
unipolar depressives with the siblings of healthy controls found a substantially 
higher As of over nine (Farmer et al., 2000).
Heritability estimates (the proportion of variance explained by additive genetic 
factors) for major depression range from 40% to 70%, depending on the 
methodology and diagnostic criteria employed (Kendler et al., 1993b,
McGuffin et al., 1996). All studies to date are consistent with models of 
inheritance that include multiple genes that interact with each other and 
environmental factors to confer susceptibility to illness [for example, Craddock 
et al (1995)].
1.4.3 Gene-Environment Interactions
In considering gene-environment interactions, Kendler et al (1998c) 
considered two potential processes by which genetic and environmental 
factors impact on liability to depression. Firstly, the genetic control of 
sensitivity to the environment theory, suggests that genetic factors alter an 
individual’s sensitivity to the depressogenic effects of stressful life events, and 
therefore impact on liability to depression. Although few studies have 
examined this, Kendler et al (1995a) found supportive evidence in their study 
of female twin pairs from the Virginia Twin Registry. They found that an
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increased risk for major depression given a severe life event was about twice 
as high in those at high genetic risk, as in those at low genetic risk.
The second model proposed by Kendler et al (1998c) involved genetic control 
of exposure to the environment. According to this model, genes influence the 
probability that an individual will be exposed to a depressogenic environment. 
There have been more studies of this theory, and McGuffin et al (1988) found 
not only increased rates of depression among relatives of depressed 
probands, but also an increased reporting of life events. Other studies 
suggest that familial or genetic factors influence risk of exposure to severe life 
events (Kendler et al., 1993a, Breslau et al., 1991, Plomin et al., 1990, Lyons 
et al., 1993). A sibling pair study conducted by Farmer et al (2000) found 
significant correlations for sibling pairs only for life events that were shared by 
both members of the pair, for example, the death of a parent.
It is clear that for a complete understanding of the aetiology of affective 
disorders it will be necessary to understand the complex interplay between 
genetic and environmental factors. Table 1-1 provides a summary of family, 
twin and adoption studies with reference to findings in unipolar and bipolar 
disorder.
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Table 1-1: Key Features of Family, Adoption and Twin Studies with Reference to Findings in
Affective Disorders
Family Studies Adoption Studies Twin Studies
What does this study 
design aim to assess?
The degree of familial 
clustering of a disorder (in 
families or sibling pairs).
Resemblance in
a) genetically related 
individuals who do not 
share a common family 
environment (biological 
parents and adopted-away 
offspring)
and/or
b) individuals who are not 
genetically related but share 
the family environment 
(adoptive parents and 
adopted offspring)
The similarity of 
Monozygotic (MZ) twin pairs 
(who are genetically 
identical) compared to 
Dizygotic (DZ) twin pairs, 
(who share approximately 
50% of their genes).
How is a familial or 
genetic effect shown?
Familial aggregation is 
indicated by a significantly 
higher morbid risk (lifetime 
expectation) for the disorder 
in relatives of probands 
(index cases) than controls.
a) Increased similarity 
between biological parents 
and adopted-away offspring 
suggests a genetic effect.
b) Increased similarity 
between adoptive parents 
and adopted offspring 
implicates the contribution 
of family (shared) 
environment.
If genetic factors are 
important, MZ twins will be 
more similar pheno-typically 
than DZ twins.
Although it is usually easy 
to tell if twins pairs are MZ 
or DZ based on their 
physical similarities, DNA 
markers may be used to 
test the zygosity of twin 
pairs.
Can this study design 
distinguish between 
genetic and shared 
environmental effects?
No Yes Yes
To date, do these studies 
provide evidence for the 
influence of familial 
and/or genetic factors in 
contributing to 
susceptibility for affective 
disorders?
A large number of family 
studies have demonstrated 
the familial aggregation of 
bipolar disorder and of 
unipolar disorder.
The few studies of unipolar 
depression that have been 
conducted have provided 
inconsistent support for the 
influence of familial or 
genetic factors.
The two studies that have 
used current definitions of 
bipolar disorder are 
consistent with a role for 
genetic factors in 
susceptibility to bipolar 
disorder.
Several large scale studies 
have provided robust 
evidence for the 
involvement of genetic and 
shared environmental 
factors in influencing 
susceptibility to unipolar and 
to bipolar disorder.
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1.5 Molecular Genetic Studies and Affective Disorders
1.5.1 Molecular Genetic Studies and Bipolar Disorder 
Linkage Studies and Bipolar Disorder
Badner and Gershon (2002) examined seven published genome scans for 
bipolar disorder and concluded from their meta-analysis that the strongest 
evidence for susceptibility loci was on 13q and 22q. A more recent meta­
analysis by Segurado et al (2003) did not find genome-wide significant 
evidence for linkage but provided a more modest level of support for regions 
on chromosomes 9p, 10q, 14q, and 18. Several further genome-wide scans 
have since been published providing genome-wide significant or suggestive 
evidence for linkage. One of the best supported regions for bipolar disorder is 
the 6p21-q25 region which demonstrated genome wide significance in one 
study, (Middleton et al., 2004) and genome-wide suggestive signals in three 
further studies (Dick et al., 2003, Ewald et al., 2002, Lambert et al., 2005). 
This region achieved genome-wide significance in a recent combined analysis 
of eleven bipolar linkage scans (McQueen et al., 2005).
Two genome scans have reported genome-wide significance for the 12q23-24 
region (Ewald et al., 2002, Shink et al., 2005), which is also supported by 
linkage analysis in unipolar depression (McGuffin et al., 2005).
Candidate Gene Studies and Bipolar Disorder
Most candidate gene studies have focussed on neurotransmitter systems 
influenced by the medications that are used to treat mood disorders, 
particularly the dopamine, serotonin, and noradrenaline systems (reviewed by
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Craddock and Jones (2001)). For most genes studied there are one or few 
positive studies, but also a number of negative replications. However, meta­
analyses of polymorphisms of known functional relevance in three genes have 
shown significance at the p<0.05 level. These are monoamine oxidase A 
(MAOA), (Preisig et al., 2000), catechol-o-methyltransferase (COMT), (Jones 
and Craddock, 2001a) and the serotonin transporter (5HTT), (Anguelova et 
al., 2003, Lasky-Su et al., 2005).
Most of the reports in the literature are from modestly sized samples, which 
are likely to be underpowered for plausible effect sizes. Independent, large 
samples are required to determine whether these genes contribute to 
susceptibility to bipolar disorder.
Examination of candidate genes should be predicated on more sophisticated 
models of pathogenesis or directed by positional information from linkage 
studies. Recently, replicable positive findings have begun to emerge from 
such approaches.
For example, at least five independent datasets have contributed evidence 
that variation at the D-amino acid oxidase activator (DAOA) G30 locus on 
chromosome 13q influences susceptibility to bipolar disorder. (Hattori et al., 
2003, Chen et al., 2004, Schumacher et al., 2004, Williams et al., 2006). No 
pathologically relevant variant has yet been identified and the biological 
mechanism remains to be found.
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A gene on chromosome 11, brain derived neurotrophic factor (BDNF), has 
been associated with bipolar disorder in some reports (Sklar et al., 2002, 
Neves-Pereira et al., 2002, Geller et al., 2004), but not in others (Oswald et 
al., 2004, Skibinska et al., 2004, Hong et al., 2003, Nakata et al., 2003). 
However, Green et al (2006) found a significant association with bipolar 
disorder in a subset of cases that had experienced rapid cycling, (four or more 
episodes per year) at some time, and a similar association on reanalysis of a 
previously reported family based association sample. This suggests that the 
BDNF gene may not play a major role in influencing susceptibility to bipolar 
disorder as a whole but, in fact, may be associated with susceptibility to a 
specific aspect of the clinical bipolar phenotype. Again, further systematic 
study of variation across the whole gene is required in further independent 
samples.
Genome-wide association studies and Bipolar Disorder
The first genome-wide association study of bipolar disorder (WTCCC, 2007) 
has confirmed that there are many genes that influence susceptibility to the 
illness and that each gene makes a relatively small contribution to risk. The 
strongest signal for bipolar disorder was on chromosome 16 and there are 
several genes at the particular locus that could have pathological relevance. 
Other higher ranked signals in this study provide support for the previously 
suggested importance of GABA and glutamate neurotransmission, and 
synaptic function.
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1.5.2 Molecular Genetic Studies and Major Depressive Disorder 
Linkage Studies and Major Depressive Disorder
Compared with other major psychiatric illnesses, (for example schizophrenia 
and bipolar disorder) there have been relatively few genome scans of major 
depressive disorder as the main phenotype although, more recently, several 
large affected sibling-pair and case-control collections of DNA for recurrent 
major depression have become available for analysis and results of genome 
scans have recently been reported.
McGuffin et al (2005) conducted a whole genome linkage scan of recurrent 
depressive disorder with two regions showing genome-wide significant 
evidence for linkage; 12q23.3-24.11 and 13q31.1-q31.3. Chromosome 12q22- 
23 overlaps with a region previously implicated by linkage studies of unipolar 
and bipolar disorders (Abkevich et al., 2003) and contains a gene, D-amino 
acid oxidase (DAO) that has been associated with both bipolar disorder and 
schizophrenia. The 13q peak lies within a region previously linked strongly to 
panic disorder (Hamilton et al., 2003). A more modest peak was also found at 
15q within a region that showed genome wide significant evidence of a locus 
for recurrent depression in a previous sibling-pair study of depression 
(Holmans et al., 2004). More recently, in the second wave of the study by 
Holmans et al (2007), evidence for linkage was again observed on 
chromosome 15q, and also on 17p and 8p when sex was included as a 
covariate. These results suggest that multiple loci contribute to risk for major 
depression.
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A study by Zubenko and colleagues of recurrent early onset depression 
identified a surprisingly large number of linkage signals; the strongest signal 
was at 2q close to the gene encoding CREB1 (Zubenko et al., 2003). A theme 
that seems to be emerging from this and other linkage studies of unipolar 
disorder is a gender-specificity in linkage signals. For example, the 12q signal 
in the study of Abkevich and colleagues (2003) was present only in males; the 
2q signal of Zubenko and colleagues (2003) was present only in females. 
These findings await replication.
Linkage Studies, Major Depressive Disorder and Comorbidity
Linkage studies have also been undertaken in which the clinical phenotype 
has included unipolar depression as a major component, together with other 
comorbid (and putatively pathogenetically related) psychiatric phenotypes. 
Nurnberger et al (2001) observed a higher prevalence of depression in 
alcoholic than non alcoholic subjects in families multiply affected with 
alcoholism. Genome-wide sibling-pair linkage analysis suggested that a gene 
or genes on chromosome 1 may predispose some individuals to alcoholism 
and others to depression.
The co-occurrence of anxiety and depression is extremely common in clinical 
practice. Twin studies have suggested that pure anxiety may be genetically 
distinct from both major depression and major depression with anxiety 
(Torgersen, 1990).
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High premorbid neuroticism scores are a robust predictor of future onset of 
major depression (Kendler et al., 1993c, Kendler et al., 2004). Kendler 
estimated that 55% of the genetic risk of major depressive disorder was 
shared with neuroticism. There may be common genetic factors that can 
predispose to major depressive disorder, neuroticism and anxiety disorders. 
Camp et al (2005) studied recurrent, early onset major depressive disorders 
and anxiety disorders and found linkage evidence for a novel locus at 3p12.3- 
q12.3, and at 18q21.33-q22.2, a susceptibility locus previously reported for 
bipolar disorder.
Although there is some evidence for convergence of linkage findings across 
studies, substantially more data are needed to permit meta-analysis, which 
will be needed to give appropriate power.
Candidate Gene Studies and Major Depressive Disorder
To date, as with linkage studies, less attention has been given to genetic 
association studies of unipolar disorder than has been the case for bipolar 
disorder or schizophrenia. There are no unambiguous positive findings but the 
literature is developing rapidly. Given the expected smaller effect sizes and 
the possibility of greater clinical heterogeneity in unipolar disorder compared 
with bipolar disorder and schizophrenia, it can be expected that larger 
samples are likely to be required both for detection and replication of 
susceptibility loci.
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Perhaps the most interesting finding to emerge to date is the report of 
interaction between a functional variant at the serotonin transporter gene (5- 
HTTLPR) and the occurrence of stressful life events. Caspi et al (2003) found 
that individuals with one or more short alleles who were exposed to adult 
stressful life events were more likely to develop depression than those 
homozygous for the long allele.
They also found that childhood maltreatment predicted adult diagnosed 
depression among individuals carrying at least one copy of the short allele. 
There have been both positive (Kaufman et al., 2004, Kendler et al., 2005) 
and negative (Surtees et al., 2005, Gillespie et al., 2005) attempts at 
replication. It is widely assumed that gene-environment interactions and co­
action will occur in mood disorder and this finding may prove to be the first 
such example. However, the evidence that effect of stressful life events on 
depression is moderated by 5-HTTLPR genotype is far from robust.
Genome-wide association studies and Major Depressive Disorder
To date, there are no published genome-wide association studies of major 
depressive disorder, although such studies are under way.
1.6 Refining the Phenotype
1.6.1 General Aims and Outline of Thesis
Some of the difficulties in identifying susceptibility genes for affective 
disorders are likely to be related to the phenotypic properties of the illness. An
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interesting example can be seen in the literature on type 2 diabetes. FTO is a 
gene which has been shown to influence susceptibility for obesity and type 2 
diabetes. The gene was originally identified in genome-wide association 
studies of type 2 diabetes (for example, (WTCCC, 2007)) but did not show a 
signal in other genome-wide studies of type 2 diabetes which had controlled 
for body weight (i.e. individuals who were obese were excluded) (Zeggini, 
2007). This example illustrates how selection on phenotypic variables can 
greatly alter the findings of genetic studies.
In psychiatry, high rates of comorbidity and instability of diagnoses throughout 
the lifespan make for heterogeneous disorders. It is likely that, rather than 
reflecting homogeneous groups, diagnostic categories represent common 
final pathways of different pathophysiological processes (Charney et al., 
2002).
Recently, researchers have begun to focus on improving phenotype definition 
in studies investigating the aetiology of affective disorder with the aim of 
identifying more homogeneous disorders that may be more likely to share 
some common aetiological basis.
For many of the “sub-phenotypes” that showed evidence for familiality in 
affective disorders (mentioned previously in section 1.4), molecular genetic 
studies have been conducted which have provided support for the existence 
of genetic factors influencing susceptibility to the particular “sub-phenotype”. 
For example, early age at onset (Faraone et al., 2004), lithium
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responsiveness (Turecki et al., 2001), bipolar affective puerperal psychosis 
(Jones et al., 2007, Jones and Craddock, 2001b, Coyle et al., 2000), and 
occurrence of psychotic features (O'Mahony et al., 2002, Craddock et al., 
2004, Potash et al., 2003).
A number of “sub-phenotypes”, such as rapid cycling in bipolar disorder, have 
been found to be influenced by genetic factors (Kirov et al., 1998), despite 
previous studies failing to find any evidence of familial aggregation 
(Nurnberger et al., 1988, Lishetal., 1993).
Table 1-2: Summary of Chapter 1
1. The usefulness of current diagnostic classification systems is limited by unknown biological validity.
2. The influence of genetic and environmental risk factors on illness susceptibility can be assessed using family, 
twin and adoption studies.
3. Family, adoption and twin studies have provided robust evidence for the familiality and heritability of affective 
disorder.
4. Certain patient and illness characteristics may influence the familiality and heritability of affective disorders.
5. Men and women likely share most, but not all, genetic influences for affective disorder.
6. Molecular genetic studies, using linkage and association techniques, may identify specific genes and genetic 
regions that may influence susceptibility to affective disorders.
7. The literature on genetic studies and affective disorder is developing rapidly.
8. Studies to date are consistent with models of inheritance that include multiple genes that interact with each 
other and environmental factors to confer susceptibility to illness.
9. Both the improvement of phenotype definition and increased focus on sub-phenotypes may facilitate the 
identification of susceptibility genes.
10. A complete understanding of the aetiology of affective disorders will require an understanding of the complex 
interplay between genetic and environmental factors.
Table 1-2 provides a summary of the main points and findings from research 
into affective disorders that have been described in chapter 1.
The overall aim of this thesis is to refine phenotype definition in affective 
disorders through the identification of novel sub-phenotypes that may be 
biologically validated by future molecular genetic studies. This will involve the
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examination of various aspects of the phenotype in well defined and 
characterised samples of subjects with affective disorder diagnoses. The 
samples will be described in chapter 2.
Studies have suggested that episode polarity at illness onset in bipolar 
disorder is familial and may predict some aspects of illness course (Kassem 
et al., 2006). Chapter 3 will investigate whether episode polarity at illness 
onset in bipolar disorder may be a characteristic of the phenotype that may 
identify sub-groups of subjects who are distinct in terms of some aspects of 
lifetime clinical characteristics.
It is generally held that there are no clear differences in the clinical 
presentation of unipolar and bipolar depression. In chapter 4 ,1 will compare 
clinical course variables and depressive symptom profiles in samples of 
unipolar and bipolar subjects.
The Hypomania Check List (HCL-32) self-report questionnaire is a tool 
designed to screen for hypomanic components in patients with major 
depressive disorder. The main aim of chapter 5 is to assess the presence of 
hypomanic symptoms in a highly selected “unipolar” sample using the HCL- 
32.
Previous studies have illustrated the frequent co-morbidity of panic disorder 
and mood disorder. In chapter 6 ,1 will examine lifetime clinical characteristics
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of illness and the lifetime presence of recurrent panic attacks in both the 
unipolar and bipolar samples.
The presence of psychotic features may identify a sub-phenotype within 
unipolar disorder. In chapter 7 I will examine the relationship between the 
presence of psychotic features and the severity of depression, using both 
lifetime and episode severity measures, in the unipolar sample.
Strong evidence for the familial aggregation of episodes of postpartum 
(puerperal) psychosis in women with bipolar disorder has previously been 
reported (Jones and Craddock, 2001b). In chapter 8, I will examine whether 
vulnerability to the postpartum triggering of depressive episodes in unipolar 
depression aggregates in families and will assess how this aggregation varies 
with the definition of postpartum depression.
Occurrence of stressful life events is associated with the onset of major 
depressive episodes. In chapter 9 I will assess whether there may be a 
familial contribution to individual variation in susceptibility to precipitation of 
depression by life events.
The in depth phenotypic analyses involved in these studies of unipolar and 
bipolar disorders should enable the identification of distinct and shared 
features of the phenotype that may help to identify underlying disease 
processes that may be specific to the particular phenotypic sub-group, as well 
as disease processes that may be shared across the disorders. In chapter 10,
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I will provide a general summary and discuss the implications of these 
studies, as well as presenting recommendations for future work.
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Methodology
2.1 Summary
This chapter describes the recruitment and assessment procedures used to 
ascertain the samples studied throughout this thesis. The samples were 
recruited by the Mood Disorders Research Team at Cardiff University and The 
University of Birmingham. I was a member of the team in Birmingham prior to 
starting my postgraduate studies and a substantial proportion of the subjects 
that were recruited to the Depression Network (DeNT) sibling-pair study 
(described below) were recruited and interviewed by myself. I was also 
involved in diagnostic and clinical rating assessments of subjects (with a 
range of mood disorders).
Methodology and sample characteristics specific to individual analyses will be 
described at the relevant points in the appropriate chapters.
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2.2 Sample Recruitment
Subjects were recruited as part of ongoing molecular genetic and clinical 
studies of affective disorders using both systematic and non-systematic 
recruitment methods. Systematic recruitment involved the screening of 
Community Mental Health Teams and Lithium Clinics for patients with 
affective disorders. With the permission of the Responsible Medical Officer, all 
potentially suitable patients were invited to participate in the study. Non- 
systematic recruitment involved advertisements in local family practitioner 
offices, local media, and via patient support organisations (for example, the 
Manic Depressive Fellowship and Depression Alliance).
The study received all necessary Multi-Region and Local Ethical Approval 
(MREC and LREC).
2.2.1 Unipolar Samples
The multi-centre Depression Case Control Study (DeCC) recruited subjects 
with recurrent major depressive disorder from three sites (Birmingham, Cardiff 
and London, UK). This study was funded by the Medical Research Council 
(MRC). The principle investigators for the study were Professors Peter 
McGuffin, Anne Farmer, Michael Owen and Nick Craddock.
The international multi-centre Depression Network (DeNT) sibling-pair study 
recruited families multiply affected with recurrent major depression for a 
linkage genome screen (Farmer et al., 2004, McGuffin et al., 2005). The eight 
sites involved in the recruitment of these families were Aarhus, Denmark;
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Bonn, Germany; Dublin, Ireland; Lausanne, Switzerland; St Louis, USA; and 
Birmingham, Cardiff and London, UK. This study was funded by 
GlaxoSmithKline (GSK) research and development. The overall principle 
investigators for the study were Professors Peter McGuffin and Anne Farmer. 
The individual site principle investigators were Ole Mors (Aarhus), Marcella 
Rietschel and Wolfgang Maier (Bonn), Mike Gill (Dublin), Martin Preisig 
(Lausanne), Theodore Reich (St Louis), Nick Craddock, Lisa Jones and Ian 
Jones (Birmingham), Ania Korszun and Michael Owen (Cardiff), and Anne 
Farmer and Peter McGuffin (London).
Subjects recruited to the Depression Case Control (DeCC) Study and the 
Depression Network (DeNT) sibling-pair study at the Birmingham site form the 
unipolar sample described in this thesis. For studies where the analysis is not 
focused on sibling pairs, an algorithm was used to randomly select one 
member of each sibling pair recruited to the DeNT study, so that all individuals 
within the sample were unrelated.
Inclusion/ Exclusion Criteria
Subjects were included in the Depression Case Control Study (DeCC) study if 
they met the following criteria: i) met Diagnostic and Statistical Manual of 
Mental Disorders (4th edition) (DSM-IV) (APA, 2000) or the International 
Classification of Diseases, (10th edition) (IDC-10) (WHO, 1993) criteria for 
major recurrent depressive disorder (MDDR) of at least moderate severity; ii) 
were above 18 years of age; and iii) were of UK/ Eire white ethnicity (due to 
the fact that they were recruited for molecular genetic studies).
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Subjects were excluded if they: i) had ever had psychotic symptoms that were 
mood incongruent or were prominent at a time when there was no evidence of 
mood disturbance; ii) had a lifetime diagnosis of intravenous drug 
dependency; iii) had depression only as a result of alcohol or substance 
dependence, or secondary to medical illness or medication; or iv) had a first 
or second degree relative with a clear diagnosis of bipolar affective disorder or 
schizophrenia, schizotypal disorder, persistent delusional disorder, acute and 
transient psychotic disorders or schizoaffective disorder.
Subjects in the Depression Network (DeNT) sibling-pair study were required 
to meet the above inclusion and exclusion criteria. In addition, probands were 
required to have at least one full biological sibling also meeting all of the 
above inclusion criteria, who was not a monozygotic twin of the proband.
Assessment Procedure
After complete description of the study to the subjects, written informed 
consent was obtained. Subjects were interviewed using Schedules for Clinical 
Assessment in Neuropsychiatry (SCAN) (Wing et al., 1990). SCAN is a set of 
instruments aimed at assessing, measuring and classifying the 
psychopathology and behaviour associated with the major psychiatric 
disorders of adult life. It consists of a structured clinical interview schedule, 
glossary of differential definitions, Item Group Checklist (IGC) (not used in this 
study), and Clinical History Schedule (CHS) (also not used in this study).
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The SCAN has two main parts. Part 1 consists of the following non-psychotic 
sections: relating to physical health, worrying, tension, panic, anxiety and 
phobias, obsessional symptoms, depressed mood and ideation, impaired 
thinking, concentration, energy, interests, bodily functions, weight, sleep, 
eating disorders, alcohol and drug abuse, and a screen for psychotic 
symptoms. Part 2 consists of sections used to assess psychotic symptoms 
and cognitive disorders and part 3 allows the interviewer to record 
observations of any abnormalities in the respondent’s behaviour, speech, 
cognition or affect. Individual SCAN items can be rated for any two time 
frames.
Subjects were asked to identify their two worst ever episodes of depression 
and SCAN items were rated for the worst and second worst episodes of 
depression. Psychiatric and family practice case-notes were also reviewed. 
These data were combined to form a written case vignette. Based on this 
vignette, best-estimate lifetime diagnoses were made according to DSM-IV 
(APA, 2000) and ICD-10 (WHO, 1993). The vignettes were also used to rate 
the Global Assessment Scale (GAS) (Endicott et al., 1976) for the worst ever 
episode of depression; the Bipolar Affective Disorder Dimension Scale 
(BADDS) (Craddock et al., 2004) and other key clinical variables (such as age 
at onset and number of episodes of illness).
The GAS (see appendix A) is a rating scale for measuring the overall 
functioning of an individual during a specified time frame on a continuum from 
psychological or psychiatric illness to health. The scale values range from 1,
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which represents the hypothetically most unwell individual, to 100, the 
hypothetically healthiest.
The BADDS (see appendix B) comprises four dimensions that provide a 
quantitative measure (on a 0-100 scale) of lifetime experience of 
psychopathology in each of four domains (Mania, Depression, Psychosis, and 
Congruence of Psychosis). The Mania dimension is a measure of the 
frequency and severity of manic-like episodes, and the Depression dimension 
a measure of the severity and frequency of depressive-like episodes. Higher 
ratings on the scale indicate higher frequency and severity. The Psychosis 
dimension is a measure of the prominence of lifetime psychotic features. The 
scale takes into account both the number and duration of episodes with and 
without psychotic features. Higher ratings indicate an increased prominence 
of psychosis as a lifetime feature of the illness. The fourth dimension is an 
estimate as to how congruent psychotic features have been with mood state 
during episodes, with 0 representing complete congruence (i.e., psychotic 
symptoms are completely congruent with affective state and only occur during 
affective episodes) and 100 representing complete incongruence (i.e., 
psychotic symptoms predominate the illness and occur chronically outside, or 
in absence of, affective episodes).
The OPCRIT (Operational CRITeria) symptom checklist (McGuffin et al.,
1991, Craddock et al., 1996) (see appendix C) was used to rate the presence 
or absence of items of depressive, manic and psychotic symptomatology on a 
lifetime ever basis as well as for the worst episode of depression.
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Each subject was diagnosed, and had key clinical variables (see appendix D), 
GAS, BADDS and OPCRIT rated independently by at least two members of 
the research team and consensus was reached. Team members involved in 
the interview, rating and diagnostic procedures were either a fully trained 
research psychologist or psychiatrist. The research teams were supervised by 
Professor Nick Craddock, Dr Lisa Jones and Dr Ian Jones. Every two months 
all members of the research team (including myself) and supervisors (NC, LJ 
and IJ) would participate in a joint consensus reliability exercise where we 
would all diagnose and rate two cases and, as a group, come to a consensus 
for each case.
Inter-rater reliability was formally assessed using joint ratings of 20 cases with 
a range of mood disorder diagnoses. Mean overall kappa statistics of 0.85 
and 0.83 were obtained for DSM-IV and ICD10 diagnoses respectively. Mean 
kappa statistics and intraclass correlation coefficients (ICCs) for other key 
clinical variables ranged from 0.81-0.99, and 0.85-0.97 respectively (Jones et 
al., 2005).
The subjects completed a pack of self-rating questionnaires which, after the 
semi-structured interview, were left with them to complete. They were given 
written instructions to complete all of the questionnaires at the same time, 
within one week of receiving them, and to then return them in the stamped, 
addressed envelope provided. If the questionnaires were not returned after 
one month, a reminder letter was sent with another copy of the questionnaires
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and a return envelope. If the questionnaires were still not returned after a 
further two weeks, a reminder telephone call was made.
In order to obtain a measure of the subject’s current mood state, two of the 
questionnaires included in the pack were the Beck Depression Inventory (BDI) 
(Beck and Steer, 1987) (see appendix E) and Altman Self- Rating Mania 
Scale (ASRM) (Altman et al., 1997) (see appendix F). The BDI assesses the 
presence and severity of current depressive symptoms. It comprises 21 items 
scored from 0 (absent) to 3 (present to a severe degree). Total scores range 
from 0-63. The ASRM assesses the presence or absence and severity of 
current manic symptoms. It comprises five items scored from 0 (absent) to 4 
(present to a severe degree). Total scores range from 0 to 20.
AH clinical and demographic data collected was manually entered by 
members of the research team (including myself) into an access database 
(The Molecular Psychiatry Database MPDB).
2.2.2 Bipolar Samples
Subjects in the bipolar sample described in this thesis were recruited for 
molecular genetic association studies of bipolar disorder at The University of 
Birmingham and Cardiff University (although predominantly at the Birmingham 
site). This study was funded by the Wellcome Trust and the principle 
investigators were Professor Nick Craddock, Dr Lisa Jones and Dr Ian Jones.
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Subjects in the bipolar sample met Diagnostic and Statistical Manual of 
Mental Disorders (4th edition) (DSM-IV) (APA, 2000) and International 
Classification of Diseases (ICD-10) (WHO, 1993) criteria for bipolar I disorder 
(BPI)/ bipolar disorder (with mania). Participants were above 18 years of age 
and were of UK/ Eire white ethnicity.
Subjects who had a lifetime diagnosis of intravenous drug dependency or had 
mood episodes only as a result of alcohol or substance dependence, or 
secondary to medical illness or medication were not included in the sample.
The assessment procedure for the subjects in the bipolar sample was the 
same as for the unipolar sample, with the following exceptions: subjects with 
bipolar disorder were asked to identify their worst ever episode of mania 
instead of their second worst ever episode of depression; the OPCRIT was 
rated for the worst episode of mania (as well as the worst episode of 
depression and on a lifetime ever basis); the GAS was rated for the worst 
ever episode of mania (as well as the worst episode of depression).
Both the unipolar and bipolar samples were recruited and assessed using 
consistent methodology. The samples were well defined and comprehensively 
characterised.
The numbers of bipolar and unipolar subjects (sample sizes) may vary 
between individual studies. This is because the mood disorders research 
team are continuously recruiting subjects to participate in the studies and at
44
the time a particular piece of research was conducted, the greatest number of 
suitable subjects was selected to form the sample for that study.
2.3 Questionnaire Follow-up Assessment 
Samples
All subjects recruited to our study sites at Cardiff University and the University 
of Birmingham were sent a postal questionnaire pack in the summer of 2007. 
The median number of months between the initial research interview and the 
completion of the follow-up questionnaire pack was 49.
Measures
The questionnaire pack included, amongst other self-report questionnaires, 
the Hypomania Checklist (HCL-32) (Angst et al., 2005a) (see appendix G) 
and a questionnaire asking about panic attacks (see appendix H). The panic 
questionnaire included six questions relating to panic attacks and panic 
disorder, taken from the Patient Health Questionnaire (PHQ) (questions 2a to 
2e and question 3 of the PHQ) (Spitzer et al., 1999). The questionnaire pack 
also included the Beck Depression Inventory (BDI) (Beck and Steer, 1987) 
(appendix E) and the Altman Self-Rating Mania Scale (ASRM) (Altman et al., 
1997) (appendix F). The BDI and ASRM referred to in chapters 5 and 6 are 
the versions described here which were completed with the 2007 
questionnaire pack.
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Procedure
The Mood Disorders Research Team keeps in regular contact with study 
subjects through annual newsletters. The questionnaire pack was sent to all 
of the subjects in the unipolar and bipolar samples who were on the 
newsletter mailing list.
Instructions were sent along with the questionnaire to the subjects stating that 
they should i) complete the questionnaires as soon as possible, preferably 
within one week; ii) write the date of completion in the space provided at the 
front of the pack; iii) complete all the questionnaires at the same time and iv) 
return the questionnaires in the freepost envelope provided.
Subjects were also informed that they did not have to complete the 
questionnaires and that they could choose not to complete them without 
giving a reason. If subjects did not want to complete the questionnaires, they 
were asked to return the blank copies to the team so that records could be 
kept up to date.
The subjects who did not return the questionnaires were sent a reminder letter 
two weeks after the initial questionnaire pack was sent, and then again after a 
further two weeks.
The total numbers of bipolar (BPI) and unipolar (MDDR) subjects who were 
sent questionnaire packs, along with the response rates, are shown in Table 
2-1. The response rates for the bipolar (BPI) and unipolar (MDDR) samples 
were 57% and 48% respectively.
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Table 2-1: Questionnaire Response Rates in the Unipolar and Bipolar Samples
TOTAL NUMBER OF SUBJECTS WHO...
Unipolar 
(MDDR) Sample
Bipolar (BPI) 
Sample
Total 
Sample (MDDR 
& BPI)
...were sent a questionnaire pack 774 513 1287
...returned a completed questionnaire pack 373 (48%) 291 (57%) 664 (52%)
...did not return a completed questionnaire pack 401 (52%) 222 (43%) 623 (48%
The rate at which the questionnaires were returned can be seen in Figure 2-1. 
Twenty-two percent of the questionnaires were returned within the first week 
following the questionnaire mail-out and forty-two percent were returned 
during the second week. Thirty-five percent were returned between weeks 
three and ten following the mail-out. So, of the total number of completed 
questionnaires that were returned, ninety-nine percent were returned within 
ten weeks following the mail-out.
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Figure 2-1 : Number of Questionnaires Returned in Each Week Following the Mail-Out 
Nearly two-thirds of the completed questionnaires were returned within the first two weeks following the 
mail-out. By week ten, ninety-nine percent of the completed questionnaires had been returned.
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Data Capture
Formic fusion (Formic Ltd: Middlesex, UK) is a data capture system that 
includes four modules. The first module allows the user to design a 
questionnaire in a specific format suitable for scanning. Completed forms can 
then be scanned using the second module, where verification checks can also 
be made. The verification checks are based on the settings that were 
specified in the design module. The third module enables the user to view and 
export the data. The fourth module is for managing the system (i.e. deleting 
files, specifying users).
The questionnaires were designed, scanned and validated by myself using 
the formic system. The data were then exported into SPSS for statistical 
analyses. Data integrity was assessed by checking that the data in the SPSS 
file matched the hard copy of the questionnaire for a sub-sample of 
participants. From a file sorted in order of the date that the questionnaires 
were returned, every twentieth participant was selected (for example, the 
twentieth, fortieth, sixtieth, and so on) until there were thirty participants 
included in the sub-sample. For these thirty participants, there were no 
discrepancies in the data.
The studies described in chapters 5 and 6 include analyses based on the data 
collected from the follow-up questionnaire assessment. Figure 2-2 illustrates 
the derivation of the samples that are used for each chapter in this thesis.
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Depression 
Case Control 
Study (DeCC)Ab
Sub- Unipolar Sample
Depression 
Network Study 
(DeNT) Aa
Sub- Bipolar Sample
Bipolar
Association
Study
Follow-up Questionnaire Pack
Systematic
Recruitment
(via Community Mental 
Health Teams)
Unipolar Sample
(subjects with a DSM-IV 
diagnosis of recurrent 
major depression)A
Non-Systematic
Recruitment
(via advertisements)
Bipolar Sample
(subjects with a DSM-IV 
diagnosis of bipolar 
disorder) B
A Chapter 7; Aa Chapters 8 & 9; B Chapter 3; A + 8 Chapter 4; c + D Chapters 5 & 6
Figure 2-2: Recruitment diagram to illustrate the derivation of the samples used for each chapter 
of the thesis.
The main samples A + B were collected and assessed as part of ongoing molecular genetic studies of affective 
disorders. All of the subjects in these samples were sent a follow-up questionnaire pack in the summer of 2007  
which was completed and returned to the research team by just over half of the subjects. These subjects formed 
the second set of samples c + D.
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Statistical Analysis
Methods of statistical analysis are described in individual chapters. All 
analyses were performed using SPSS version 12 unless stated otherwise. As 
the continuous data were not normally distributed, medians, interquartile 
ranges, and ranges are reported and non-parametric tests are used 
throughout the thesis. Histograms showing the distributions of scores in the 
unipolar and bipolar samples for the scales and questionnaires used 
throughout the thesis can be found in appendix J.
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3 Polarity at Illness Onset in Bipolar I Disorder and
Clinical Course of Illness
Reported by Forty et al (2009b)
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3.1 Summary
Studies have suggested that episode polarity at illness onset in bipolar 
disorder may be predictive of some aspects of lifetime clinical characteristics. 
Here I examine this possibility in a large, well characterized, sample of 
subjects with bipolar I disorder.
I assessed polarity at onset in subjects with bipolar I disorder (N=553) 
recruited as part of ongoing studies of affective disorders. Lifetime clinical 
characteristics of illness were compared in subjects who had a depressive 
episode at first illness onset (N=343) and subjects who had a manic episode 
at first illness onset (N=210).
Several lifetime clinical features differed between subjects according to the 
polarity of their onset episode of illness. A logistic regression analysis showed 
that the lifetime clinical features significantly associated with a depressive 
episode at illness onset in this sample were: an earlier age at illness onset; a 
predominantly depressive polarity during the lifetime; more frequent and more 
severe depressive episodes; and less prominent lifetime psychotic features.
Knowledge of pole of onset may help the clinician in providing prognostic 
information and management advice to an individual with bipolar disorder and 
may also be useful in genetic studies of phenotypically refined sub-groups.
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3.2 Introduction
Bipolar disorders are heterogeneous and the identification of more 
homogeneous sub-groups of patients/ subjects has the potential to facilitate 
more targeted clinical advice and interventions, as well as being useful in 
studies investigating the aetiology of affective disorders. One clinical feature 
that may identify such sub-groups is the type of episode, depressive or manic, 
that occurs first in the bipolar illness. This “polarity at onset” has been shown 
to be familial (Kassem et al., 2006) and to distinguish groups of bipolar 
individuals who differ in lifetime clinical features of illness (Kassem et al.,
2006, Perlis et al., 2005, Perugi et al., 2000, Daban et al., 2006).
The aim of the present study was to examine lifetime clinical course 
characteristics in a large sample of subjects with bipolar I disorder according 
to the episode polarity at illness onset. I have examined a large, well 
characterized sample of unrelated subjects with narrowly defined bipolar I 
disorder recruited within the UK. Unlike previous studies I have also examined 
measures of episode severity and frequency using the Bipolar Affective 
Disorders Dimension Scales (BADDS) (Craddock et al., 2004). These scales 
were developed by our group as an adjunct to conventional categorical 
diagnosis in order to provide a richer characterization of the individual’s 
lifetime experience of illness (Craddock and Owen, 2007, Peralta and Cuesta, 
2007) and we have found them useful in our research (Macgregor et al., 2006, 
Green et al., 2005, O'Mahony et al., 2002, Raybould et al., 2005).
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Based on the findings of previous studies (Daban et al., 2006, Kassem et al., 
2006, Perlis et al., 2005, Perugi et al., 2000), I hypothesised that patients 
whose onset episode of illness was depression would have a predominantly 
depressive course of illness and that there may be differences between 
manic-onset and depressive-onset patients in clinical characteristics such as 
age at onset, predominant pole of illness, rapid cycling and lifetime 
experience of psychosis.
3.3 Method
3.3.1 Subjects
For further methodological details, see chapter 2. Of 553 suitable subjects 
with bipolar I disorder, 210 (38%) were included in the manic onset group 
(predominant polarity coded as “1”) and 343 (62%) were included in the 
depressive onset group (predominant polarity coded as “0”). There were 173 
subjects for whom I could not clearly establish the polarity of the onset 
episode of illness. These individuals were not included in this study.
3.3.2 Assessment
Polarity of the onset episode (first ever episode of mood illness) was 
determined by comparing the reported age at onset for the first ever major 
depressive episode and the first ever manic episode (episodes displaying 
predominantly manic features, including mixed episodes and hypomanic 
episodes). Where subjects reported the same age at onset for both episode 
poles, vignettes were examined to establish which pole occurred first. Only
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subjects for whom the polarity of the onset episode could clearly be 
established were included in the analyses (N=553).
3.3.3 Statistical Analysis
As the continuous data were not normally distributed, medians, interquartile 
ranges, and ranges are reported. The demographic and lifetime clinical 
characteristics of the two groups were compared using chi-square tests for 
categorical data and the Mann-Whitney test for continuous data.
Binary logistic regression using forward stepwise likelihood ratio for variable 
selection was performed to assess which variables were most associated with 
the polarity of the onset episode of illness. Odds ratios of greater than 1 
indicate that a higher score is associated with greater likelihood of a manic 
episode at illness onset; whereas odds ratios of less than 1 indicate that a 
higher score is associated with a greater likelihood of a depressive episode at 
illness onset.
3.4 Results
There was no statistically significant difference between the two groups for 
age at interview or method of recruitment. There were significantly less males 
(28.3%) in the depression onset group compared to the mania onset group 
(37.6%) (p=0.022). The mean illness duration for the depressive onset group 
(22 years) was significantly longer than for the mania onset group (15 years)
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(p<0.001). Family history of affective disorder was not significantly different 
between the two groups.
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Figure 3-1: Number of Episodes of Depression and Number of Episodes of Mania According to 
the Polarity of the Onset Episode of Illness in Subjects with a Diagnosis of Bipolar I Disorder 
This figure illustrates how subjects whose onset episode was depression reported more depressive 
episodes during their lifetime, and less manic episodes (blue regression line), when compared to 
subjects whose onset episode was mania (green regression line).
Table 3-1 shows the clinical characteristics that differed significantly between 
the two groups. Subjects in the depression onset group experienced 
significantly more illness episodes (p= 0.031), more depressive episodes 
(p<0.001), and less manic episodes (p=0.004) when compared to the mania 
onset group (see Figure 3-1). The lifetime predominant polarity of episodes of
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illness experienced by the depressive onset group was depression (57.7% of 
episodes), whereas for the mania onset group the lifetime predominant 
polarity was mania (57.1% of episodes). Subjects in the depressive onset 
group had a significantly longer duration of the longest ever depressive 
episode (p<0.001) compared to subjects in the mania onset group, whereas 
there was no significant difference in the mean duration of the longest ever 
manic episode between the two groups.
Table 3-1: Lifetime Clinical Characteristics (N=553) that Differed Significantly Between Subjects 
According to the Polarity of the Onset (First Ever) Episode of Illness in Subjects with a Diagnosis
of Bipolar I Disorder
Clinical Characteristic Onset Episode 
Mania
210(38%)
Onset Episode 
Depression
343 (62%)
p-value
Gender
Male 79 (37.6%) 97 (28.3%) 0.022
Female 131 (62.4%) 246 (71.7%)
Illness Duration (years)
Median 15 22 <0.001
Interquartile Range 16 18
Range 1-57 1-54
Number of Episodes of
Depression Median 3 5 <0.001
Interquartile Range 5 6
Range 1-50 1-70
Number of Episodes of
Mania Median 5 4 0.004
Interquartile Range 5 4
Range 1-75 1-100
Total Number of Episodes
Median 9 9.2 0.031
Interquartile Range 9.15 8.9
Range 2-125 2-110.2
Predominant Polarity of
Episodes Mania 120 (57.1%) 95 (27.9%) <0.001
Depression 42 (20%) 196 (57.7%)
Equal 48 (22.9%) 49 (14.4%)
Longest Episode of
Depression (weeks) Median 14 26 <0.001
Interquartile Range 19 40
Range 1-156 2-416
Age at First Episode of Mood
Illness (mania or depression) Median 25 21 <0.001
(years) Interquartile Range 12 11
Range 7-64 10-59
Age at First Episode of
Depression (years) Median 29 21 <0.001
Interquartile Range 13 11
Range 16-65 10-59
Age at First Episode of
Mania (years) Median 25 30 <0.001
Interquartile Range 12 16
Range 7-64 13-64
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Table 3-1 Continued
Clinical Characteristic Onset Episode Onset Episode p-value
Mania Depression
210(38%) 343 (62%)
Suicide Attempt
Absent 141 (73.1%) 170 (53.5%) <0.001
Present 52 (26.9%) 148 (46.5%)
Rapid Cycling
(4 or more episodes in a year) Present 26 (17.7%) 65 (28.5%) 0.017
Absent 121 (82.3%) 163 (71.5%)
GAS
Worst Depression Median 39 35 <0.001
Interquartile Range 18 10
Range 12-71 10-59
Worst Mania Median 25 28 <0.001
Interquartile Range 10 15
Range 8-51 9-68
BADDS
Depression Median 61 66 <0.001
Interquartile Range 16 20
Range 40-95 40-97
Mania Median 82 81 <0.001
Interquartile Range 7 19
Range 60-100 60-100
Psychosis Median 27 22 <0.001
Interquartile Range 32 32
Range 0-100 0-100
GAS: Global Assessment Scale
BADDS: Bipolar Affective Disorder Dimension RatingJJcale
Comparisons of dichotomous items were analysed using chi-square tests and the Mann-Whitney test
was applied to continuous data. N values may vary due to missing data.
As can be seen in Table 3-1, the mean age at illness onset (age at first mood 
episode) and age at onset of depression for subjects in the depression onset 
group was significantly lower (both p<0.001), and the age at onset of mania 
higher (p<0.001), compared to the mania onset group. There were no 
significant differences between the two groups in the age at first contact with 
psychiatric services or in the number of psychiatric admissions. There was 
significantly more suicidal behaviour in the depressive onset group (p<0.001) 
and more rapid cycling (4 or more episodes in a year) (p=0.017) when 
compared to the mania onset group.
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Subjects in the depressive onset group were significantly less functionally 
impaired according to the GAS during their worst ever manic episode 
(p<0.001), but more impaired during their worst ever depressive episode 
(p<0.001), than subjects in the mania onset group. Similarly, subjects in the 
depressive onset group scored significantly higher on the BADDS Depression 
dimension (p<0.001), but lower on the BADDS Mania dimension (p<0.001), 
reflecting the increased occurrence and severity of depressive episodes, and 
the decreased occurrence and severity of manic episodes in the depressive 
onset group, when compared to the mania onset group (see Table 3-1).
When comparing the presence of psychotic features in the two groups as a 
categorical variable (present or absent on a lifetime ever basis) there was no 
statistically significant difference. However, significantly lower scores on the 
BADDS Psychosis dimension for the depression onset group (p<0.001) reflect 
a lower prominence of psychotic features in episodes of illness during the 
lifetime of subjects in the depression onset group compared to subjects in the 
mania onset group.
Logistic regression was carried out to determine which combination of lifetime 
clinical features was best associated with the polarity of the onset episode of 
illness. Variables that were significant at the p<0.05 level in the univariate 
comparisons were entered into the regression, including gender and illness 
duration. The significant variables in the best fitting model were: predominant 
polarity (OR=4.4, 95% Cl 2.3-8.4), age at onset of illness (OR=1.06, 95% Cl
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1.03-1.09), BADDS Depression (OR=0.96, 95% Cl 0.94-0.98) and BADDS 
Psychosis (OR=1.026, 95% Cl 1.01-1.04).
3.5 Discussion
This study provides supporting evidence for significant differences in the 
clinical features of subjects with bipolar I disorder according to the polarity of 
their onset episode of illness. Consistent with the hypothesis, several 
measures indicating a more “depressive” lifetime course were significantly 
more common in those whose illness started with a depressive episode. Thus, 
in agreement with previous studies I found that a depressive onset was 
associated with a greater number of depressive episodes (Daban et al., 2006, 
Perlis et al., 2005, Perugi et al., 2000), an increased risk of suicide attempt 
during the lifetime (Perugi et al., 2000, Daban et al., 2006, Perlis et al., 2005) 
and more rapid cycling (four or more episodes in a year) (Perugi et al., 2000) 
compared to subjects with an onset episode of mania.
Previous studies examining clinical characteristics in relation to polarity at 
onset have not included measures of functional impairment in episodes of 
depression or mania. In addition to assessing the frequency of depressive 
episodes, as has been done in previous studies, the use of the Bipolar 
Affective Disorder Dimension Scale (BADDS) (Craddock et al., 2004) and the 
Global Assessment Scale (GAS) (Endicott et al., 1976) also enabled me to 
take into account the severity of episodes. I found more severe impairment in 
functioning during the worst ever episode of depression in subjects whose 
onset episode was depression, compared to those whose onset episode was
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mania. Similarly, I found that subjects whose onset episode was mania 
experienced more severe impairment in functioning during their worst ever 
manic episode compared to subjects with an onset episode of depression.
Some previous studies have suggested that there is no difference in the 
presence of psychotic features according to the polarity of the onset episode 
of illness (Perlis et al., 2005, Kassem et al., 2006), although others have 
found that subjects with a depressive episode at illness onset are less likely to 
experience psychosis during their life course (Daban et al., 2006, Perugi et 
al., 2000). When I compared the definite presence or absence of lifetime 
psychotic features as a binary variable in this sample I found no difference 
between those with depressive and those with manic poles of onset. This lack 
of difference is consistent with two of four previous studies (Kassem et al., 
2006, Perlis et al., 2005). However, using the BADDS Psychosis scale I found 
that the lifetime prominence of psychotic features during mood episodes is 
significantly greater in subjects who experienced a manic episode at illness 
onset compared to those who experienced a depressive episode at onset.
This is consistent with the other two of four previous studies (Daban et al., 
2006, Perugi et al., 2000). So, although there is no difference between the 
mania onset and depression onset groups in terms of presence or absence of 
lifetime psychotic features, there is a difference in the predominance of 
lifetime psychotic features between the two groups. This illustrates the 
importance of a more detailed consideration of clinical features beyond a 
simple “presence/ absence” dichotomy.
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The finding of the current study that a depressive onset is more common in 
females contrasts with Kassem et al (2006) but is in agreement with Perlis et 
al (2005). The finding of depressive onset being associated with an earlier 
age at onset is consistent with two previous studies (Kassem et al., 2006, 
Perlis et al., 2005).
These findings are of potential clinical importance. Once a patient has 
experienced his/ her first manic episode, the clinician can use knowledge of 
polarity of the illness onset as an indicator of the likely predominant pole of 
illness. This may be helpful in providing information and advice to the patient. 
This applies to the situation where a patient has experienced their first manic 
episode and, hence, a diagnosis of bipolar disorder can be made. It is of note 
that studies have suggested that there are differences in the clinical 
characteristics of depressive episodes in subjects with unipolar and bipolar 
disorder (Forty et al., 2008, Bowden, 2005, Mitchell et al., 1992) and this will 
be investigated further in chapter 4. Such differences could potentially be of 
use in predicting the risk of bipolar disorder in patients who experience a 
depressive episode without having experienced a prior manic episode.
Strengths of this study include a large, well characterized sample and the use 
of measures of episode frequency, severity and impairment. None-the-less, a 
number of limitations should be considered when interpreting these findings. 
First, retrospective assessment measures were used to obtain clinical course 
information and to establish the polarity of the onset episode of illness. 
However, I found good agreement between the information obtained from
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subjects during the in depth semi-structured interviews and the information 
obtained from the case note reviews. Another limitation relating to the 
retrospective nature of this study was that I was unable to assess the effects 
of medication on illness course. It is possible that there may have been 
differences in treatment regimes between the two groups that could potentially 
impact on illness course/ severity.
I focused my analyses on a narrowly defined sample of subjects with bipolar I 
disorder and, hence, these findings relate to this group of bipolar subjects. It 
will be important for future studies to also examine polarity at onset in subjects 
with bipolar II disorder in order to establish the generalizability of these 
findings across the bipolar spectrum.
This study focused on the first clinically significant mood episodes. Some 
individuals in the mania onset group may have experienced sub-clinical 
depressive symptoms prior to the first clinically significant episode. It is 
possible that these subjects may represent a clinically significant subgroup, 
however assessing this was beyond the scope of this study.
In summary, I found, in agreement with previous studies, that the polarity of 
the first episode of illness in bipolar disorder is depressive for at least two 
thirds of individuals (Judd et al., 2003, Perugi et al., 2000, Daban et al., 2006). 
This study also found that subjects with a depressive pole of onset tend to 
have a course of illness characterised by more frequent depressive episodes 
and more lifetime depressive morbidity. The increase in severity of depressive
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episodes and the associated impairment in functioning in subjects with an 
onset episode of depression illustrate a need for treatment regimes more 
targeted at preventing and reducing the burden associated with depressive 
episodes in individuals for whom depressive episodes are associated with 
greater morbidity. Similarly, the findings regarding increased severity and 
associated impairment during manic episodes in subjects with a manic 
episode at onset, point to the need for improved prevention and treatment 
regimes in order to reduce the burden of manic episodes in individuals for 
whom these episodes result in the greatest impairment. The division of 
patients/ subjects with bipolar I disorder according to polarity at onset and 
predominant polarity during illness course (i.e., “depression prone” and “manic 
prone” sub types) may not only have implications in clinical practice, but may 
also provide more homogenous sub groups of subjects for the purpose of 
research.
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4 Clinical Differences Between Bipolar and Unipolar
Depression
Reported by Forty et al (2008)
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4.1 Summary
It is commonly, but wrongly, assumed that there are no important differences 
in the clinical presentation of unipolar and bipolar depression.
Here I compare clinical course variables and depressive symptom profiles in a 
large sample of subjects with a diagnosis of recurrent major depressive 
disorder (MDDR) (N=593) or bipolar I disorder (BPI) (N=443).
Clinical characteristics associated with a bipolar course included the presence 
of psychosis; diurnal mood variation and hypersomnia during depressive 
episodes; and a greater number of shorter depressive episodes.
Such features should alert a clinician to a possible bipolar course. This is 
important because optimal management varies between bipolar and unipolar 
depression. These features may identify useful sub-groups of subjects for the 
purposes of molecular genetic studies focusing on more refined phenotypes.
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4.2 Introduction
Distinguishing between unipolar and bipolar depression is an important issue 
because there are differences in optimal management. Antidepressant 
treatment of bipolar depression can adversely affect long-term prognosis by 
causing destabilisation of mood, more frequent depressive episodes and can 
lead to the development of treatment resistance (Sharma et al., 2005). Most 
bipolar patients experience depression rather than mania as their first episode 
of illness. It is clinically desirable to recognise, or at least have a high degree 
of suspicion of, bipolar depression at an early stage of a bipolar illness.
If depressive episodes occurring in unipolar and bipolar disorders do have 
distinctive clinical characteristics it is possible that these reflect at least 
partially distinct, underlying, biological processes. The identification of factors 
that distinguish bipolar and unipolar depression, as well as factors that appear 
to be common to both forms of illness, is therefore of both clinical and 
theoretical importance.
Here, I compare clinical course and depressive symptomatology in unipolar 
and bipolar depression by analysing phenotypic data in the unipolar and 
bipolar samples.
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4.3 Method
4.3.1 Subjects
For further methodological details, see chapter 2. The sample comprised 443 
subjects with a diagnosis of bipolar I disorder (BPI) and 593 subjects with a 
diagnosis of recurrent major depressive disorder (MDDR).
4.3.2 Assessment
Assessment procedures are described in chapter 2.
4.3.3 Statistical Analysis
The demographic and lifetime clinical characteristics of the two groups were 
compared using chi-square tests for categorical data and the Mann-Whitney 
test for non-parametric continuous data.
Binary logistic regression using forward stepwise likelihood ratio for variable 
selection was performed to examine which variables relating to depression 
significantly predicted BPI versus MDDR classification.
4.4 Results
The proportions of females in the MDDR group and the BPI group were 
70.2% and 71.3% respectively (p=0.68). The median age at interview was 49 
for the MDDR group, and 46.5 for the BPI group (p=0.31). Forty-six percent of 
the MDDR group were recruited systematically, compared to 37% of the BPI
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group (p=0.004). The median illness duration was 19 years for the MDDR 
group and 20 years for the BPI group (p=0.48). The MDDR group had a 
median BDI score at interview of 16, compared to a median BDI score of 8 in 
the BPI group (p<0.001).
Forward step-wise logistic regression was used to establish the best 
depression-related predictors of bipolar versus unipolar group membership.
All lifetime variables relating to depressive episodes that were significant at 
the p<0.1 significance level in univariate analyses comparing bipolar and 
unipolar groups were entered into the regression. To control for sample 
differences in recruitment and current mental state, BDI score at interview and 
method of recruitment were included in the regression. Gender was also 
included in the logistic regression analysis.
Significant predictors of diagnosis in the logistic regression model are shown 
in Table 4-1.
Table 4-1: Lifetime Clinical Characteristics Predicting Bipolar (BPI) Versus Unipolar (MDDR)
Group Membership (N=1036)
Clinical
Characteristic
Unipolar 
Group 
593 (57%)
Bipolar 
Group 
443 (43%)
Odds
Ratio
95%
Confidence
Interval
p-value
Psychotic
Features
During
Depression
Present
Absent
61 (10.5%) 
522 (89.5%)
134 (30.2%) 
309 (69.8%)
0.160 0.080-0.318 < 0.001
No. of Episodes 
of Depression Median 
Interquartile Range 
Range
4
2
2-40
5
6 
1-70
0.932 0.886-0.980 0.006
Longest Episode 
of Depression 
(weeks)
Median 
Interquartile Range 
Range
69
60
8-624
26
29
2-416
1.011 1.006-1.016 < 0.001
Diurnal Mood 
Variation Present
Absent
285 (50.4%) 
281 (49.6%)
219(59%) 
152 (41%)
0.536 0.305-0.942 0.030
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Table 4-1 Continued
Clinical
Characteristic
Unipolar 
Group 
593 (57%)
Bipolar 
Group 
443 (43%)
Odds
Ratio
95%
Confidence
Interval
p-value
Excessive Self- 
Reproach Present
Absent
550 (96.2%) 
22 (3.8%)
342 (87.7%) 
48 (12.3%)
6.272 2.335-16.847 < 0.001
Loss of Energy
Present
Absent
584 (99.2%) 
5 (0.8%)
386 (95.5%) 
18(4.5%)
6.031 1.003-36.266 0.050
Hypersomnia
Present
Absent
120 (21.5%) 
437 (78.5%)
148 (42.8%) 
198 (57.2%)
0.371 0.205-0.671 < 0.001
Diminished
Libido Present
Absent
231 (63.5%) 
133 (36.5%)
123 (34.8%) 
230 (65.2%)
7.537 4.135-13.738 < 0.001
The odds ratios shown are from a logistic regression analysis predicting bipolar or unipolar group 
membership according to lifetime clinical characteristics.
With the coding used, odds ratios of greater than 1 indicate that a higher score is associated with 
greater likelihood of unipolar group membership whereas odds ratios of less than 1 indicate that a 
higher score is associated with a greater likelihood of bipolar group membership.
N values may vary due to missing/ unclear data.
4.5 Discussion
Although there were, of course, similarities between unipolar and bipolar 
depression, I also found important clinical differences: characteristics that best 
predicted bipolar over unipolar depression were the presence of psychosis, 
diurnal mood variation and hypersomnia during depressive episodes, a 
greater number of depressive episodes and a shorter duration of the longest 
depressive episode. Unipolar subjects were characterised by the presence of 
excessive self-reproach, loss of energy and diminished libido during 
depressive episodes.
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These results are consistent with, and extend the findings of, previous studies 
that have shown “atypical” depressive features (such as hypersomnia and 
weight gain) may be more common in bipolar than in unipolar depression 
(Bowden, 2005, Swann et al., 2005, Mitchell et al., 2001). Compared to 
previous studies, this study has several advantages, including the very large 
number of subjects involved and the high degree of consistent and 
comprehensive clinical data collected.
Distinguishing between bipolar and unipolar depression is of great clinical 
importance as optimal management is very different. For example, 
antidepressants should be used with caution in bipolar depression because of 
the risk of precipitating mood switches, cycling or mixed or agitated states 
(NICE, 2006a). It is desirable that clinicians use all available information to 
guide management (including choice of treatment, advice to patient and 
intensity of monitoring). The clinical features of depression are not, of course, 
a definitive guide to diagnosis but can help alert the clinician to a possible 
bipolar course.
The finding of differences, as well as similarities, in clinical features of 
depression between groups of bipolar and unipolar subjects suggests the 
presence of both distinct (at least partially) as well as shared underlying 
disease processes. This is in keeping with a recent twin study analysis using 
bivariate structural equation modelling suggesting both genetic overlap and 
qualitative distinctions between the two syndromes (McGuffin et al., 2003).
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These findings also have important implications for future research on bipolar 
II disorder and sub-threshold bipolar disorders. Current evidence suggests 
that between 25% and 50% of all patients with recurrent unipolar depression 
(and particularly those within atypical, early-onset or treatment-refractory sub­
groups) may in fact suffer from a broadly-defined bipolar disorder (Angst, 
2007). Currently, very little is known about how best to treat these broadly- 
defined bipolar patients. Future studies in this field will need to move beyond 
strict diagnostic categories and examine sub-groups of subjects defined by 
extended phenotypic measures such as dimensional assessments of bipolar 
features, bipolar symptom clusters and longitudinal illness course variables 
(Smith et al., 2008).
An important limitation of the current study is that there may be differences 
between the unipolar and bipolar samples that I have not been able to 
examine, for example, subtle differences in treatment regimes or patterns of 
comorbid illness. It is of note that although the proportion of females in the 
unipolar sample is typical of studies of this nature, the proportion of females in 
the bipolar sample is higher than is typically reported (nearly three quarters 
compared to 50%) and this may limit the generalisability of the findings. A 
further limitation was the use of retrospective rather than prospective 
assessments, even though in-depth semi-structured clinical interviews were 
used, supplemented by a case note review. Prospective ratings of symptoms 
are obviously preferable but can be prohibitively expensive.
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The key message from this study is that it is not appropriate or sensible to 
assume that membership of an operational diagnostic category adequately 
defines homogenous sets of individuals for the purposes of aetiological 
research or clinical management. It is essential to take account of both the 
overlapping elements as well as the distinct elements of illness seen in 
diagnostically defined groups.
In summary, these findings support and add substantially to evidence that 
there are differences between the depressive symptomatology and illness 
course of bipolar and unipolar mood disorders. Clinical factors such as the 
occurrence of psychosis, hypersomnia, diurnal mood variation and frequent 
episodes should lead clinicians to a high index of suspicion for a bipolar, 
rather than unipolar, depressive illness.
The implication for research aimed at studying the biology and psychology of 
depression is that more attention should be paid to describing the clinical 
characteristics of research samples and undertaking analyses that take 
account of clinical characteristics.
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5 Identifying Hypomanic Features in Major 
Depressive Disorder using the Hypomania 
Checklist (HCL-32)
Reported by Forty et al (2009c)
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5.1 Summary
Recent studies have challenged the traditional unipolar/ bipolar divide with 
increasing support for a more dimensional view of affective disorders.
Here I examine the occurrence of hypomanic symptoms in subjects with a 
history of major depression selected to exclude indicators of underlying 
bipolarity.
The presence of hypomanic symptoms was assessed by the Hypomania 
Checklist (HCL-32) self-report questionnaire in a sample of almost 600 
subjects meeting DSM-IV criteria for bipolar I disorder (BPI N=260) or 
recurrent major depressive disorder (MDDR N=322). Subjects were recruited 
and assessed using consistent, robust methodology.
I found that a score of 20 or more on the HCL-32 yielded the best combination 
of sensitivity (65%) and specificity (83%) to distinguish between BPI and 
MDDR. Within this highly selected and well defined MDDR sample (for which 
exclusion criteria included personal or family histories of bipolar or psychotic 
illness), 17% of MDDR subjects scored over the threshold of 20 on the HCL- 
32.
The HCL-32 identified a substantial number of subjects meeting DSMIV 
criteria for recurrent major depression (even when selected to exclude 
personal and family histories of bipolar illness) who reported bipolar 
symptoms at a level similar to that reported by subjects meeting diagnostic
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criteria for bipolar disorder. This demonstrates the limitations of using DSM-IV 
criteria to distinguish those with and without bipolar features of illness.
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5.2 Introduction
Kraepelin’s description of manic depressive illness included syndromes 
featuring both mania and depression, as well as recurrent depression alone 
(Kraepelin, 1921). Modern diagnostic systems take into account the chronicity 
of the disorder and classify affective disorders as either unipolar or bipolar in 
nature, a distinction introduced into modern psychiatry by Leonhard (1959). 
Recent thinking has begun to question the categorical splitting of mood 
disorders into bipolar and unipolar disorders and there is increasing support 
for a more dimensional view of affective disorders (Akiskal, 2003, Angst et al., 
2003, Cassano et al., 2004, Ghaemi et al., 2002, Angst, 2007).
The Hypomania Check List (HCL-32) self-report questionnaire is a tool 
designed to screen for hypomanic components in patients with Major 
Depressive Disorder (MDD) (Angst et al., 2005a). It has been used in different 
countries and languages (Meyer et al., 2007, Wu et al., 2008, Vieta et al., 
2007). In a study of Italian and Swedish subjects with bipolar I (BPI, N=102) 
or bipolar II disorder (BPII, ISM64) or MDD (N=160), Angst et al (2005a) 
found that a cut off score of 14 or more on the HCL-32 yielded the best 
combination of sensitivity (true bipolars) (80%) and specificity (true non- 
bipolars) (51%) to distinguish between bipolar disorder (BP) and MDD. They 
concluded that the HCL-32 is a sensitive instrument for distinguishing 
between BP and MDD, although it does not distinguish between BPI and BPII 
disorders.
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The primary aim of this study was to assess the presence of hypomanic 
symptoms in a highly selected “unipolar” sample. In order to do this I first 
established the cut-off score on the HCL-32 that best distinguished between 
recurrent major depressive disorder (MDDR) and bipolar I disorder (BPI), in 
this large, well characterised UK sample.
5.3 Method
5.3.1 Subjects
For further methodological details, see chapter 2. The sample comprised 260 
subjects with a diagnosis of bipolar I disorder (BPI) and 322 subjects with a 
diagnosis of recurrent major depressive disorder (MDDR) who correctly 
completed the Hypomania Checklist (HCL-32) in the 2007 questionnaire pack.
5.3.2 Assessment
Subjects completed the HCL-32 (appendix G), the Beck Depression Inventory 
(BDI) (Beck and Steer, 1987) (appendix E) and the Altman Self Rating Mania 
Scale (ASRM) (Altman et al., 1997) (appendix F) as part of the questionnaire 
pack that was sent out in 2007.
The HCL-32 is a self-report measure that comprises a checklist of 32 possible 
symptoms of hypomania that are rated yes (present or typical of me) or no 
(not present or not typical). The questionnaire also includes a question about 
current mood state (relative to usual mood state) where subjects rate
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themselves on a seven point scale (worse than usual - neither worse no better 
than usual - better than usual). The total score on the HCL-32 was obtained 
by summing all items rated “Yes” on the 32 item checklist (so each item rated 
“Yes” scored 1 to give a total out of 32).
5.3.3 Statistical Analysis
Comparisons of dichotomous items were analysed using chi-square tests and 
the Mann-Whitney test was applied to continuous data. Spearman 
correlations were used to assess the relationship between HCL-32 score and 
current mood state, as assessed by the HCL-32 current mood state item, the 
BDI and the ASRM.
Logistic regression analysis yielded the sensitivity and specificity of the HCL- 
32 to discriminate between MDDR and BPI. The area under the ROC curve 
(AUC) was also computed as a measure of the overall predictive validity of the 
HCL-32, where AUC=0.50 signals random prediction, 0.60<AUC<0.70 poor, 
0.70<AUC<0.80 fair, 0.80<AUC<0.90good and AUC>0.90 excellent predictive 
validity (Tape, 2004).
5.4 Results
Clinical characteristics of the sample are described in Table 5-1. Although the 
BPI group had a significantly younger age at interview (p=0.019) when 
compared to the MDDR group, there was no significant difference in illness 
duration (p=0.80) between the two groups. The total BDI score was
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significantly higher for the MDDR group compared to the BPI group (p<0.001), 
and the total ASRM score was significantly higher for the BPI group compared 
to the MDDR group (p=0.03).
Table 5-1: Clinical Characteristics of the Bipolar (BPI) and Unipolar (MDDR) Samples and the
Unipolar (MDDR) with HCL-32 Score >19 Sub-Sample
Clinical
Characteristic
BPI
N=260
MDDR
N=322
MDDR 
HCL-32 >19 
N=47
Total HCL 32 Score
(out of 32) Median 24 17 23
Interquartile Range 7.25 7 3
Range 4-31 0-29 20-29
Beck Depression
Inventory Median 10 14 14
Total score Interquartile Range 12 15 12
Range 0-52 0-46 1-35
Altman Mania Scale
Total score Median 3 2 3
Interquartile Range 4 3 3
Range 0-15 0-13 0-12
Age at Interview
(years) Median 47 51 46
Interquartile Range 17 16 15
Range 21-73 18-85 26-69
Gender
Male 76 (29.2%) 105 (32.6%) 20 (42.6%)
Female 184(70.8%) 217 (67.4%) 27 (57.4%)
Illness Duration
(years) Median 22 21 19
Interquartile Range 19 18.75 17.25
Range 1-54 1-71 4-49
Age at 1st
Impairment Median 24 27 22.5
Interquartile Range 59 54 13
Range 7-66 9-63 12-46
Age at 1st Contact
Median 28 34 27
Interquartile range 15 20 12
Range 11-66 10-63 12-49
Age at 1st
Admission Median 29 34 31
Interquartile Range 15 18 11
Range 16-66 17-68 17-47
Number of
Admissions None 26 (10%) 156 (48.4%) 18(38.3%)
One or more 233 (90%) 166 (51.6%) 29(61.7%)
Comparisons of dichotomous items were analysed using chi-square tests and the Mann-Whitney test 
was applied to continuous data [to compare BPI (N=260) versus M DDR (N=322)].
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There was no significant difference in gender between the BPI and MDDR 
samples (p=0.38). As expected, total HCL-32 scores were significantly lower 
in the MDDR sample, compared to the BPI sample (p<0.001). Of the subjects 
in the MDDR sample, 156 (48.4%) rated feeling “neither better nor worse than 
usual” when asked how they were feeling today compared to their usual state 
(the first question on the HCL-32). Of the subjects in the BPI sample, 94 
(36.2%) reported feeling “neither better nor worse than usual” on the HCL-32 
(see Table 5-2). There was no significant correlation between the HCL-32 
total score and the subject’s rating on the HCL-32 of current mental state or 
between the HCL-32 total score and the BDI total score (Spearman’s 
correlations, p > 0.5). There was a significant correlation between the HCL-32 
total score and the ASRM total score (p=0.002). Table 5-2 also shows that 
BPI subjects were more likely to complete the questionnaire pack when they 
were feeling “a little better”, “better” or “much better than usual”, a finding not 
seen in the MDDR sample.
Table 5-2: Current Mental state of the Bipolar (BPI) and Unipolar (MDDR) Samples as Assessed 
by the HCL-32
How are you feeling today compared to your 
usual state?
BPI
N=260
MDDR
N=322
Much worse than usual 11 (4.2%) 11 (3.4%)
Worse than usual 20 (7.7%) 26 (8.1%)
A little worse than usual 35(13.5%) 45 (14%)
Neither better nor worse than usual 94 (36.2%) 156 (48.4%)
A little better than usual 47(18.1%) 36(11.2%)
Better than usual 39 (15%) 33 (10.2%)
Much better than usual 14 (5.4%) 15(4.7%)
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Figure 5-1: ROC Curve Showing the Power of the HCL-32 to Discriminate Between Bipolar 
(BPI) and Unipolar (MDDR) Subjects (AUC= Area Under Curve)
The ROC curve (Figure 5-1) shows the ability of the HCL-32 to discriminate 
between MDDR and BPI cases. The AUC of 0.82 reflects the “good” overall 
predictive validity of the HCL-32 (Tape, 2004). Data on sensitivity and 
specificity of the checklist suggest that a score of 20 or more yields the best 
combination of sensitivity (65%) and specificity (83%) to distinguish between 
BPI and MDDR cases when accounting for current mental state (BDI total 
score and AMS total score). This cut-off was selected as optimal as it 
correctly classified the largest number of subjects (75%). The positive and 
negative predictive values for this cut-off were 76% and 75% respectively.
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Including gender as a covariate did not alter the optimal cut-off score on the 
HCL-32.
Diagnostic G roup
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 BPI
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Figure 5-2: Total Scores on the Hypomania Checklist (HCL-32) According to Diagnostic Group: 
Bipolar Disorder (BPI) Versus Unipolar Disorder (M DDR)
Of the MDDR subjects, 47 (17.2%) rated 20 or more symptoms on the HCL- 
32 and 105 (32.6%) subjects rated 14 or more symptoms on the HCL-32. 
Figure 5-2 shows the total HCL-32 scores for the MDDR subjects and the BPI 
subjects. Table 5-1 also shows the clinical characteristics of the 47 MDDR 
subjects who rated 20 or more on the HCL-32.
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5.5 Discussion
This study focussed on subjects with MDDR and BPI and did not include 
subjects in the “middle ground” -  those with BPII and those MDDR individuals 
with a family history of bipolar disorder or who have shown mood incongruent 
psychotic symptoms. Unsurprisingly given these inclusion criteria and in 
agreement with previous studies (Angst et al., 2005a), the HCL-32 showed 
good discrimination between BPI and MDDR subjects. In this sample I found 
that a cut-off score of above 20 offered the best combination of sensitivity 
(true bipolars) (65%) and specificity (true non-bipolars) (83%). The cut-off 
score found in this study is higher than the cut-off score of 14 found by Angst 
et al (2005a). This is consistent with my focus on subjects with BPI disorder, 
contrasting to Angst et al’s focus on BPI (38%) and BPII (62%) disorder. As 
might be expected, the higher cut-off score used in this study resulted in a 
reduced sensitivity and higher specificity when compared to the study of 
Angst et al (2005a).
Given the exclusion of bipolar and unipolar subjects in the middle ground of 
the spectrum I do not suggest that the cut off is of use in other contexts, rather 
I have used it to examine the proportion of selected unipolar subjects who 
score higher than this more conservative level. Even in this highly selected 
sample, 47 (17.2%) unipolar subjects rated 20 or more hypomanic symptoms 
on the HCL-32 and 105 (32.6%) rated 14 or more symptoms on the HCL-32. 
These findings are consistent with previous reports suggesting that individuals 
with recurrent unipolar depression experience a substantial number of manic/
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hypomanic symptoms over their lifetimes (Cassano et al., 2004, Angst et al., 
2005b). It is of interest that these 47 “unipolar” subjects resembled the bipolar 
subjects in that they had a younger age at onset, younger age at first contact 
with psychiatric services, younger age at first admission, and more hospital 
admissions. Thus, it is possible that they represent a form of mood disorder 
which, although meeting DSM-IV criteria for unipolar recurrent depression, 
share features of pathogenesis with bipolar disorder. This has implications for 
understanding of nosology and classification and may also have implications 
for treatment.
BPI subjects were younger at interview when compared to MDDR subjects, 
although as they also had an earlier age at illness onset (as would be 
expected when comparing bipolar and unipolar subjects), there was no 
significant difference between the two samples in terms of illness duration.
Angst et al (2005a) found that current mental state had no impact on the self- 
assessment of hypo-manic symptoms using the HCL-32 and in agreement 
with this, I found no correlation between total HCL-32 scores and current 
mental state as assessed by the HCL-32 or by the Beck Depression 
Inventory. As would be expected there was a significant correlation between 
total HCL-32 score and current mental state as assessed by the Altman Self- 
Rating Mania Scale. Interestingly, subjects in the bipolar sample were more 
likely to complete the questionnaire pack when they were feeling “a little 
better”, “better” or “much better than usual”. However, this finding does not 
affect the conclusions of this study focusing on the unipolar sample.
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A major strength of this study, along with the large sample size of nearly 600 
subjects, is that all subjects in the unipolar and bipolar samples were recruited 
from within the same geographical regions within the UK and were assessed 
using the same standardised procedures. To the best of my knowledge, this is 
the first report from the UK using the HCL-32.
The time duration between the initial research interview and the completion of 
the questionnaire pack, of 3.8 years, can be seen as the main limitation of this 
study. It is possible that at least some of the MDDR subjects who scored 
highly on the HCL-32 may have experienced a hypomanic or manic episode 
since the time of the research interview and may therefore have switched 
from a unipolar to a bipolar categorical diagnosis. Angst el al (2005b) found 
that a diagnostic change from depression to bipolar I disorder occurred in 
about 1% of patients per year and to bipolar II disorder in about 0.5% of 
patients per year. However, studies have suggested that younger subjects, 
with a personal history of psychotic features or a family history of bipolar 
disorder, are more likely to switch to a bipolar diagnosis than unipolar subjects 
without such characteristics (Coryell et al., 1995).
The focus on subjects with BPI disorder (not including subjects with a 
diagnosis of BPII) could be seen as a limitation of this study. However, my 
focus was on groups of subjects who would, in theory, be at opposite ends of 
the bipolar diagnostic spectrum, and, in particular, on subjects with MDDR 
who were thought to be at low risk of experiencing hypomanic features.
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Another potential limitation of this study is that I only included patients of UK/ 
Eire white ethnicity and so findings may therefore not be representative of all 
populations.
It is well known that detecting hypomanic symptoms, even via clinical 
interview, can be difficult as subjects/ patients may not recognise such 
symptoms as being significant. It is important to note, that even using the 
HCL-32, I may still be underestimating the presence of manic symptoms. 
However, I feel that this study illustrates the usefulness of the HCL-32 in 
detecting hypomanic symptoms, and it’s potential utility in identifying 
individuals where there is a need for further investigations into the possibility 
of a bipolar II, or even bipolar I diagnosis.
In summary, these findings of an overlap in manic/ hypomanic symptoms 
across bipolar and unipolar diagnostic groups, challenge the traditional simple 
unipolar/ bipolar categorical divide and illustrate the difficulties inherent in 
allocating subjects to a particular diagnostic group. Dimensional measures of 
manic/ hypomanic symptoms across subjects with mood disorder diagnoses 
are likely to be useful in both clinical and etiological studies of the unipolar- 
bipolar interface.
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6 Clinical Characteristics of Unipolar Disorder and 
Bipolar Disorder According to the Lifetime 
Presence of Recurrent Panic Attacks
Reported by Forty et al (In Press)
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6.1 Summary
The frequent comorbidity of panic and affective disorders has been described 
in previous studies. However, it is not clear how panic disorder comorbidity in 
unipolar disorder and bipolar disorder is related to illness course.
I have compared lifetime clinical characteristics of illness and items of 
symptomatology in samples of subjects with bipolar I disorder (N=290) and 
unipolar disorder (MDDR) (N=335) according to the lifetime presence of 
recurrent panic attacks.
I found significant differences in clinical course of illness characteristics that 
were shared across the unipolar and bipolar samples according to the lifetime 
presence of panic attacks. For example, both the unipolar and bipolar 
samples with a history of panic attacks i) had more frequent and more severe 
depressive episodes (as measured by the BADDS depression dimension) and
ii) were more likely to have experienced suicidal ideation and slowed activity 
during depressive episodes in their lifetime, compared to those with no history 
of panic attacks.
I also found a number of differences according to the presence of panic 
attacks that were specific to the diagnostic group. For example, subjects with 
bipolar disorder and a history of recurrent panic attacks were more likely to 
have i) a family history of affective disorder, ii) more severe impairment during 
their worst ever episode of depression, iii) attempted suicide during their
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lifetime, and iv) experienced diurnal morning variation, insomnia and agitated 
activity during depressive episodes during their lifetime, compared to subjects 
in the bipolar sample with no history of panic attacks. These differences were 
not seen between the unipolar groups with and without a history of panic 
attacks.
Distinguishing patients/ subjects who have mood disorder diagnoses, 
especially bipolar I disorder, according to the lifetime presence of recurrent 
panic attacks may not only be of use in clinical practice, but may also be 
informative for aetiological research, such as, molecular genetic studies.
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6.2 Introduction
Refining phenotypic descriptions and sub-typing in mood disorders may 
facilitate clinical studies that focus on improving treatment strategies for 
particular sub-groups of patients and may also be informative for aetiological 
studies of mood disorders, such as genetic studies. Studies have suggested 
that mood disorders may be distinguished by their relationship to specific 
anxiety disorders (Simon et al., 2003).
Comorbid panic disorder has been associated with a worse course of illness 
(Johnson and Lydiard, 1998, Fawcett et al., 1990, Brown et al., 1996) and 
poorer treatment outcome in major depression (Johnson and Lydiard, 1998) 
and in bipolar disorder (Simon et al., 2004, Frank et al., 2002, Frank et al., 
2000, Feske et al., 2000, Dilsaver and Chen, 2003).
Evidence from twin studies has suggested that genes that predispose to 
major depression are essentially the same as those that influence generalised 
anxiety disorder, but are relatively distinct from those influencing panic 
disorder (Kendler et al., 1995b). Results from family studies (Maier et al., 
1995b, Weissman et al., 1993) have indicated that although panic disorder 
and unipolar disorder aggregate in families, the comorbid condition does not 
represent a distinct subtype in terms of familial aggregation and the major 
proportion of comorbidity between panic disorder and unipolar disorder 
appears to be due to non-familial factors. Studies of bipolar disorder, 
however, have shown that there may be shared genetic influences in some
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families for bipolar disorder and panic disorder (MacKinnon et al., 2002, 
Rotondo et al., 2002).
It seems that comorbid panic disorder may identify a familial subtype of 
bipolar disorder (MacKinnon et al., 1997), but not of unipolar disorder, 
suggesting that bipolar and unipolar disorders may differ in their relationship 
to panic disorder.
To date, no-one has examined the clinical course of illness in relation to the 
lifetime presence of panic attacks across unipolar and bipolar samples within 
the same study. The aim of the current study was to assess the lifetime 
clinical characteristics of illness in both subjects with bipolar disorder and 
subjects with unipolar disorder according to their lifetime presence of 
recurrent panic attacks.
6.3 Method
6.3.1 Subjects
See chapter 2 for further methodological details. The bipolar (BPI N=290) and 
unipolar (MDDR N=335) samples included subjects who correctly completed 
the panic questionnaire in the 2007 questionnaire pack.
6.3.2 Assessment
Subjects completed the panic questionnaire (appendix H), the Beck 
Depression Inventory (BDI) (appendix E) and the Altman Self-Rating Mania
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Scale (ASRM) (appendix F) in the questionnaire pack that was sent out in 
2007.
Subjects were classified as having experienced recurrent panic attacks during 
their lifetime according to the following criteria: The panic attacks occurred on 
more than one occasion (question 2) with symptoms such as shortness of 
breath, sweating, etc (question 5). The panic attacks caused some 
impairment with everyday functioning (question 6, rating of at least “somewhat 
difficult”). In addition, the panic attacks came suddenly out of the blue 
(question 3) and/ or the panic attacks bothered the subject a lot or made the 
subject worry about having another attack (question 4) (see appendix H).
In order to assess the reliability of the questionnaire measure of panic attacks, 
SCAN sections assessing anxiety and panic were completed at interview for 
24 subjects. These subjects also completed the panic questionnaire. For 
these subjects, I was able to examine the agreement between the two 
methods of assessing the lifetime ever presence of recurrent panic attacks 
(i.e. interview versus questionnaire). A Kappa statistic (Cohen, 1960) of 0.71 
was obtained, indicating good agreement (Fleiss, 1981) between the two 
measures for the lifetime presence of recurrent panic attacks. For twenty-one 
subjects the two measures were concordant, and for three subjects the 
measures were discordant. Using the SCAN interview as a gold standard for 
defining the lifetime presence of recurrent panic attacks, the panic 
questionnaire correctly classified 88% of subjects, with a sensitivity of 94% 
and a specificity of 75%.
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6.3.3 Statistical Analysis
Demographic/ clinical characteristics were compared in the bipolar sample 
and the unipolar sample according to the lifetime presence of recurrent panic 
attacks. As the continuous data were not normally distributed, medians, 
interquartile ranges, and ranges are reported. Numbers (N) and proportions 
are reported for the categorical data.
In order to test for an association between a characteristic and the lifetime 
presence of recurrent panic attacks, a logistic regression model was 
constructed for each characteristic, with the presence/ absence of lifetime 
recurrent panic attacks as the outcome/ dependent variable. Multivariate 
logistic regression models were used so that the following potentially 
confounding variables could be included as covariates; BDI score, age at 
interview, and gender.
Odds ratios (OR) and 95% confidence intervals (95% Cl) for the odds ratios 
are reported. Odds ratios of greater than 1 indicate, for the particular variable, 
that a higher score is associated with the lifetime presence of recurrent panic 
attacks; whereas odds ratios of less than 1 indicate that a higher score is 
associated with the lifetime absence of recurrent panic attacks.
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6.4 Results
Of the 290 subjects with bipolar disorder (BPI), 136 (47%) had a lifetime 
history of recurrent panic attacks. Of the 335 subjects with unipolar disorder 
(MDDR), 194 (58%) had a lifetime history of recurrent panic attacks.
Demographic characteristics
A higher score on the BDI was significantly associated with the lifetime 
presence of panic attacks in the bipolar sample (OR 1.05, 95% Cl 1.02-1.08, 
p=0.0014), as was a lower age at interview (OR 0.97, 95% Cl 0.95-0.99, 
p=0.002). There was a trend towards a higher proportion of females in the 
bipolar group with a history of panic attacks, although this did not reach 
statistical significance. There were no significant associations between panic 
status and method of recruitment, illness duration or ASRM score (see Table 
6- 1).
A higher score on the BDI was also significantly associated with the lifetime 
presence of panic attacks in the unipolar sample (OR 1.05, 95% Cl 1.02-1.07, 
p<0.001). There were no associations between panic status and age at 
interview, gender, method of recruitment, illness duration or ASRM score (see 
Table 6-1).
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Table 6-1: Lifetime Clinical Characteristics of the Bipolar (BPI) and Unipolar (MDDR) Samples 
According to the Lifetime Presence or Absence of Panic Attacks
Clinical
Characteristic
BPI
-Panic
N=154
(53%)
BPI
+Panic
N=136
(47%)
p-value
MDDR
-Panic
N=141
(42%)
MDDR
+Panic
N=194
(58%)
p-alue
Beck
Depression Median 8.5 12 0.0014 11.5 16 <0.001
Inventory Interquartile 11 14 13 17
Total score Range
Range 0-52 0-49 0-42 0-46
Altman Mania
Scale Median 3 4 0.12 2 2 0.57
Total score Interquartile 4 5 4 3
Range
Range 0-15 0-15 0-13 0-11
Age at
Interview Median 49 44.5 0.023 52 49 0.38
(years) Interquartile 18 17 18 15
Range
Range 21-73 24-67 18-85 26-78
Method of
Recruitment Systematic 66 (47%) 48 (40%) 0.80 54 (38%) 91 (48%) 0.20
Non-Systematic 76 (53%) 73 (60%) 85 (60%) 100(52%)
Gender
Male 54 (35%) 31 (23%) 0.057 48 (34%) 58 (30%) 0.52
Female 100(65%) 105(77%) 93 (66%) 136(70%)
Illness
Duration Median 22 20 0.78 21 20 0.90
(years) Interquartile 17.25 19.25 22 18
Range
Range 2-54 0-52 1-71 2-55
Age at Illness
Onset (Mania Median 25 23 0.80 27 26 0.90
or Depression) Interquartile 15 13 18 14
Range
Range 10-66 7-49 9-61 10-63
Age at 1s1
Contact with Median 28 26 0.89 34 33 0.88
psychiatric Interquartile 17 15 22 53
services range
Range 13-66 11-51 14-63 10-63
Age at 1st
Admission Median 30 28 0.76 40 33 0.25
(if applicable) Interquartile 14 15 16 17
Range
Range 16-66 16-53 17-68 0-61
Number of
Admissions None 17(11%) 13 (10%) 0.15 83 (59%) 84 (43%) 0.0069
One or more 136 (89%) 123 (90%) 58(41%) 110(57%)
Family History
of Affective Absent 40 (29%) 17(14%) 0.037 16(14%) 18(12%) 0.68
Disorder Present 99 (71%) 103 (86%) 102 (86%) 139 (88%)
No. of
Episodes of Median 4 5 0.58 4 4 0.51
Depression Interquartile 7 7 3 3
Range
Range 0-70 0-40 2-70 2-30
No. of
Episodes of Median 5 5 0.97 - - -
Mania Interquartile 5 5
Range
Range 1-50 1-100
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Table 6-1 Continued
Clinical
Characteristic
BPI
-Panic
N=154
(53%)
BPI
+Panic
N=136
(47%)
p-value
MDDR
-Panic
N=141
(42%)
MDDR
+Panic
N=194
(58%)
p-value
Predominant
Polarity Mania
Depression
71 (57%) 
54 (43%)
40 (40%) 
60 (60%)
0.71 - - -
Longest 
Episode of 
Depression 
(weeks)
Median
Interquartile
Range
Range
22
32
1-286
26
32
0-416
0.99 74
69
2-624
64
62
9-376
0.74
Longest 
Episode of 
Mania (weeks)
Median
Interquartile
Range
Range
8
11
0-104
9
11
1-104
0.95 - - -
Suicide
Attempt Absent
Present
101 (68%) 
47 (32%)
68 (53%) 
60 (47%)
0. 036 110(79%) 
30 (21%)
141 (73%) 
51 (27%)
0.84
Rapid Cycling
Absent
Present
78 (72%) 
30 (28%)
61 (68%) 
29 (32%)
0.99 - - -
Psychotic
Features
(lifetime-ever)
Absent
Present
35 (25%) 
103 (75%)
20 (17%) 
98 (83%)
0.21 130 (93%) 
10(7%)
171 (89%) 
20(11%)
0.34
GAS
Worst
Depression
Median
Interquartile
Range
Range
37
14
5-71
34
12
5-81
0.034 37
7
10-54
36
8
10-51
0.23
Worst Mania
Median
Interquartile
Range
Range
28
13
10-55
28
15
9-55
0.68 - - -
BADDS
Depression Median
Interquartile
Range
Range
63
21
0-99
66
22
0-93
0.0059 62
10
40-85
63
5
50-90
0.028
Mania
Median
Interquartile
Range
Range
82
19
60-99
82
19
41-94
0.71 0
0
0-20
0
0
0-20
-
Psychosis
Incongruence
Median
Interquartile
Range
Range
21.5
26
0-100
22
37
0-100
0.13 0
0
0-50
0
0
0-75
-
Median
Interquartile
Range
Range
20
20
0-60
20
15
0-47
0.94 0 0
0
0-20
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P values are obtained from multivariate logistic regression models which included the demographic/ 
clinical characteristic (item) along with the following potentially confounding variables (BDI score, age at 
interview, and gender), with the outcome variable being presence/ absence of lifetime recurrent panic 
attacks. Significant p-values are in bold. N values may vary due to missing data.
Comparing clinical characteristics in unipolar and bipolar samples 
according to a lifetime history of recurrent panic attacks
The following characteristics were significantly associated with the lifetime 
presence of recurrent panic attacks in the bipolar sample: a family history of 
affective disorders (OR 2.09, 95% Cl 1.05-4.16, p=0.037); suicide attempt 
(OR 1.71, 95% Cl 1.04-3.01, p=0.036); more severe impairment during the 
worst ever depressive episode (as rated on the GAS) (OR 0.97, 95% Cl 0.95- 
0.99, p=0.034); a higher score on the BADDS depression dimension 
(indicating more frequent and severe depressive episodes). There were no 
significant associations between panic status and any other clinical lifetime 
course characteristics (see Table 6-1).
The following OPCRIT rated items of depressive symptomatology were 
significantly associated with the lifetime presence of recurrent panic attacks in 
the bipolar sample: diurnal (morning) variation (OR 1.91, 95% Cl 1.08-3.40, 
p=0.027); suicidal ideation (OR 2.07, 95% Cl 1.03-4.19, p=0.042); slowed 
activity (OR 2.18, 95% Cl 1.19-3.98, p=0.011); initial and middle insomnia 
(OR 2.12, 95% Cl 1.15-3.92, p=0.016; OR 1.94, 95% Cl 1.08-3.48, p=0.027); 
early morning waking (OR 3.74, 95% Cl 1.99-7.06, p<0.001); agitated activity 
(OR 3.79, 95% Cl 2.003-7.05, p<0.001). For the other OPCRIT rated items of
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depressive symptomatology there were no significant associations with panic 
status.
I also looked for associations between panic status and items of OPCRIT 
rated manic symptomatology present during the lifetime and found no 
significant associations.
The following characteristics were significantly associated with the lifetime 
presence of recurrent panic attacks in the unipolar sample: inpatient treatment 
at least once during the lifetime (OR 1.95, 95% Cl 1.20-3.15, p=0.0069); a 
higher score on the BADDS depression dimension (again, indicating more 
frequent and/ or severe depression episodes) (OR 1.033, 95% Cl 1.004- 
1.064, p=0.028) (see Table 6-1).
The following OPCRIT rated items of depressive symptomatology were 
significantly associated with the lifetime presence of recurrent panic attacks in 
the unipolar sample: suicidal ideation (OR 2.16, 95% Cl 1.079-4.34, p=0.030); 
slowed activity (OR 1.79, 95% Cl 1.069-3.01, p=0.027). There were no other 
significant associations according to panic status for any other OPCRIT rated 
items of depressive symptomatology.
6.5 Discussion
I found that several clinical characteristics of illness, relating to the severity 
and frequency of depressive episodes, were significantly associated with the 
lifetime presence of recurrent panic attacks in both subjects with bipolar
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disorder and unipolar disorder. In the bipolar sample, I found no association 
between the lifetime presence of panic attacks and clinical characteristics of 
illness relating to mania.
I believe that this study is the first to compare clinical characteristics of illness 
in both subjects with unipolar disorder and bipolar disorder, who were 
recruited using the same sampling approach and assessed using consistent 
methodology, according to the lifetime presence of panic attacks.
Dilsaver and Chen (2003) found that anxiety disorders appear to be related to 
states of depression rather than to what is regarded to be classic manic 
symptomatology. In agreement with this, the associations that I found in the 
bipolar sample with panic attacks tended to be related to the course of 
depression. For example, I found that subjects with bipolar I disorder and a 
lifetime history of recurrent panic attacks were more likely to have attempted 
suicide during their lifetime, to have more severe impairment during their 
worst depressive episode, and to have more frequent and severe depressive 
episodes (according to the BADDS). In terms of items of psychopathology 
(rated using OPCRIT), in the bipolar sample, I found a number items of 
depressive symptomatology that were significantly associated with the lifetime 
presence of recurrent panic attacks, but no associations for items of manic 
symptomatology. Similarly, Frank et al (2002) found that in a sample of 66 
subjects with bipolar I disorder, those who rated highly on an instrument 
measuring the presence of lifetime panic-agoraphobic symptoms were more 
likely to have experienced a greater number of depressive episodes, a greater
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number of depressive symptoms and more suicidal ideation than subjects with 
lower scores on the scale. They found no difference in the number of 
episodes of mania or in manic symptoms between these groups.
The measure of current mood state (BDI) indicated that at the time of the 
questionnaire assessment, subjects with a history of recurrent panic attacks 
displayed more depressive symptomatology than subjects who had never 
experienced panic attacks. This finding, of higher rates of current depressive 
symptomatology in subjects with a history of panic attacks, suggests that 
history of recurrent panic attacks could be a marker of a more chronic 
depressive course of illness. Unfortunately, my measure of panic attacks did 
not ask about the presence of current panic attacks. It may be that those 
subjects who were currently experiencing panic attacks may have been the 
subjects were currently experiencing higher rates of depressive symptoms.
As well as finding associations that were shared across the unipolar and 
bipolar samples according to the lifetime presence of panic attacks, I also 
found a number of associations according to the presence of panic attacks 
that appeared to be present only in the bipolar sample. For example, in 
subjects with bipolar disorder, those with a history of panic attacks were more 
likely to have a family history of affective disorder, to have attempted suicide 
and to have experienced more severe impairment during their worst episode 
of depression than those with no history of panic attacks. In addition, I found 
that subjects in the bipolar sample who had a history of panic attacks were 
more likely to have experienced diurnal variation, insomnia and agitated
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activity than those with no history of panic attacks. These findings point to the 
possibility that the presence of lifetime panic attacks may differentiate 
between subjects with bipolar disorder to a greater degree than for unipolar 
subjects. If this is the case, defining the presence of panic attacks may be 
more useful nosologically in bipolar than in unipolar disorder. However, it is 
important to note that these differences may also exist in the unipolar sample, 
but to a smaller extent.
Previous studies have generally found significantly higher rates of comorbid 
panic disorder in subjects with bipolar disorder compared to subjects with 
unipolar disorder (Chen and Dilsaver, 1995, Simon et al., 2003), although 
others have not (Rihmer et al., 2001, Pini et al., 1997). In this study, I found a 
higher rate of recurrent panic attacks in the unipolar sample, compared to the 
bipolar sample. Methodological differences may explain the variation in 
prevalence estimates between studies. This study focused on subjects with 
narrowly defined bipolar I disorder or recurrent major depression. It has been 
argued that the inclusion of subjects with bipolar II disorder may contribute 
towards the higher overall prevalence of panic disorder in bipolar disorder 
compared to unipolar disorder seen in previous studies (Doughty et al., 2004). 
Some studies have shown higher rates of comorbid panic disorder in subjects 
with bipolar II disorder compared to subjects with bipolar I disorder (Doughty 
et al., 2004, MacKinnon et al., 2002, Perugi et al., 1999). Similarly, higher 
rates of panic disorder have been found in recurrent depressive disorder 
compared to single episode depressive disorder (Doughty et al., 2004, 
MacKinnon et al., 2002). These considerations may suggest the need for a
102
careful characterisation of bipolar II disorder in samples of apparently 
“unipolar” subjects.
My focus on recurrent panic attacks, rather than panic disorder, may also 
have influenced the prevalence rates in these samples. I felt that the use of a 
less restrictive definition of lifetime recurrent panic attacks (that caused 
impairment in everyday functioning), rather than a strict definition of panic 
disorder, would enable me to focus on the phenotype of interest whilst 
maximising the sample size. Mackinnon et al (2002) found that loosening the 
phenotype to include panic attacks not meeting criteria for panic disorder did 
not alter their main finding that familial bipolar disorder is associated with 
increased risk for panic disorder. It is important to note that some caution is 
indicated here. To demonstrate clinically significant differences between two 
groups according to the presence of a weakly defined characteristic may 
illustrate the robust influence of that characteristic although it is also possible 
that the findings may be reflecting differences in the subject’s temperament or 
cognition, with respect to how subjects respond to questionnaires in general.
In order to assess this I evaluated the main results using two more restrictive 
definitions of panic attacks. The first of these restrictive definitions differed 
from the main definition in that subjects had to answer yes to both questions 3 
and 4 on the panic questionnaire (rather than 3 or 4) to be classified as having 
experienced recurrent panic attacks. In addition to this, for the second 
restrictive definition (the most restrictive definition) subjects also had to 
indicate that the panic attacks made it “very difficult” or “extremely difficult” to 
function effectively in their everyday lives.
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For all of the clinical characteristics that showed statistically significant 
differences between groups, according to panic status using the main 
definition, similar effect sizes were found when using the two more restrictive 
definitions of panic attacks although for some of these variables the reduction 
in sample size resulted in the findings no longer showing statistical 
significance.
In agreement with previous studies (Eaton et al., 1994, MacKinnon et al., 
2002) in both the unipolar and bipolar samples, I found a trend (not 
statistically significant) for females to have a greater prevalence of panic 
attacks compared to males.
I believe that this study is the first to compare unipolar and bipolar subjects 
with and without a history of recurrent panic attacks for clinical characteristics 
of illness and items of depressive psychopathology. These well characterised, 
relatively large unipolar and bipolar samples were recruited and assessed 
using consistent robust methodologies.
The use of postal questionnaires, rather than interview measures, to establish 
the presence or absence of panic attacks is a limitation of this study.
However, when I compared the rates of lifetime recurrent panic attacks in 
those subjects who were assessed using the anxiety/ panic section of the 
SCAN interview and also completed the self-rated questionnaire measure of 
panic attacks I found good agreement between the two measures.
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Another potential limitation of the current study is that I did not include 
subjects with bipolar II disorder in the study. As I was looking to see if there 
were differences between subjects with bipolar and unipolar disorders in 
terms of clinical characteristics associated with co-morbid panic attacks, I 
focused on well defined, homogeneous groups of subjects with either bipolar I 
disorder or recurrent major depression.
These results suggest that the lifetime presence of recurrent panic attacks 
may differentiate between sub-groups of individuals with mood disorders, 
especially in those with bipolar disorder. The presence of recurrent panic 
attacks in bipolar and unipolar disorder may be indicative of a course of illness 
associated with greater depressive morbidity. The clinical assessment of 
panic attacks may be informative in diagnostic assessment and has the 
potential to guide treatment decisions particularly for individuals with a 
diagnosis of bipolar I disorder.
Defining individuals who have a mood disorder diagnosis, especially bipolar I 
disorder, according to the lifetime presence of recurrent panic attacks may not 
only be of use in clinical practice, but may also be informative for aetiological 
research, such as molecular genetic studies.
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7 Is Depression Severity the Sole Cause of Psychotic 
Symptoms During an Episode of Unipolar Major 
Depression? A Study Both Between and Within
Subjects.
Reported by Forty et al (2009a)
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7.1 Summary
Despite the common clinical assumption that psychosis is an indicator of 
severity in depression, it is not known what determines the presence of 
psychotic features in major depression. My aim was to answer the question: Is 
depression severity the sole cause of psychotic symptoms during an episode 
of unipolar major depression?
In a sample of 585 subjects with a diagnosis of major recurrent depression, I 
assessed measures of severity of depression and the presence of psychotic 
features, both within and between subjects.
Within subjects, psychotic episodes tended to be more severe than non- 
psychotic episodes. However, between subjects there was wide variation in 
severity in both those that did, and did not, experience psychotic episodes.
Subjects with a predisposition to psychotic features tend to display such 
features during more severe episodes of depression. However, subjects with 
no history of psychosis may experience non-psychotic depressive episodes of 
equal or greater severity, in terms of depressive symptomatology, compared 
to subjects with psychotic depression. Thus, there is individual variation in 
susceptibility to psychosis during mood episodes and severity is not the sole 
determinant.
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and optimize the power of clinical, biological and psychological research 
studies. The occurrence of psychotic symptoms (delusions and/ or 
hallucinations) during episodes is one potentially important clinical feature tha 
may identify such a subgroup.
The primary aim of the current study was to examine whether the severity of 
depression, using both lifetime and episode severity measures, can on its owr 
account for the presence of psychotic features during depressive episodes. In 
contrast to previous studies, rather than focusing on episode diagnoses, I 
examined a large, well-characterized group of subjects with a lifetime 
diagnosis of recurrent unipolar major depressive disorder. In addition, I made 
comparisons between psychotic and non-psychotic episodes within subjects 
as well as between groups of subjects in this homogeneous sample.
7.3 Method 
7.3.1 Subjects
See chapter 2 for further methodological details. Subjects recruited to the 
unipolar samples (DeCC and DeNT studies) were included in this study 
(N=585).
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7.3.2 Assessment
In addition to the assessment procedure described in chapter 2, for each 
subject the following information was collected for the worst ever episode of 
depression and the second worst ever episode of depression: Psychotic 
features (present/ absent); age at onset of episode (years); duration of 
episode (weeks); psychiatric contact during episode (present/ absent); 
admission during episode (present/ absent); functional impairment according 
to the Global Assessment of Functioning Scale (GAS) (Endicott et al., 1976). 
As described in chapter 2, the OPCRIT symptom checklist (McGuffin et al., 
1991, Craddock et al., 1996) was used to rate the presence or absence of 
items of depressive and psychotic symptomatology during the worst and 
second worst episodes of depression and also on a lifetime ever basis. As it is 
standard practice to define episode severity according to the number of 
depressive symptoms present (WHO, 1993), I have used the total number of 
depressive symptoms as a measure of severity that is independent of the 
presence of psychotic symptoms.
Of the 585 unrelated subjects with recurrent major depression (unipolar 
disorder), 64 (11%) had experienced one or more psychotic feature at some 
stage during their illness (Psychosis Group, PG) and 460 (78.6%) had never 
experienced a psychotic feature during their illness (No Psychosis Group, 
NPG). For 61 (10.4%) subjects I was unable to establish the definite presence 
or absence of lifetime psychotic features and so these subjects were excluded 
from the analysis.
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7.3.3 Statistical Analysis
As the continuous data did not follow a normal distribution, non-parametric 
analyses were used and medians, interquartile ranges, and ranges are 
reported. Three sets of analyses were conducted:
i) Between Groups Analysis of Demographic and Lifetime Clinical 
Variables
The PG (N=64) and the NPG (N=460) were compared on lifetime 
demographic and clinical variables using chi-square tests for categorical 
variables and the Mann-Whitney test for continuous variables.
ii) Between Groups Analysis of Worst Ever Episode of Depression
Differences between the PG (N=64) and NPG (N=460) during the worst ever 
episode of depression were examined using chi-square tests for categorical 
variables and the Mann-Whitney test for continuous variables.
iii) Within Groups Analysis of Psychotic and Non-Psychotic Episodes of 
Depression
For the within groups analysis, subjects were selected from the PG where one 
of the two most severe depressive episodes featured psychotic symptoms but 
the other one of the two most severe episodes did not (N=37). These subjects 
therefore had experienced at least one psychotic depressive episode and one 
non-psychotic depressive episode.
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Differences between the psychotic and non-psychotic episodes of the PG 
(N=37) were examined using McNemar tests for categorical variables and the 
Wilcoxon signed ranks test for continuous variables.
7.4 Results
Between Groups Analysis of Demographic and Lifetime Clinical 
Variables
There were no significant differences between the PG and the NPG in terms 
of gender, age at interview, or illness duration. Seventy percent of the PG 
were female compared to sixty-eight percent of the NPG (p=0.66). The 
median age at interview for both groups was 49 years (p=0.51), and although 
illness duration was less for the NPG (19 years compared to 22.5 years), the 
difference was not statistically significant (p=0.18). As can be seen in Table 7- 
1, subjects in the PG had a significantly younger age at illness onset (defined 
as age at first impairment) when compared to the NPG (p=0.027), were 
significantly more likely to have attempted suicide (p=0.042) and were more 
likely to have required contact with psychiatric services (p=0.0078) and 
received inpatient treatment (p<0.001) during their lifetime. The age at first 
contact with psychiatric services was significantly younger for the PG
(p=0.0062).
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Table 7-1: Lifetime Clinical Characteristics of the No Psychosis Group (NPG LE) and the 
Psychosis Group (PG LE)
Clinical Characteristic NPG LE 
N= 460 (88%)
PG LE 
N= 64 (12%)
p-value
Age at First Illness Onset
(years) Median 26 22.5 0.027
Interquartile Range 15 14
Range 9-61 10-48
Total Number of Depressive
Episodes Median 4 4 0.10
Interquartile Range 2.1 3
Range 2-40 2-15
Duration of Longest
Depressive Episode (weeks) Median 69 64.5 0.95
Interquartile Range 64 59
Range 8-728 8-376
Suicide Attempt
Absent 335 (73.1%) 39 (60.9%) 0.042
Present 123 (26.9%) 25 (39.1%)
Contact with Psychiatric
Services Contact 389 (84.6%) 62 (96.9%) 0.0078
No Contact 71 (15.4%) 2(3.1%)
Age at First Contact (years)
Median 33 28 0.0062
Interquartile Range 20 17.25
Range 12-63 12-55
Psychiatric Hospital
Admission Admission 141 (30.7%) 39 (60.9%) <0.001
No Admission 319 (69.3%) 25 (39.1%)
Age at First Admission
(years) Median 35 31 0.071
Interquartile Range 17 17
Range 13-68 19-55
Comparisons of dichotomous items were analysed using chi-square tests and the Mann-Whitney test
was applied to continuous data. N values may vary due to missing/ incomplete data. Significant p-values 
are in bold.
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Between Groups Analysis of Worst Ever Episode of Depression
Table 7-2: Clinical Characteristics of the Worst Ever Depressive Episode in Subjects Who Have 
Not (No Psychosis Group NPG) and Who Have (Psychosis Group PG) Experienced Psychotic 
Features During Their Lifetime
Clinical Characteristic NPG 
N = 460 (88%)
PG
N = 64 (12%)
p-value
Age at Onset of Episode
(years) Median 37 36 0.41
Interquartile Range 19 19
Range 9-73 16-57
Duration of Depressive
Episode (weeks) Median 52 52 0.58
Interquartile Range 78 57
Range 4-464 9-395
Total Number of
Depressive Symptoms Median 11 11 0.42
Interquartile Range 2 3
Range 6-17 6-16
GAS Score
Median 37 31 <0.001
Interquartile Range 7 8
Range 10-74 10-50
Psychiatric Contact
During Episode Present 304 (68%) 56 (88.9%) <0.001
Absent 143 (32%) 7(11.1%)
Psychiatric Admission
During Episode Present 104(23.2%) 36 (57.1%) <0.001
Absent 345 (76.8%) 27 (42.9%)
Comparisons of dichotomous items were analysed using chi-square tests and the Mann-Whitney test 
was applied to continuous data. N values may vary due to missing/ incomplete data. Significant p-values 
are in bold.
The PG scored significantly lower on the GAS (p<0.001) (indicating more 
severe functional impairment), and were significantly more likely to need 
psychiatric contact (p<0.001) and psychiatric admission (p<0.001) during their 
worst episode than the NPG (see Table 7-2). However, there was no 
difference between the two groups in terms of the amount of depressive 
symptomatology experienced during the worst episode of depression. Figure 
7-1 illustrates this graphically.
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Figure 7-1: Total Number of OPCRIT Rated Depressive Symptoms in Worst Ever Depressive 
Episodes of Subjects With (N=64) and Without (N=460) a History of Psychotic Features 
There was no statistically significant difference between the No Psychosis Group and the Psychosis 
Group for the total number of depressive symptoms experienced during the worst ever episode of 
depression (p=0.42).
There were no statistically significant differences between the PG and the 
NPG for the individual depressive symptoms rated as present during the worst 
ever episodes of depression.
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Within Groups Analysis of Psychotic and Non-Psychotic Episodes of
Depression
Table 7-3: Clinical Characteristics of a Non Psychotic Episode (PE) and a Psychotic Episode
(NPE) Within Individuals (N=37)
Clinical Characteristic NPE PE p-value
Age at Onset of Episode
(years) Median 37 35.5 0.58
Interquartile Range 23.75 18
Range 17-65 16-57
Duration of Depressive
Episode (weeks) Median 34 38 0.13
Interquartile Range 39 65
Range 2-208 9-177
Total Number of
Depressive Symptoms Median 10 11 <0.001
Interquartile Range 2 4
Range 5-14 6-16
Psychiatric Contact
During Episode Present 26 (76.5%) 32 (86.5%) 0.34
Absent 8 (23.5%) 5(13.5%)
Psychiatric Admission
During Episode Present 10(28.6%) 20 (54.1%) 0.0039
Absent 25 (71.4%) 17 (45.9%)
McNemar tests were used for categorical variables and the Wilcoxon signed ranks test was applied to
continuous data. N values may vary due to missing/ incomplete data. Significant p-values are in bold.
Table 7-3 shows the significant differences in clinical characteristics for the 
worst psychotic and the worst non-psychotic depressive episode for the 
individuals in the psychosis group (N=37). Psychotic episodes were 
significantly more likely to require inpatient treatment (p<0.0039) than non 
psychotic episodes and involved significantly more depressive 
symptomatology (p<0.001). Figure 7-2 shows the distributions for the total 
number of depressive symptoms in psychotic episodes and non-psychotic 
episodes.
115
■  Non Psychotic Episode
■  Psychotic Episode30 -
20 -
*->c
05
goQ-
10 -
5 6 7 8 g 10 11 12 13 14 15 16
T o ta l n u m b e r o f s y m p to m s
Figure 7-2: Total Number of O PCRIT Rated Depressive Symptoms in Psychotic and Non- 
Psychotic Depressive Episodes Within Patients W ith Recurrent M ajor Depression (N=37) 
Subjects in the Psychosis Group were significantly more likely to experience a greater total number of depressive 
symptoms during a psychotic episode compared to a non-psychotic episode (P=0.00017).
Subjects were significantly more likely to display suicidal ideation (p=0.031) 
and/ or psychomotor retardation (p=0.031) during their psychotic episode 
compared to their non-psychotic episode. There were no other significant 
differences between psychotic and non-psychotic episodes in terms of the 
depressive symptoms experienced by the subjects.
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7.5 Discussion
It is important to understand what the occurrence of psychosis indicates about 
the underlying depressive disease process because this has implications for 
treatment and research. The focus of this study is to examine the evidence in 
this dataset in support of the model that psychosis simply reflects severity of 
the depressive episode. The widespread use of this assumption by clinicians 
complicates attempts to study its validity. For example, the need for admission 
is a useful measure of episode severity but for many clinicians the presence 
of psychotic features may be a sufficient indication for admission. This, 
therefore, introduces non-independence between presence of psychosis and 
this measure of severity. It is important, therefore, to consider which severity 
measures may be directly influenced by presence of psychosis and which can 
be considered as an independent measure of severity.
If the severity model is correct, occurrence of psychotic features will identify 
individuals who tend to have more severe illness episodes but the underlying 
disease process will be similar to that in individuals who do not experience 
psychotic episodes. There are data in the prior literature for and against the 
model. I consider below the support in this data set for the severity model.
Within Groups Analysis of Psychotic and Non-Psychotic Episodes of 
Depression
The finding of the current study that a subject is likely to display psychotic 
features during their more severe depressive episodes (indexed by increased 
need for inpatient care and more depressive symptoms) is in agreement with
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Coryell et al (1996). Figure 7-2 provides a graphical illustration of the 
increased number of depressive symptoms experienced during psychotic, as 
compared with non-psychotic depressive episodes. The difference in number 
of symptoms can be seen particularly clearly when considering whether there 
were more depressive symptoms described in psychotic or non-psychotic 
episodes within an individual (to avoid biases only non-psychotic depressive 
symptoms are considered). Of the 37 subjects in the within subjects analysis, 
24 (65%) experienced a greater number of depressive symptoms during their 
psychotic episode when compared with their non-psychotic episode compared 
to only five subjects (14%) who experienced a greater number of depressive 
symptoms during their non-psychotic episode. (For the remaining subjects 
either there was no difference (16%) or the number of symptoms for each 
episode was uncertain (5%)). The preponderance of psychotic episodes 
having more depressive symptoms is highly statistically significant (McNemar 
test; p = 0.0002).
At the individual symptom level, psychotic episodes were significantly more 
associated with suicidal ideation and psychomotor retardation and all 
depressive symptoms were more likely to occur in psychotic than non- 
psychotic episodes, except for early morning waking and excessive sleep.
Thus, the within subjects analysis points clearly and consistently to severity of 
depressive episode having an important influence on expression of psychosis 
during depression.
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Between Groups Analysis of Worst Ever Episode of Depression
These findings contrast with those of Serretti et al (1999) who found no 
differences in clinical features (for example, age at onset, number and 
frequency of episodes, number of admissions, suicide attempt) between 
subjects with delusional or non-delusional major depression.
In agreement with Johnson et al (1991), I found that the subjects in the PG 
tended to have a more severe lifetime course of illness than the subjects in 
the NPG as indexed by: a significantly younger age at first onset of 
depression; being significantly more likely to have attempted suicide during 
their lifetime; being significantly more likely to require contact with psychiatric 
services during their lifetime and to require inpatient treatment and 
experiencing such contact at a significantly younger age. Consistent with 
Coryell et al (1996), who found that psychosocial impairment differentiated 
subjects who had and had not experienced psychotic features during 
depression, I found that subjects who had experienced psychotic features 
tended to score lower on the GAS, indicating more severe impairment in 
functioning during their worst ever depressive episode.
Of the subjects in the PG (N=64), 53 identified a psychotic episode as their 
worst episode of depression. It is of note, that subjects in the psychosis group 
generally experienced psychotic features in only one (64%) or two (28%) of 
their depressive episodes, predominantly in their more severe episodes. This 
finding is in agreement with previous studies (Lattuada et al., 1999, Ohayon 
and Schatzberg, 2002) and is consistent with the argument that, in some
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individuals, psychotic features are a reflection of severity. These individuals 
are not prone to psychosis in all depressive episodes.
However, I found no difference between subjects in terms of the total amount 
of depressive symptomatology experienced during the worst episode of 
depression. Figure 7-1 illustrates the similarity in the distributions of the two 
groups for the total number of depressive symptoms experienced during the 
worst ever episode of depression. This is in agreement with several previous 
findings (Johnson et al., 1991, Jeste et al., 1996, Schatzberg and Rothschild, 
1992, Breslau and Meltzer, 1988) but contrasts with other studies where 
differences were found in the severity, type and number of depressive 
symptoms present in psychotic and non-psychotic depression (Thakur et al., 
1999, Lattuada etal., 1999, Glassman and Roose, 1981, Parker etal., 1995).
Thus, compared to the within subjects analysis, the between subjects analysis 
provides less consistent support for severity being the key determinant of 
psychosis in depression. Two specific points are worth highlighting. First, the 
symptom counts can be considered independent measures of severity and 
show no differences between psychotic and non-psychotic groups. Second, 
there is huge variation in severity measures across both those with and 
without psychotic episodes. These observations demonstrate that factors 
other than severity make important contributions to influencing expression of 
psychosis during depressive episodes. Regardless of how severe a 
depressive episode may be, some individuals do not develop psychotic 
features. Biological and/ or psychosocial factors may influence susceptibility
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to psychosis. Severity of depression does appear to be related to the 
expression of psychotic features in susceptible individuals.
This study has several important strengths including: i) the focus on a 
relatively homogeneous set of subjects with recurrent unipolar depression 
who were selected to have illnesses that are, as far as possible, unrelated to 
bipolar disorder or schizophrenia, ii) the use of standardized lifetime 
assessment approaches including both interview and case notes review, iii) 
the assessments included both psychopathology items as well as measures 
of lifetime illness course and functioning, and iv) the use of both within groups 
and between groups designs.
However, it is important to consider several limitations. First, the use of 
retrospective assessment of psychotic and other features is limited by the 
subject’s ability to clearly recall, and possible reluctance to report, specific 
features of illness. However, subjects in the current study were asked in detail 
about these symptoms during a face to face interview. The researcher was 
able to build a rapport with the subject prior to obtaining information about 
more sensitive subjects such as psychotic features, which tended to be 
discussed towards the end of the interview. Psychiatric case notes were 
available for a large majority of the subjects and I found good agreement 
between the case note information and the subjects reports of their illness 
history at interview. A second limitation relates to the generalizability of the 
findings. Although the use of a sample, of UK/ Eire white ethnicity, selected to 
exclude cases likely to be related to bipolar disorder or schizophrenia has
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advantages in terms of clinical homogeneity, it may limit the generalizability of 
findings. As with many psychiatric studies of depression, the findings may not 
extend to the full spectrum of recurrent depression commonly encountered in 
clinical practice. Although this may be a limitation, it is also important to note 
that for the majority of patients with unipolar depression and psychosis these 
findings will be relevant. A third limitation, referred to earlier, relates to the 
difficulty of defining measures of episode or illness severity that are 
independent of the presence of psychosis. For some of the differences 
observed between subjects with and without a history of psychosis it is not 
clear whether they could simply be a consequence of the presence of 
psychosis. For example, the presence of psychotic symptomatology directly 
influences scores on the GAS and could be the main factor in a decision to 
admit to hospital. I did, however, find significant differences that I can be 
confident are independent of the effects of psychosis including a significantly 
younger age of illness onset in the PG compared to the NPG, and a 
significantly increased number of depressive symptoms present in psychotic 
episodes compared to non-psychotic episodes in the within groups 
comparisons. Finally, it is of note that this analysis is limited by treating 
psychosis as a categorical distinction (presence or absence). Future studies 
may benefit from taking into account the nature, amount and the severity of 
the psychotic features themselves.
In summary, the results of this study suggest that in subjects who have a 
predisposition (biological and/ or psychosocial) to experience psychosis, 
psychotic features tend to emerge in their more severe depressive episodes.
122
However, the data also show that severity alone cannot account for the 
presence of psychotic features, as non-psychotic depressive episodes in 
subjects with no personal history of psychosis may be as severe as, or more 
severe than, those seen in subjects with psychotic depression. Thus, there is 
individual variation in susceptibility to psychosis during depressive episodes 
with psychosis being more likely to be expressed during the more severe 
episodes, in those subjects with increased susceptibility.
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8 Familiality of Postpartum Depression in Unipolar 
Disorder: Results of a Family Study
Reported by Forty et al (2006)
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8.1 Summary
Strong evidence for familial aggregation of episodes of postpartum (puerperal) 
psychosis in women with bipolar disorder has previously been reported. I here 
examine whether vulnerability to postpartum triggering of depressive episodes 
in unipolar depression aggregates in families and assess how this 
aggregation varies with the definition of postpartum onset.
I studied the occurrence of postpartum depression in the female members of 
120 sibling pairs recruited at the Birmingham site of the DeNT study of 
recurrent unipolar depression. I examined the concordance for postpartum 
episode status in sisters, employing a range of definitions of postpartum 
onset.
Episodes of depression with onset within four weeks of delivery clustered in 
families (tetrachoric correlation coefficient = 0.55, 95% Cl 0.11- 0.83, 
p=0.015) but there was no significant evidence of familial clustering of broadly 
defined postpartum depression with onset within six months. Women with 
recurrent major depression with a family history of narrowly defined 
postpartum episodes experienced postpartum depression following 42% of 
first deliveries compared to only 15% of first deliveries to women with no such 
family history. The evidence for familiaility maximised with a definition of 
postpartum onset of between six to eight weeks.
These results implicate familial factors in susceptibility to the triggering of 
narrowly defined postpartum depressive episodes in women with recurrent
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major depression. They suggest that a definition of postnatal onset of within 
six to eight weeks of delivery may be optimal in studies of the triggering of 
depressive illness by childbirth.
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8.2 Introduction
A spectrum of affective illness follows childbirth, from the common, mild and 
transient baby blues, to postpartum (puerperal) psychoses, which can be 
classed among the most severe episodes of illness seen in clinical practice. 
The postpartum period is clearly a time of increased risk for episodes of 
affective psychosis, particularly for bipolar women (Kendell et al., 1987, Terp 
and Mortensen, 1998). Compelling evidence has previously been reported for 
the familial clustering of postpartum episodes in women with bipolar disorder 
-  episodes of postpartum psychosis occurred in 74% of parous bipolar 
women who had a family history of puerperal psychosis in a first-degree 
relative but in only 30% of women with bipolar disorder with no such family 
history (Jones and Craddock, 2001b).
Postpartum (postnatal) depression (PPD) is perhaps the most common 
psychiatric disorder following childbirth and is a term used to cover a wide 
variety of episodes of illness that occur in the months following delivery. 
Prevalence estimates vary widely according to the definition of postpartum 
onset (four weeks, six weeks, or six months for example), and the methods 
used to establish postpartum depression (clinical interview versus self-report). 
Based on the results of a large number of studies, however, a meta-analysis 
found the prevalence rate of non-psychotic postpartum depression to be 13% 
(O'Hara and Swain, 1996).
Postpartum depression is a significant mental health issue, with serious 
consequences for the mother, infant and family and the term has undoubtedly
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been useful in the fight for clinical services for women who become ill at this 
time. Despite its clinical and political importance, however, there have been a 
number of challenges to the scientific validity of the concept of postpartum 
depression including the suggestion that postpartum depression is no different 
in nature to episodes of depression that occur at other times (Whiffen, 1991). 
This has led to the idea that childbirth is acting as a non-specific stressor 
rather than as a specific trigger for illness onset at this time.
However, while there is no evidence to support postpartum depression as a 
separate nosological entity, evidence that childbirth is a specific trigger of 
depressive illness in a proportion of women has been presented. Cooper and 
Murray (1995) in a study that has yet to be replicated, found that, compared to 
women who had postpartum depression as a recurrence of a previous non­
postpartum depressive disorder, women whose postpartum depressive 
episode was their first experience of depressive disorder were at greater risk 
for subsequent postpartum depressive episodes, but a lower risk of 
subsequent non-postpartum depression. Second, in a paradigm that 
simulated the hormonal fluctuations of pregnancy and childbirth, Bloch and 
colleagues (2000) found that women with a history of postpartum depression 
display significantly greater mood sensitivity to changes in gonadal steroid 
levels than controls. Third, Treloar and colleagues (1999) suggested that 
different genetic factors may play a role in postpartum and non-postpartum 
depression. Although the scientific status of postpartum depression as a 
specific nosological category is weak, a number of lines of evidence, 
therefore, suggest that childbirth can act as a specific trigger of depressive
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episodes in some women and that a sub group of women with major 
depression are vulnerable to a postpartum trigger be it biological or 
psychosocial in nature.
The aims of the current study were to examine further the concept of a 
specific childbirth related trigger, to determine whether vulnerability to the 
postpartum triggering of depressive episodes aggregates in families, and to 
assess how this aggregation varies with the definition of postpartum 
depression.
8.3 Method
8.3.1 Subjects
See chapter 2 for further methodological details. Of the 240 subjects from the 
120 sibling pairs (one pair per family), recruited at the Birmingham site of the 
DeNt study, 135 were parous women. There were 60 female-female pairs, 52 
male-female pairs, and 8 male-male pairs. Of the 60 female-female pairs, 
there were 45 where both sisters were parous, and these were the main focus 
of these analyses.
8.3.2 Assessment
In addition to the assessment procedure described in chapter 2, detailed 
information was also collected on the relationship of episodes of mood illness 
to childbirth. Each pregnancy was assessed according to the following criteria: 
i) narrowly defined postpartum depression (an onset of DSM-IV major
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depression within four weeks of delivery), and ii) broadly defined postpartum 
depression (an onset of DSM-IV major depression within six months of 
delivery).
8.3.3 Statistical Analysis
The association of lifetime and first pregnancy postpartum depression status 
between pairs of parous sisters was assessed by the tetrachoric correlation 
coefficient as implemented in Mx (Neale et al., 2003).
8.4 Results
The median age at onset of depression for the 90 parous women (45 sibling 
pairs) was 22 years, and the median number of depressive episodes was four 
(see Table 8-1.). Twenty-six women (29%) had been admitted to a psychiatric 
unit for depression at some stage during their lives. Eight (9%) women had 
experienced psychotic symptoms during a depressive episode. The median 
number of pregnancies was 2.5, and the median number of deliveries was 
two.
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Table 8-1: Lifetime Clinical Characteristics of 90 Parous Women Recruited Within a Study of 
Sibling Pairs Affected With Recurrent Major Depressive Disorder
Clinical Characteristic
Parous Women 
(N=90)
Age at Interview Median 47.5
Interquartile Range 11
Range 28-72
No Episodes of Depression Median 4
Interquartile Range 2
Range 2-27
Age at Onset of Depression Median 22
Interquartile Range 10
Range 11-51
Number of Admissions None 64(71.1%)
One or more 26 (28.9%)
Psychosis Absent 82 (91.1%)
Present 8 (8.9%)
Number of Pregnancies Median 2.5
Interquartile Range 1
Range 1-9
Number of Deliveries Median 2
Interquartile Range 1
Range 1-8
Postpartum Depression Narrow (onset within 4 weeks) 31 (34%)
Broad (onset within 6 months) 45 (50%)
Thirty-one (34%) of the women had experienced at least one postpartum 
depressive episode with onset within four weeks of delivery and 45 (50%) had 
experienced a postpartum depression with an onset within six months. Of the 
210 deliveries to the 90 women, 18% were followed by postpartum depression 
with onset within four weeks or 26% with onset within six months of delivery.
Concordance between sibling pairs for postpartum episodes
For narrowly defined postpartum depression, 32 sibling pairs were concordant 
and 13 were discordant (tetrachoric correlation coefficient = 0.55, p=0.015, 
95% Cl 0.11-0.83) (see Table 8-2). Employing the broad definition of 
postpartum depression, 26 of the 45 sibling pairs were concordant and 19
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were discordant (tetrachoric correlation coefficient = 0.24, p= 0.28, 95% Cl 0-
0.63).
Table 8-2: Concordance Within Pairs of Recurrently Depressed Parous Sisters for Narrowly 
Defined Postpartum Depression (PPD) and Broadly defined Postpartum Depression
Narrow Definition of 
Postpartum Depression
Broad Definition of 
Postpartum Depression
Sib 2.
No PPD PPD
Sib 2.
No PPD PPD
No PPD 23 8 13 14
Sib 1.
PPD 5 9a 5 13b
The narrow definition of postpartum depression included women with postpartum depression with onset 
within four weeks of delivery. The broad definition of postpartum depression included women with 
postpartum depression with onset within six months of delivery. 
a Tetrachoric correlation coefficient = 0.55, p= 0.015, 95%  Cl 0.11-0 .83  
b Tetrachoric correlation coefficient = 0.24, p= 0.28, 95%  Cl 0- 0 .63
Women differed in the number of children they had had, and therefore in the 
opportunity to experience an episode of postpartum depression. In order to 
take account of these differences, and to ensure that the familiality being 
demonstrated is not due merely to familial influences on parity, I have also 
analysed the concordance of postpartum episodes following the women’s first 
delivery only. This analysis supports the familiality of narrowly defined 
postpartum depression (tetrachoric correlation coefficient = 0.62, p= 0.01,
95% Cl 0.16-0.88).
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Variation in the definition of postpartum onset
Given the difference in results between the narrow and broad definitions
employed above 1 was interested to see how varying the definition of
postpartum onset more widely influenced the evidence for familiality. Figure 8-
1 demonstrates that in varying the definition between 1 week and 26 weeks
the evidence for familiality maximised for a definition of postpartum onset in
between 6 and 8 weeks.
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Figure 8-1: Tetrachoric Correlation Coefficient Depending on the Definition of Postpartum
Onset Employed
Risk of postpartum depression per delivery
While the tetrachoric correlation coefficients reported above demonstrate the
familiality of liability to narrowly defined postpartum depression, it may be of
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clinical benefit to consider these results in terms of the risk of postpartum 
episodes per delivery.
Of the 90 parous women, 31 had a sister with a history of narrowly defined 
postpartum depression and 29% of all deliveries (42% of first deliveries) to 
these women were followed by an episode of postpartum depression. This 
compares to 12% of all deliveries (15% of first deliveries) to the 59 women 
whose sister had not suffered an episode of postpartum depression (see 
Figure 8-2).
No Sister with PPD N=59Sister with PPD N=31
Figure 8-2: Rates of Narrowly Defined Postpartum Depression (PPD) Following First Deliveries 
to Women With and Without a Sister With Postpartum Depression
In those women who had a sister with a history of PPD, 42% of first deliveries were followed by an 
episode of PPD, compared to only 15% in women with no sister with a history of PPD.
134
8.5 Discussion
This study provides evidence for the familiality of postpartum depression, in a 
well-characterised sample of siblings with recurrent major depression. It adds 
to the evidence suggesting that a sub-group of women with major depression 
have a specific vulnerability to the triggering of episodes by childbirth. In 
addition, I have demonstrated that familiality is dependant on the definition of 
postpartum episode. The evidence for familial aggregation was significant for 
narrowly defined postpartum depression (onset within four weeks of delivery, 
corresponding to the postpartum onset specifier in DSM-IV) but not for a 
broader definition (onset within six months of delivery) that is perhaps more 
typical of the way the diagnosis is used as a lay term and applied in clinical 
practice. The evidence for familiality maximised with a definition of postpartum 
onset of six to eight weeks.
The results provide further support for the well-established finding that a 
history of major depression is an important risk factor for depression in the 
postpartum period. Of the sample of subjects diagnosed with recurrent major 
depression, narrowly defined postpartum depression followed 18% of 
deliveries and 26% of deliveries were followed by an episode of depression 
within 6 months. Comparisons with previous studies examining rates of 
postpartum depression in the general population are not straightforward due 
to very different methodology and definitions of episodes of illness. However, 
the rates reported here are higher than those described in O’Hara & Swain’s 
(1996) meta-analysis and, furthermore, are likely to represent more severe 
episodes than those picked up by questionnaire measures alone.
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That family history is an important risk factor for major depression is well 
established: the influence of family history on vulnerability to postpartum 
depression is much more controversial. Indeed, the meta-analysis of O’Hara 
and Swain did not support family history as a risk factor for depressive 
episodes at this time (O'Hara and Swain, 1996). What then, could account for 
the differences between this and previous studies? It is likely that there are 
substantial methodological differences including the definition of postpartum 
depression, the methods used to assess postpartum depression, and finally, 
the assessment of family history. In this study, episodes of depression 
(including postpartum depression) and family history were assessed by direct 
interview of subjects. Consensus diagnoses were made by at least two 
members of the research team and the sample consisted only of subjects who 
had suffered with recurrent major depression. In contrast, previous studies 
relying on questionnaire measures may have resulted in a more 
heterogeneous sample including single episode depressive disorder, minor 
depressive disorder and, with regard to onset, a wide definition of postpartum 
episode. In addition, I was asking a related, but slightly different, question to 
previous studies. While the question previously regarded whether a family 
history of depression increases risk for an episode of depression following 
childbirth, I have asked whether a family history of postpartum episodes 
influences vulnerability to postpartum episodes in women from families 
multiply affected with recurrent major depression.
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The findings of this study have implications for clinical practice, nosology and 
research.
Clinical: Women with recurrent major depression with a family history of 
narrowly defined postpartum episodes are much more likely to experience a 
depressive episode following childbirth (42% of first deliveries), than those 
with no such family history (15% of first deliveries). Questions about postnatal 
episodes in first-degree relatives will therefore enable a more individualised 
risk assessment to be made for women with a history of major depression 
contemplating pregnancy.
Nosology: The definitions of postpartum onset in the classification systems 
are essentially arbitrary. Despite wide confidence intervals for the tetrachoric 
correlations under the various definitions of postpartum onset, this study 
suggests that neither a very broad nor restrictively narrow definition of 
postpartum onset is appropriate. These results provide some indication that 
the four week postpartum onset specifier in DSM-IV may be too narrow with 
familiality maximising for a six to eight week definition of postpartum onset.
Research: Postpartum depression remains an under-researched area, 
particularly with regard to studies focussing on the aetiology of episodes of 
depression occurring at this time. The results reported here suggest that a 
focus on postpartum triggering of episodes may be a productive strategy, 
informing us not only about postnatal episodes but having implications for the 
aetiology of affective disorders more generally. In addition, these results 
suggest that the definition of postpartum episode employed is important in
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studies of the postnatal triggering of depression. Future work should 
concentrate on episodes with a close temporal relationship to childbirth.
The current study must be interpreted in the light of a number of limitations. 
First, the sample was not systematically ascertained, but rather was identified 
from various sources. It would be very difficult and expensive, however, to 
systematically recruit a similar number of parous female sibling pairs with 
recurrent major depression in a community sample.
Second, the sample was limited to those with a positive family history of 
depression and it is possible, although perhaps unlikely, that the results would 
not generalise to women with major depression unselected for family history.
It is of note, however, that the women included here were recruited 
independently of their history of postpartum episodes which have not been 
reported to be either more or less common in women with a family history of 
depression. Further family studies examining postpartum episodes in women 
unselected for a family history of major depression would be of benefit, but 
would need to be considerably larger than the current study to have 
reasonable power to replicate the reported findings here.
Third, the assessments of postpartum depressions were made 
retrospectively, in some cases many years after the episode itself. Childbirth 
is a memorable event, however, occurring at most on only a few occasions in 
a woman’s life. It is likely, therefore, that episodes of major depression 
occurring in close relationship to childbirth would be well remembered. In
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addition, I was able to review contemporary case notes for one third of 
postpartum episodes and found excellent agreement with the woman’s own 
account at interview. With regard to onset, for example, in only one case was 
there no information in the case note record enabling confirmation of the 
woman’s account of the week of onset following delivery.
Finally, the study does not specify the cause of the apparent familiality, which 
may be due to either common (shared) environment, genetic factors or - 
perhaps most likely - a combination of both. The study of Treloar and 
colleagues (1999) found a moderate heritability for postpartum symptoms of 
depression but assessments of postpartum symptoms in this study were not 
ideal. Further twin studies employing more robust assessments of narrowly 
defined postnatal depression would be beneficial. Given the compelling 
evidence for the influence of genes in vulnerability to major depression 
(Sullivan et al., 2000), however, it is plausible that genetic factors play a role 
in determining an individual’s susceptibility to depression in the postpartum 
period. Molecular genetic studies focussing on women who have experienced 
narrowly defined postpartum depression may therefore prove productive in 
identifying genetic variants that increase vulnerability to the puerperal 
triggering of episodes.
These results suggest that familial factors play a role in determining 
vulnerability to narrowly defined postpartum depression, but have either less 
or no effect in determining vulnerability to postpartum depressive episodes 
defined more widely.
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If replicated, this narrowly defined subgroup provides a more homogenous 
sample in which to investigate the aetiological basis of postpartum 
depression. A greater understanding of the causes of postpartum depression 
will facilitate advances in the prevention and treatment of perinatal affective 
episodes, with obvious benefits to mother and child, and may also provide 
important clues into the aetiology of mood disorders in general.
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9 Family Study of Life Events Preceding Depressive 
Episodes in Recurrent Major Depressive Disorder
141
9.1 Summary
Occurrence of stressful life events is associated with the onset of major 
depressive episodes, particularly early episodes.
In 120 sibling pairs affected by recurrent major depression I tested for a 
familial contribution to the reporting of life events in the six month periods prior 
to the first, and the worst episodes of depression.
I found no significant evidence for the familiality of reporting of life events for 
the two time periods studied in this sample. With a sample size of 120 sibling 
pairs, this study has 80% power to detect heritability of 0.5, but for lower 
heritabilities power is reduced.
These findings do not support a large familial (nor genetic) contribution to 
susceptibility to reporting life events in familial recurrent depression, however, 
larger studies will be needed to rule out more modest levels of familiality.
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9.2 Introduction
There is a clear association between the occurrence of stressful life events 
and the onset of a major depressive episode, with the strength of association 
progressively decreasing as the number of episodes experienced by an 
individual increases (Paykel, 1978). The cause of individual variation in 
susceptibility to precipitation of depression by life events is not clear. A 
greater understanding of this relationship will facilitate advances in prevention 
and treatment. Here I have examined whether there may be a familial 
(perhaps genetic) contribution to this individual variation by estimating, in a 
sample of sibling pairs with recurrent major depression, the familiality of 
reporting of life events for six month periods prior to the onset (i.e. first) 
episode of depression and the worst ever episode of depression. I 
hypothesised that any evidence for familiality would be most obvious in 
relation to events occurring earlier rather than later in the course of illness.
9.3 Method
9.3.1 Subjects
See chapter 2 for further methodological details. Subjects (N=240) consisted 
of 120 sibling pairs, from 120 families, recruited at the Birmingham site of the 
DeNT study of unipolar depression.
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9.3.2 Assessment
The Brief Life Events Questionnaire (BLEQ) (Brugha et al., 1985, Brugha and 
Cragg, 1990, Farmer et al., 2000) (see appendix I) was used to ask about the 
occurrence and impact of twelve threatening life events. The impact of the 
event was rated as very distressing (score 3), moderately distressing (score 
2), or not very distressing (score 1) and a summated score produced. The 
time frames investigated were the six month periods prior to (a) the first ever 
episode of depression (FD) and (b) the worst ever episode of depression 
(WD).
The BLEQ for the WD time period was completed by the subject at the end of 
the research interview. After agreeing with the subject on the time period for 
the BLEQ FD, the questionnaire was then left in the questionnaire pack 
(described in chapter 2) for the subject to complete (due to time constraints). 
As previous research assessing the familiality of life events has not included 
childbirth as a life event, the twelfth item of the BLEQ concerning the 
occurrence of childbirth was excluded from the current analyses, enabling 
more straightforward comparison between this and previous studies. Hence, 
all analyses were based on the remaining 11 BLEQ items.
9.3.3 Statistical Analysis
A maximum likelihood variance components method (SOLAR) (Almasy and 
Blangero, 1998) was used to assess familiality in the sibling pairs for total 
BLEQ scores for each of the time periods. Since the data were non-normal, 
this familiality estimate was obtained assuming a t-distribution for the
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likelihood. This estimate of familiality includes genetic and/ or shared 
environmental factors.
As previous findings have indicated a need to control for “shared events” (i.e. 
stressful life events shared by both members of a sibling pair, such as the 
death of a parent), (Farmer et al., 2000), the current analysis included 
occurrence of “shared events” for the particular time period as a covariate.
9.4 Results
Twenty-two (18.3%) probands were recruited through local Mental Health 
Services and the remainder through media advertisements. One hundred and 
seventy-one subjects (71%) were female. The number of subjects who 
completed each questionnaire was as follows: BLEQ FD, N= 181 (75%); 
BLEQ WD, N= 236 (98.3%).
Familiality estimates for logarithmically transformed BLEQ scores, including 
shared events as a covariate, are shown in Table 9-1. Neither of the 
estimates differed significantly from zero.
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Table 9-1: Familiality Estimates for the Reporting of Life Events in Siblings with a Diagnosis of 
Recurrent Major Depression, Including Shared Events as a Covariate
Brief Life Events Questionnaire 
(BLEQ) for the six month period prior 
to the:
N Familiality Estimate p-value
First ever episode of depression (FD) 
with shared events covariate
181 0.00 0.5
Worst ever episode of depression 
(WD) with shared events covariate
236 0.08 0.35
“Familiality” refers to both genetic factors and environmental factors that are shared by members of a 
family. The estimate of familiality reflects the estimated contribution of familial factors to the variation of 
life events observed in this dataset. A value of 0 .00 indicates no contribution of familial factors. A value 
of 1.00 indicates that all variation can be explained by familial factors.
There were some subjects for whom the worst ever episode of depression 
was also the onset (first) episode of depression. As these subjects were rating 
the same episode I performed the analyses on the sample removing these 
individuals. The results were similar to those for the entire sample, and were 
not significant.
9.5 Discussion
I found no significant evidence for familiality of life events for the six month 
periods prior to either the onset (i.e. first) episode of depression or the worst 
ever episode of depression. These findings suggest that neither genetic nor 
shared environmental factors play a major role in the susceptibility to life 
events directly preceding depressive episodes in individuals with familial, 
recurrent depression.
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An important strength of this study is that I have examined the familiality of life 
events in relation to the onset and worst episodes of depression rather than a 
current episode. This is the first study to do this. Given that life events appear 
to have a bigger role in the earlier episodes of depression that an individual 
experiences, the focus on first episodes should optimize the chances of 
identifying pathogenetically relevant familiality. A further strength is that I have 
taken account of shared life events as a covariate because this has been 
shown to inflate estimates of familiality in studies of current depressive 
episodes (Farmer et al., 2000).
It is important to recognise that the findings relate to proximal life events, i.e. 
life events that occur in close temporal relationship to the onset of depressive 
episodes. I have not addressed the issue of life events occurring at other 
times, for example, during childhood, which may be better considered as 
predisposing, rather than precipitating, factors for illness.
It is also possible, that the failure of the current study to illustrate familiality for 
the reporting of life events occurring prior to the onset episode or worst ever 
episode of depression may have resulted from the use of retrospective 
assessment methods to establish the presence of such events. However, the 
questionnaire asks about major life events, most of which in the current study 
were reported to have had at least a moderate impact on the subject. Further, 
the List of Threatening Experiences has been shown to have high test-retest 
reliability and good agreement with informant information (Brugha and Cragg, 
1990).
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Although the current sample is of comparable size to those of previous 
studies that have found significant evidence for familiality of current life 
events, a second limitation of this study is sample size. With a sample size of 
120 sibling pairs, the current study has 80% power to detect a heritability of 
0.5. For lower heritabilities the power is reduced.
In conclusion, these results do not support the existence of strong familial 
factors (genetic or shared environmental factors) that influence susceptibility 
to life events in subjects with familial, recurrent major depression. I can 
confidently rule out large effects but larger studies will be needed to rule out 
more modest levels of familiality. The ideal designs would be large, 
prospective and include twins as well as siblings.
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10 General Discussion
10.1 Summary of Main Findings
Affective disorders are both clinically highly heterogeneous and multi-factorial 
in their aetiology. Phenotypic definition has become more sophisticated in 
studies investigating the causes of affective disorders with the aim of 
identifying more homogeneous disorders that may be more similar in terms of 
aetiology.
The overall aim of this thesis was to refine phenotype definition in affective 
disorders through the identification of sub-phenotypes that may be biologically 
validated by future molecular genetic studies. This involved the examination of 
various aspects of the phenotype in well defined and characterised samples 
of subjects with affective disorders. Table 10.1 provides a summary of the 
main findings of my studies.
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Table 10-1: Summary of Main Findings of Studies Described Within this Thesis
Chapter Number and Title Main Findings
3. Polarity at Illness Onset in 
Bipolar 1 Disorder and Clinical 
Course of Illness
In subjects with a diagnosis of bipolar 1 disorder, a depressive 
episode at illness onset is associated with a more “depressive” 
lifetime course of illness, with more frequent and severe 
depressive episodes and a predominantly depressive polarity. A  
depressive pole at illness onset is also associated with an earlier 
age at illness onset and less prominent psychotic features during 
the lifetime.
4. Clinical Differences Between  
Bipolar and Unipolar Depression
Clinical characteristics associated with a bipolar course, rather 
than a unipolar course of illness, include the presence of 
psychosis; diurnal mood variation and hypersomnia during 
depressive episodes; and a greater number of shorter depressive 
episodes.
5. Identifying Hypomanic Features  
in Major Depressive Disorder 
using the Hypomania Checklist 
(HCL-32)
A substantial minority of subjects (17% ) meeting D SM IV  criteria 
for recurrent major depression (even when selected to exclude 
personal and family histories of bipolar illness) report bipolar 
symptoms at a level similar to that reported by subjects meeting 
diagnostic criteria for bipolar disorder.
6. Clinical Characteristics of 
Unipolar Disorder and Bipolar 
Disorder According to the Lifetime 
Presence of Recurrent Panic 
Attacks
Subjects, with a diagnosis of bipolar disorder or unipolar disorder, 
with a history of panic attacks i) have more frequent and severe 
depressive episodes and ii) are more likely to have experienced  
suicidal ideation and slowed activity during depressive episodes in 
their lifetime, compared to those with no history of panic attacks.
Subjects with bipolar disorder and a history of recurrent panic 
attacks are also more likely to have i) a family history of affective 
disorder, ii) more severe impairment during their worst ever 
episode of depression, iii) attempted suicide during their lifetime, 
and iv) experienced diurnal morning variation, insomnia and 
agitated activity during depressive episodes during their lifetime, 
compared to subjects in the bipolar sample with no history of panic 
attacks. These differences were not seen between the unipolar 
groups with and without a history of panic attacks.
7. Is Depression Severity the Sole 
Cause of Psychotic Symptoms 
During an Episode of Unipolar 
Major Depression? A Study Both 
Between and Within Subjects
Within subjects with unipolar depression, psychotic episodes tend 
to be more severe than non-psychotic episodes. However, 
between subjects with unipolar depression there is wide variation 
in severity in both those that did, and did not, experience psychotic 
episodes.
8. Familiality of Postpartum 
Depression in Unipolar Disorder: 
Results of a Family Study
In women with recurrent major depression, episodes of post­
partum depression with an onset of within four weeks following 
childbirth, appear to aggregate in families. The evidence for 
familiality is maximised with a definition of postpartum onset of 
between six to eight weeks.
9. Family Study of Life Events 
Preceding Depressive Episodes in 
Recurrent Unipolar Major 
Depression
I found no significant evidence for familiality of reporting of life 
events in the six month periods prior to the first, or the worst 
episodes of depression. These findings do not support a large 
familial (nor genetic) contribution to susceptibility to reporting life 
events in familial recurrent depression, however larger studies will 
be needed to rule out more modest levels of familiality.
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Each chapter has included a discussion of specific issues relating to the 
particular study. This final discussion chapter will focus on more general 
issues.
10.2Methodological Strengths and Limitations
The main strength of these studies is the use of large well characterized 
samples of subjects recruited from within the same geographical regions from 
within the UK and assessed using the same standardized, rigorous and robust 
clinical assessment methods.
Most of the studies within this thesis focused on samples including at least 
500 subjects. With this sample size, at the p<0.05 significance level, these 
studies have 93% power to detect small effect sizes, and over 99% power to 
detect medium or large effect sizes when using an independent t-test (two- 
tailed). When using a chi-square test (2x2 table, 1 degree of freedom) these 
studies would have 61% power to detect small effect sizes and over 99% 
power to detect medium or large effect sizes (Cohen, 1988).
The clinical homogeneity of the samples employed can also be seen as a 
major strength of the studies included in this thesis. As samples were 
recruited as part of ongoing molecular genetic studies, subjects included in 
the unipolar and bipolar samples had to meet strict inclusion and exclusion 
criteria. As previously discussed, heterogeneity in mood disorders is a factor 
that is likely to hinder the identification of aetiological factors that contribute to 
susceptibility to these illnesses. By focusing on narrowly defined unipolar and
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bipolar samples, this heterogeneity has been reduced. It is also important to 
note that this homogeneity could also be seen as a limitation in some of these 
studies as the samples may not be representative of all populations. When 
considering the generalisability of the findings of these studies it is also 
necessary to take into account i) the high proportion of females in the bipolar 
sample ii) the ethnicity of the samples (UK/ Eire White), and iii) the use of 
systematic and non-systematic methods of recruitment. I will now consider 
these points individually.
i) The proportion of females in the unipolar sample was as would be expected 
for studies of this nature with about two-thirds of the sample being female.
This reflects firstly, the well established prevalence rates for unipolar 
depression indicating that women are at least twice as likely as men to 
experience depression during their lifetime (Kessler et al., 1994, Klerman and 
Weissman, 1989); and secondly, the bias often seen in studies of this nature 
in women being more likely than men to agree to participate. The prevalence 
rates for bipolar disorder have generally been shown to be similar for males 
and females (Mitchell et al., 2004, Goodwin and Jamison, 2007), although 
some studies have shown differences in the course of illness between males 
and females with bipolar disorder (Arnold, 2003, Kennedy et al., 2005). 
However, in my bipolar sample the proportion of females was greater than for 
males, again with around seventy percent of the sample being female. As in 
the unipolar sample, a bias towards women being more likely to agree to 
participate may partially explain the large proportion of female subjects in the 
sample. An additional explanation for this may be related to the research
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group’s focus on episodes of mood illness in relation to childbirth. This may 
have resulted in larger numbers of females with bipolar disorder being 
recruited to the studies. The greater number of females in my bipolar sample 
than would be expected for a study of this nature should be taken into account 
when considering the generalisability of the findings.
ii) As subjects were recruited as part of ongoing molecular genetic studies 
they were required to be of UK/ Eire white ethnicity. When studying the 
genetic risk factors involved in complex diseases, restricting ascertainment to 
a single ethnic/ racial group is important in order to reduce heterogeneity and 
thereby minimize the likelihood of false positives caused by differences in the 
genetic background of participants. However, the use of this inclusion criterion 
could potentially limit the generalisability of my findings.
iii) In order to obtain large sample sizes both systematic and non-systematic 
methods of ascertainment were used to recruit potential research subjects. It 
is possible that this may have introduced a recruitment bias. However, in 
analyses where I thought this may be a potential source of bias, I included 
method of recruitment as a covariate.
In chapters 5 and 6 it is possible that there may have been a response bias in 
terms of which subjects completed and returned the 2007 questionnaire pack. 
The time period between the initial research interview and the questionnaire 
mail-out varied between subjects and non-response, to the request to 
complete the questionnaires, was significantly associated with a longer
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duration between the initial interview and the questionnaire mail-out. Although 
there were some differences in clinical characteristics between responders 
and non responders, for example, in age at interview, diagnosis, and BADDS 
scores, none of these remained statistically significant when taking into 
account the duration of the interval between the research interview and the 
questionnaire mail-out.
A limitation that has been consistently mentioned throughout this thesis 
relates to the retrospective assessment methods that were used. However, as 
I have also mentioned, I consistently found good agreement between the 
information obtained from subjects during the in depth semi-structured 
interviews and the information obtained from the case note reviews. The use 
of retrospective assessment methods allowed the greatest insight into the 
overall lifetime course of illness in these subjects with affective disorder 
diagnoses and was also a cost effective method of study.
Related to the use of retrospective measures, is the limitation that medication 
use could not be assessed effectively in these samples. It may be that some 
of the variables that I have considered in these chapters could have been 
influenced by the use of particular medication regimes, for example, the 
increased use of mood stabilising medication in subjects with bipolar disorder, 
compared to subjects with unipolar disorder.
For many of the studies included in this thesis, it would have been interesting 
to examine the variables of interest in samples of subjects with a diagnosis of
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bipolar II disorder. However, as the molecular genetic studies have focused 
on subjects with a diagnosis of bipolar I disorder, the sample size of patients 
with bipolar II disorder (N=57) was small. Although this sample would have 
99% power to detect large effects, at the p<0.05 significance level, power 
would be reduced to 73% for moderate effects and 18% for small effects 
when using an independent t-test (two-tailed). When using a chi-square test 
(2x2 table, 1 degree of freedom, p<0.05), this sample when compared to a 
sample of similar size, would have over 99% power to detect large effects, 
91% for moderate effects, and only 19% for small effects (Cohen, 1988).
10.3 Future Directions
Large samples of individuals with affective disorders are continuing to be 
assembled. The results of the studies in this thesis highlight the importance of 
collecting detailed phenotypic data in such studies aimed at investigating the 
aetiology of these disorders. Focusing on diagnostic groups using current 
classification systems may not be adequate in studies aimed at identifying the 
multiple factors contributing to susceptibility for these illnesses.
The studies described in chapters 3, 5 and 7 also highlight the need for the 
use of more dimensional measures of the phenotype, rather than solely 
focusing on the simple categorical distinctions that are traditionally used.
As many of the studies in this thesis have been exploratory in nature (and no 
correction has been made for multiple testing) it will be important to replicate 
these findings in large independent, well characterized samples.
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10.3.1 Potential sub-phenotypes for use in molecular genetic studies
The main aim of this thesis was to identify sub-phenotypes that may be 
biologically validated by future molecular genetic studies. Of the sub­
phenotypes investigated in this thesis, there are four that I feel will be of 
benefit in such studies. I will now discuss these, in order, according to those 
that I feel most confident will be of utility in future genetic studies.
i) Familial post-partum depression in subjects with a diagnosis of major 
recurrent depression
In chapter 8, I found strong evidence for the familial aggregation of 
vulnerability to narrowly defined episodes of post-partum depression. This 
familial aggregation maximised with an onset of between six to eight weeks 
following childbirth. Familial vulnerability to postpartum episodes in women 
with bipolar disorder has previously been shown (Jones and Craddock, 
2001b), but the study presented in chapter 8 is the first to focus on the 
familiality of post-partum depression in unipolar disorder. In samples of 
individuals with bipolar disorder, further studies have identified chromosomal 
regions that are likely to harbour genes that predispose individuals to affective 
puerperal psychosis. A genome-wide significant linkage signal was observed 
on chromosome 16p13, and a genome-wide suggestive linkage was observed 
on chromosome 8q24 (Jones et al., 2007). Additionally, candidate gene 
studies of women with puerperal psychosis have shown suggestive, although 
preliminary, evidence for an association between puerperal psychosis and a 
variant at the serotonin transporter gene on chromosome 17 (Coyle et al.,
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2000). These previous findings illustrate the potential benefits of focusing on 
clinical sub-types of affective disorder in molecular genetic studies. Focusing 
on women with bipolar disorder who have experienced postpartum episodes 
has facilitated genetic studies of bipolar disorder. Future studies aimed at 
identifying genes and genomic regions that may be implicated in susceptibility 
to post-partum depression, and affective disorders more generally, could 
refine the phenotype by focusing on families where at least one member has 
experienced an episode of narrowly defined post-partum depression.
ii) Polarity at illness onset in subjects with a diagnosis of bipolar I 
disorder
Another clinical sub-type investigated in this thesis was defined according to 
the polarity of the onset episode of illness (chapter 3). Previous studies have 
suggested that polarity at illness onset is a familial feature of bipolar affective 
disorder (Kassem et al., 2006) and is associated with important clinical 
indicators which may help define more homogeneous subtypes of bipolar 
affective disorder. In support of this, I found that certain clinical characteristics 
were associated with a depressive pole at illness onset. In addition, I 
assessed the severity and impairment associated with mood episodes and 
found that in those subjects with a depressive pole at illness onset, the 
impairment associated with, and severity of, depressive episodes was 
increased when compared to those participants with a manic pole at onset. 
These sub-groups of subjects defined according to polarity at illness onset, 
who share clinical characteristics of illness may also share aetiological factors 
in common. Kassem et al (2006), as a preliminary test of genetic validity,
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assessed the impact of polarity at onset on genetic linkage findings previously 
detected in their sample. They found that mania at onset substantially 
increased the genetic linkage signal on chromosome 16p but had no effect on 
linkage to chromosome 6q. Further large scale molecular genetic studies that 
take into account polarity at illness onset are required.
When considering these findings it is of interest that two sub-types of bipolar 
affective disorder, the first identified through a vulnerability to post-partum 
manic/ psychotic episodes and the second identified according to the polarity 
of the onset episode of illness, identified a linkage region of interest on 
chromosome 16p. These studies could potentially be identifying the same 
region and it is possible that they may be indexing the same underlying 
pathogenesis. It is also possible that this chromosome may harbour two or 
more vulnerability genes for various forms of bipolar disorder.
iii) Comorbid recurrent panic attacks in subjects with a diagnosis of 
bipolar I disorder or major recurrent depression
Studies have indicated that although bipolar disorder comorbid with panic 
disorder appears to aggregate in families (MacKinnon et al., 2002, Rotondo et 
al., 2002), unipolar disorder comorbid with panic disorder does not appear to 
represent a distinct subtype in terms of familial aggregation (Maier et al., 
1995b, Weissman et al., 1993).
Although I did not assess the familial aggregation of panic disorder or 
recurrent panic attacks in my samples, I did find important clinical differences
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between subjects with and without a lifetime history of recurrent panic attacks 
(chapter 6). Both unipolar and bipolar subjects with a history of recurrent 
panic attacks reported increased morbidity associated with depression, in that 
they reported more severe and more frequent depressive episodes and more 
suicidal ideation and slowed activity during depressive episodes. To the best 
of my knowledge, this is the first such study to include both subjects with 
unipolar disorder and bipolar disorder, where all subjects were assessed 
using robust, consistent methodologies.
Interestingly, in addition to the findings that were shared across the unipolar 
and bipolar samples, I also found additional clinical features that appeared to 
distinguish between subjects with and without a history of panic attacks in the 
bipolar sample but not in the unipolar sample. For example, subjects with a 
diagnosis of bipolar disorder and a history of recurrent panic attacks were 
more likely to have a family history of affective disorder, more severe 
impairment during the worst ever episode of depression, attempted suicide 
during their lifetime, and to have experienced diurnal morning variation, 
insomnia and agitated activity during depressive episodes during their lifetime.
Thus it appears that the presence of comorbid panic disorder may also 
identify a potentially useful sub-type for future studies investigating the 
aetiology of affective disorders, in particular bipolar disorder.
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iv) Psychotic features in subjects with a diagnosis of major recurrent 
depression
The findings presented in chapter 7 suggest that in subjects who have a 
predisposition (biological and/ or psychosocial) to experience psychosis, 
psychotic features tend to emerge in their more severe depressive episodes. 
However, the data also illustrate how severity alone cannot account for the 
presence of psychotic features, as non-psychotic depressive episodes in 
subjects with no personal history of psychosis may be as severe as, or more 
severe than, those seen in subjects with psychotic depression.
This study found individual variation in susceptibility to psychosis during 
depressive episodes with psychosis being more likely to be experienced 
during the more severe episodes, in those individuals with increased 
susceptibility. However, I have not assessed the familiality of psychotic 
unipolar depression. The familiality of psychotic features in bipolar disorder is 
well established (Schulze et al., 2006, Saunders et al., 2007). Although some 
previous studies have found that subjects with psychotic major depression 
had an increased risk of family prevalence of unipolar major depression 
(Leckman et al., 1984, Nelson et al., 1984), and bipolar disorder, (Weissman 
et al., 1984b, Leckman et al., 1984), others have found that family history of 
unipolar depression was similar between subjects with major depression, with 
and without psychotic features (Coryell and Tsuang, 1982). To date, no study 
has examined the familiality of psychosis in siblings or families of unipolar 
probands. Further studies, involving systematic gathering of family data for 
unipolar major depression, are required in order to determine the familiality of
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psychotic unipolar depression and to better understand genetic influences. 
The use of dimensional measures as well as binary distinctions would be 
beneficial.
10.3.2 Potential sub-phenotypes that may be of use in clinical terms
I will now consider three of the sub-phenotypes described in this thesis which 
I feel could potentially be of clinical importance. Again, I will describe the sub­
phenotypes, in order, according to those that I feel would be of most use in 
clinical terms.
i) Polarity at illness onset in subjects with a diagnosis of bipolar I 
disorder
The findings in chapter 3 relating to the significance of the polarity of the onset 
episode of illness are of potential clinical importance. Once a patient has 
experienced his/ her first manic episode, the clinician can use knowledge of 
polarity of the illness onset as an indicator of the likely predominant pole of 
illness. This may be helpful in providing information and advice to the patient. 
This applies to the situation where a patient has experienced their first manic 
episode and, hence, a diagnosis of bipolar disorder can be made.
ii) Clinical characteristics of depression in subjects with a diagnosis of 
bipolar I disorder or major recurrent depression
Studies have suggested that there are differences in the clinical 
characteristics of depressive episodes in subjects with unipolar and bipolar 
disorder (Bowden, 2005, Mitchell et al., 1992, Mitchell et al., 2008) and my
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findings in chapter 4 support previous findings in this large well characterised 
sample. Clinical characteristics associated with a bipolar course included the 
presence of psychosis; diurnal mood variation and hypersomnia during 
depressive episodes; and a greater number of shorter depressive episodes. 
Such differences could potentially be of use in increasing clinical suspicion of 
bipolar disorder in patients who experience a depressive episode without 
having experienced a prior manic episode.
iii) Hypomanic features in subjects with a diagnosis of major recurrent 
depression
My findings in chapter 5 highlighted an overlap in manic/ hypomanic 
symptoms across bipolar and unipolar diagnostic groups, challenging the 
traditional simple unipolar/ bipolar categorical divide. These findings illustrate 
the difficulties inherent in allocating subjects to a particular diagnostic group 
and suggest the need for dimensional measures of manic/ hypomanic 
symptoms across patients with mood disorder diagnoses in order to optimise 
treatment. For example, it may be that patients with unipolar disorder who 
score highly on a measure of lifetime hypomanic symptoms may respond less 
favourably to antidepressants, although this has yet to be proven. Future 
studies assessing treatment response across mood disorder diagnoses may 
benefit from such dimensional measures.
10.4Final Conclusions
Affective disorders are relatively common and highly morbid. These illnesses 
can cause a great deal of suffering and, although there are treatments such
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as medication and psychotherapy that may be helpful to some people, there 
are a large number of individuals who do not respond adequately or who 
suffer adverse effects from treatment.
Research investigating the aetiology of affective disorders will increase public 
awareness of these disorders, and hopefully help in reducing the stigma 
associated with mental illness. Such research will also increase our 
understanding about the causes of these illnesses and the complex interplay 
between genes and environment. This knowledge may facilitate the 
development of improved preventative strategies aimed at reducing the risk of 
mood episodes, as well as improving treatment regimes, both 
pharmacological and psychological.
The studies in this thesis demonstrate the complexity of the mood disorders 
phenotype and illustrate how if future studies are to understand the aetiology 
of these disorders it will be necessary to dissect the heterogeneity within the 
mood disorders phenotype. The findings of these studies provide examples of 
ways in which the phenotype may be usefully dissected.
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Appendices
Appendix A
The Global Assessment Scale (GAS) 
(Endicott et al., 1976)
100-91  No symptoms, superior functioning in a wide range of activities, life’s
problems never seem to get out of hand, is sought out by others because of 
his warmth and integrity.
90 -  81 Transient symptoms may occur, but good functioning in all areas, interested
and involved in a wide range of activities, socially effective, generally satisfied 
with life, “everyday” worries that only occasionally get out of hand.
8 0 - 71  Minimal symptoms may be present but no more that slight impairment in
functioning, varying degrees of “everyday” worries and problems that 
sometimes get out of hand.
70 -  61 Some mild symptoms (e.g. depressive mood and mild insomnia) OR some
difficulty in several areas of functioning, but generally functioning pretty well, 
has some meaningful interpersonal relationships and most untrained people 
would not consider him “sick”.
60 -  51 Moderate symptoms OR generally functioning with some difficulty (e.g. few
friends and flat affect, depressed mood and pathological self-doubt; euphoric 
mood and pressure of speech, moderately severe antisocial behaviour).
50 -  41 Any serious symptomatology or impairment in functioning that most clinicians
would think obviously requires treatment or attention (e.g. suicidal 
preoccupation or gesture, severe obsessional rituals, frequent anxiety 
attacks, serious antisocial behaviour, compulsive drinking).
40 -  31 Major impairment in several areas, such as work, family relations, judgement,
thinking or mood (e.g. depressed woman avoids friends, neglects family, 
unable to do housework), OR some impairment in reality testing or 
communication (e.g. speech is at times obscure, illogical or irrelevant), OR 
single serious suicide attempt.
30 -  21 Unable to function in almost all areas (e.g. stays in bed all day), OR
behaviour is considerably influenced by either delusions or hallucinations, OR 
serious impairment in communication (e.g. sometimes incoherent or 
unresponsive) or judgement (e.g. acts grossly inappropriately).
20 -  11 Needs some supervision to prevent hurting self or others, or to maintain
minimal personal hygiene (e.g. repeated suicide attempts, frequently violent, 
manic excitement, smears faeces), OR gross impairment in communication 
(e.g. largely incoherent or mute).
1 0 - 1  Needs constant supervision for several days to prevent hurting self or others,
or makes no attempt to maintain minimal personal hygiene.
Notes: Rate the subject’s lowest level of functioning in the last week by selecting the lowest range that 
describes his functioning on a hypothetical continuum of mental health illness. For example, a subject 
whose “behaviour is considerably influenced by delusions” (range 21-30) should be given a rating in that 
range even though he has “major impairment in several areas” (range 31-40). Use intermediary levels 
when appropriate (e.g. 35, 58, 63). Rate actual functioning independent of whether or not subject is 
receiving, and may be helped by, medication or some other form of treatment.
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Appendix B
The Bipolar Affective Disorder Dimension Scale (BADDS)
(Craddock et al., 2004)
General information
The Bipolar Affective Disorder Dimension Scale (BADDS) has been developed in order to 
address some of the disadvantages of a purely categorical approach to diagnostic 
classification of Bipolar Spectrum Disorders.
BADDS is a dimensional rating scheme that retains and builds upon current 
categorical classifications. It is intended for use in clinical samples from populations over­
represented by Bipolar Spectrum illness. It was not developed for use in general population 
samples.
BADDS has been under development since 1996 and has now been used by a 
variety of researchers within our group on more than 1100 cases. It has proved to be user 
friendly and has excellent reliability, even on sets of diagnostically challenging cases.
BADDS comprises 4 dimensions: M: Mania; D: Depression; P: Psychosis; I: 
Incongruence. Each dimension is rated using integer scores on a 0 -  100 scale. Ratings are 
made after review of all available clinical data on a subject (eg. case records, semi-structured 
psychiatric interview and information from an informant) and can be performed as a simple 
addition to the conventional consensus lifetime psychiatric diagnostic procedures already in 
use by many research groups. Each rating reflects a mixture of severity and frequency of 
clinical features. Guidelines are provided that define anchor points in the rating scales and 
specify how ratings should be made.
BADDS: General rating guidelines
1) Do not rate a dimension if there is insufficient information - just leave the dimension blank.
2) Use all available information to make the best judgement for each rating.
3) It is expected that when used for research BADDS will be used within the accepted 
framework of the lifetime best-estimate consensus diagnostic procedure.
4) All ratings should be made using integers in the range 0-100.
5) Ratings for M and D are a mixture of severity and frequency. Generally the severity of the 
most severe episode identifies a range in which the rating will be made and the frequency 
determines the score assigned within the range. In assigning a rating, start at the lowest 
score in the range and then add points according to any relevant psychopathology over and 
above that of the most severe episode according to the following guidelines:
a) In general each additional episode of that level of severity will add a score of 2 in a 
20 point range and 1 in a 10 point range.
b) Scores in the identified severity range can and should be modified according to 
severity and duration of total episodes -  but with a substantial down-weighting for 
episodes of lower severity.
c) For episodes that are one level of severity lower than the rating range, add 0.25 
points for each episode of lower severity for a score in a 10 point range and 0.5 
points for each episode of lower severity for a score in a 20 point range.
d) For episodes that are more than one level of severity lower than the rating range 
the total adjustment should not normally exceed 1 or 2 points.
6) For the P and I dimensions anchor points are given in these guidelines. Judgment is used 
to assign scores between anchor points.
7) Under very exceptional circumstances a score can be rated outside the severity range. 
However, this should always be agreed by at least two raters and the rating should lie in the 
interval 0-100.  Such a rating should be indicated by an asterisk (*) following the rating for 
that dimension. An example of the applicability of this rule is the rating up of an episode in 
which the balance of evidence clearly suggests a severe illness that is not adequately 
supported by the documented evidence because of poor documentation. Another example 
would be the rating down of an episode if the balance of evidence strongly suggests that the 
formal evidence clearly over-represents the clinical significance of the episode.
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Disrupts work or social life more or less completely
Markedly inappropriate overspending that is reckless within the
context of the subject’s financial position
Fights
Lost job
Police involvement 
Family split up
Received specific treatment (including dose increase of mood 
stabilizer) for acute mania 
Psychotic features
• Incapacitating mania refers to a severe manic episode that includes the presence of 
one or more of the following features: incoherence, disorientation, loss of contact with 
reality (which includes psychotic features), frenzied or bizarre psychomotor activity. 
NB: Being admitted on a Section is an example of incapacitating mania.
• Mixed episodes are rated on the M dimension. If all manic episodes are mixed, add 
“m” to the rating (eg. 65m).
Key points and ranges on the M dimension
0 No manic features.
1-19  Mild sub-hypomanic features. Elation/irritability and less than 3
symptoms.
20 - 39 Sub-hypomanic features. Elation/irritability and 3+ symptoms for at
least 1 day.
40 - 59 Hypomanic features. At least one hypomanic episode.
60 - 79 Manic features. At least one manic episode.
80-100 Severe manic features. At least one episode of incapacitating mania.
NB: a) if * enter as .01, e.g., 65* = 65.01
b) if m enter as .02, e.g., 65m = 65.02
c) if both * and m enter as .03, e.g., 65*m = 65.03)
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2) Depression (D)
• Rating reflects severity and duration.
• Use ICD10 to define depressive syndromes. This includes 10 symptoms of 
depression that count for the purposes of diagnosis:
A Depressed mood
Loss of interest/pleasure 
Loss of energy
B Suicidal ideation 
Pathological guilt 
Loss of confidence/self esteem 
Loss of concentration 
Slowed activity 
Change of appetite or weight 
Change in sleep pattern
• Depression severity: Mild - 4+ symptoms (2+ from A); moderate - 6+ symptoms (2+ 
from A); severe - 8+ symptoms (3 from A). Refer to ICD10 for full definition of 
syndromes and symptoms.
• Duration criterion for Major Depressive Episode is 2 + weeks. If 1- 2 weeks, classify 
as Minor Depression.
• Rate depression as severe if (a) ICD10 criteria fulfilled, or (b) criteria for major 
depression are fulfilled and there has been a serious suicide attempt, ECT treatment 
or hospital admission for depression.
• Minor depression refers to at least 1 week of low mood accompanied by 2 or more 
depression items or to brief episodes that would otherwise meet criteria for Major 
Depression.
• Incapacitating depression refers to severe major depression that includes presence of 
one or more of the following features: stupor; mutism; loss of contact with reality 
(including psychotic features). NB: Being admitted on a Section is an example of 
incapacitating depression.
• If psychotic features are present, a depressive episode can be rated as incapacitating 
if the minimum criteria for major depression are satisfied (ie. 4 items).
Key points and ranges on D dimension
0 No features of depression during
1 - 1 9 Sub-Minor depression.
20- 39 Minor depression.
40- 49 Mild major depression.
50-59 Moderate major depression.
60- 79 Severe depression.
80-100 Incapacitating depression
NB: if * enter as .01, e.g., 65* = 65.01
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3) Psychotic features (P)
• Psychotic features refers to delusions, hallucinations, positive formal thought 
disorder, catatonia or grossly disorganized behaviour (but see exclusions below).
• Ratings on this dimension exclude stupor or excitement during an affective episode or 
positive formal thought disorder during mania.
• Lifetime occurrence of psychotic features is rated.
• Near psychotic schizotypal features refers to the following DSMIV schizotypal items: 
ideas of reference; odd beliefs or magical thinking that influences behaviour and is 
inconsistent with sub-cultural norms; unusual perceptual experiences including bodily 
illusions; odd thinking and speech; suspiciousness or paranoid ideation; behaviour or 
appearance that is odd eccentric or peculiar. Depersonalization and derealization are 
not classified as near psychotic features.
• The period of illness considered refers to all affective and non-affective periods of 
psychopathology.
• Rating should take account of both number and duration of episodes with and without 
psychotic features. If in doubt, “rate up” the psychotic features. Examples:
o If there have been two 1 week long affective psychotic episodes and a 1 year 
non-psychotic depressive episode, rate 60 (ie. approx. 2/3 of illness 
episodes).
o If there have been nine 1 month non-psychotic affective episodes, one 1 
month psychotic affective episode and 4 years of chronic hallucinations 
outside affective episodes, rate 80 (ie. approx. 80% of illness duration).
• The Uncertain category (P = 1) is used for situations in which insufficient information 
is available to determine if sign or symptom meets criteria for near psychotic feature.
Key points and ranges on P dimension
0 Absent.
1 Uncertain.
2 -9  Near psychotic features: occasional at low end of range, frequent at
high end of range. Occurrence of true psychotic symptoms should not 
be rated in this range.
10-20 Brief clear-cut psychotic symptom that are not a prominent
feature of illness.
10 -  Single.
20 -  Multiple.
2 1 - 1 0 0  Psychotic symptoms that are a prominent feature in one of more
episodes of illness.
25 - present for 25% of illness.
50 - present for 50% of illness.
75 - present for 75% of illness.
100 - prominent psychotic features present throughout illness.
NB: a) If there is only one manic episode which is psychotic, then P=100.
b) Experiences which are unusual but not definitely schizotypal or 
psychotic should be rated ‘1 ’ (uncertain) here. Such experiences should 
be rated as ‘1’ on the ‘near section 2 features’ variable.
c) When calculating the % of episodes that are psychotic, milder episodes 
of illness may be weighted down compared with more severe episodes (use 
clinical judgement). In general use the rule of counting a mild episode as 
equivalent to 1/4 of a more severe episode. For example, if there have 
been 2 episodes of psychotic mania and 3 episodes of mild depression 
which have not needed treatment this would be counted as equivalent to [2 
+ (3x0.25)] = 2 .75 episodes of mood disturbance and rated P as 73, i.e., 2 
/ [  2 + (3x0.25)] = 73.
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4) Mood incongruence (I)
• DSMIV definitions of congruence and incongruence are used.
• Rate incongruence of lifetime occurrence of psychotic features.
• For convenience, the set of psychotic symptoms recognized as having special weight
in the diagnosis of schizophrenia and schizoaffective disorder (thought echo, 
insertion, withdrawal or broadcasting; passivity experiences; hallucinatory voices 
giving running commentary, discussing subject in third person or originating in some
part of the body; bizarre delusions; catatonia) are denoted in the guidelines as the “S
set”.
• If Psychosis Features dimension, P < 10, leave I blank.
Key points on I dimension
0 -40 Psychotic symptoms occur only during affective episodes and do not include
any of the S set.
Rating 0 -  virtually completely mood congruent.
Rating 20 -  approximate balance between mood congruent and incongruent. 
Rating 40- virtually completely mood incongruent 
43 Psychotic symptoms occur only during affective episodes and include one or
more of the S set which have not definitely been present for 2 weeks.
47 Psychotic symptoms occur only during affective episodes and include one or
more of the S set which have definitely been present for 2 weeks.
50 - 59 Psychotic symptoms probably present for at least 2 weeks either side of an
affective episode.
Rating 50 -  on at least one occasion.
Ratings of 51-59 used to reflect recurrence and/or certainty.
60 - 100 Psychotic symptoms definitely present for at least 2 weeks either side of an
affective episode.
Rating 60 -  on at least one occasion.
Rating 80- on many occasions.
Rating 100 -  Psychotic symptoms predominate illness and occur chronically 
outside (or in absence of) affective episodes.
NB: a) a rating of 100 does not necessarily imply schizophrenia.
b) when rating congruence rate psychotic symptoms occurring outside the affective 
states as incongruent.
c) if there is a delusional system -  some can be congruent and others incongruent 
with the affective state. Rate as congruent if all the delusions are understandable in 
relation to the mood.
d) mixed episodes -  if  it is not possible to determine a temporal relationship between 
the affective states and psychotic symptoms rate 20 (approx. balance between 
congruence and incongruence). If it is possible to determine a temporal relationship, 
rate congruence in relation to the affective states.
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Appendix C
Part 1:
Modified O PC R IT  Symptom Checklist 
Rating Form
DEPRESSIVE SYMPTOMS WE LE
1. Dysphoria □ □
2. Loss of pleasure □ □
3. Diurnal variation (mood worse mornings) □ □
4. Suicidal ideation □ □
5. Excessive self reproach □ □
6. Poor concentration □ □
7. Slowed activity □ □
8. Loss of energy/tiredness □ □
9. Poor appetite □ □
10. Weight loss □ □
11. Increased appetite □ □
12. Weight gain □ □
13. Initial insomnia □ □
14. Middle insomnia (broken sleep) □ □
15. Early morning waking □ □
16. Excessive sleep □ □
17. Diminished libido □ □
18. Agitated activity □ □
MANIC SYMPTOMS
19. Elevated mood
20. Irritable mood
WE LE
□ □ 
□ □
¥21. Thoughts racing □ □
22. Pressured speech □ □
23. Distractibility □ □
24. Excessive activity □ □
25. Increased self esteem □ □
26. Reckless activity □ □
27. Reduced need for sleep □ □
28. Increased sociability □ □
PSYCHOTIC SYMPTOMS LE
29. Third person auditory hallucinations □
30. Running commentary voices □
31. Abusive/accusatory/persecutory voices □
32. Other (non affective) auditory hallucinations □
33.* Non-affective visual hallucinations □
34. Non-affective hallucination in any other modality □
35. Thought echo □
36. Thought insertion □
37. Thought broadcast □
38. Thought withdrawal □
39. Delusions of passivity □
40. Delusions of influence □
41. Primary delusional perception □
42. Persecutory delusions □
43. Bizarre delusions □
44. Other primary delusions □
45. Bizarre behaviour □
46. Catatonia □
47. Speech difficult to understand □
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48. Incoherent □
49. Positive formal thought disorder □
50. Negative formal thought disorder □
51. Restricted affect □
52. Blunted affect □
53. Inappropriate affect □
54.* Perplexity □
PSYCHOTIC AFFECTIVE SYMPTOMS WE LE
55. Grandiose delusions □  □
56. Delusions of guilt □  □
57. Delusions of poverty □  □
58. Nihilistic delusions □  □
59.* Mood congruent third person auditory 
hallucinations □  □
60.* Mood congruent second person auditory 
hallucinations □  □
61.* Mood congruent visual hallucinations □  □
62.* Mood congruent hallucinations in any
other modality □  □
63.* Other secondary delusions □  □
WE Worst Ever Episode 
LE Lifetime Ever
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Appendix C
Part 2:
Modified OPCRIT Symptom Checklist
Item Definitions 
(McGuffin et al., 1991)
DEPR ESSIVE S Y M P T O M S
Should be rated as present if present for at least 2 weeks.
Items marked * are not in the original OPCRIT.
All items are rated 0 No
1 Yes
9 Unknown/Missing
1. Dysphoria
Persistently low or depressed mood, irritable and sad mood or pervasive loss of 
interest.
Note that this item includes irritability which does not occur in the context of a manic 
syndrome. Includes pervasive loss of interest as well as depressed mood.
2. Loss of pleasure
Pervasive inability to enjoy any activity. Include marked loss of interest or loss of 
libido.
3. Diurnal variation (mood worse mornings)
Dysphoria/low mood and/or associated depressive symptoms are at their worst soon 
after awakening with some improvement (even if only slight) as the day goes on.
4. Suicidal ideation
Preoccupation with thoughts of death (not necessarily own). Thinking of suicide, 
wishing to be dead, attempts to kill self.
Include moderate and severe tedium vitae here.
5. Excessive self reproach
Extreme feelings of guilt and unworthiness. May be of delusional intensity ('worse 
person in the whole world').
Primarily guilt, but also low self-esteem. Rated if out of proportion to the situation.
6. Poor concentration
Subjective complaint of being unable to think clearly, make decisions etc.
7. Slowed activity
Patient complains that he feels slowed up and unable to move. Others may report 
subjective feeling of retardation or retardation may be noted by examining clinician.
8. Loss of energy/tiredness
Subjective complaint of being excessively tired with no energy.
9. Poor appetite
Subjective complaint that patient has poor appetite. Not necessarily observed to be 
eating less.
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10. Weight loss
Rate as present for a loss of at least 2 lbs a week over several weeks. Do not score 
those who have reduced weight as a result of dieting.
11. Increased appetite
Patient reports increased appetite and/or 'comfort eating'.
12. Weight gain
Rate as present for a gain of at least 2 lbs a week over several weeks.
13. Initial insomnia
Patient complains that unable to get off to sleep and lies awake for at least one hour.
Rate positively if  the patient has considerably more difficulty than usual in getting off 
to sleep, even if they cannot specify the time during which they lie awake
14. Middle insomnia (broken sleep)
Most nights sleep disturbed; subject awakes in the middle of sleep and experiences 
difficulty in getting back to sleep.
NB IF YOU ONLY HAVE INFORMATION ON 'INSOMNIA', SCORE ITEM 13 AND 14.
15. Early morning waking
Patient complains that persistently wakes up at least one hour earlier than usual 
waking time.
Rated positively if the patient wakes considerably earlier than usual, even if they are 
unable to specify the time of waking.
16. Excessive sleep
Patient complains that sleeping too much.
17. Diminished libido
Definite and persistent reduction in sexual drive or interest as compared with before 
onset of disorder.
18. Agitated activity
Patient shows excessive repetitive activity, such as fidgety restlessness, wringing of 
hands, pacing up and down, all usually accompanied by expression of mental 
anguish.
MANIC S Y M P TO M S
Should be rated as present if present for at least 4  days.
Items marked * are not in the original O PCRIT.
All items are rated 0 No
1 Yes
9 Unknown/Missing
19. Elevated mood
Patient's predominant mood is one of elation. (Can be co-rated with irritable mood).
20. Irritable mood
Patient's mood is predominantly irritable. (Can be co-rated with elevated mood).
21. Thoughts racing
Patient experiences thoughts racing through his head or others observe flights of 
ideas and find difficulty in following what patient is saying or in interrupting because of 
the rapidity and quantity of speech.
196
22. Pressured speech
Patient much more talkative than usual or feels under pressure to continue talking. 
Include manic type of formal thought disorder with clang associations, punning and 
rhyming etc.
23. Distractibility
Patient experiences difficulties concentrating on what is going on around because 
attention is too easily drawn to irrelevant or extraneous factors.
24. Excessive activity
Patient is markedly over-active. This includes motor, social and sexual activity.
25. Increased self esteem
Patient believes that he is an exceptional person with special powers, plans, talents 
or abilities. Rate positively here if overvalued idea but if delusional in quality also 
score grandiose delusions.
26. Reckless activity
Patient is excessively involved in activities with high potential for painful 
consequences which is not recognised, e.g. excessive spending, sexual indiscretions, 
reckless driving, etc.
Include sexual recklessness leading to risk of pregnancy or venereal disease.
27. Reduced need for sleep
Patient sleeps less but there is no complaint of insomnia. Extra waking time is 
usually taken up with excessive activities.
28. Increased sociability
Rate as present for loss of social inhibitions resulting in behaviour which is 
inappropriate to the circumstances and out of character.
PSYCHOTIC S Y M P TO M S
Should be rated as present if present for at least a significant portion of time in a 1 month period or less 
if successfully treated
Items marked * are not in the original O PC R IT.
All items (except #) are rated 0 No
1 Yes
9 Unknown/Missing
29. Third person auditory hallucinations
Two or more voices discussing the patient in the third person. Score if either 'true' or 
'pseudo' hallucinations, i.e. differentiation of the source of the voices is unimportant.
Two or more voices talking about the patient in the third person. May be rated 
without an example if a clear description is given that these occur. Rate if the notes 
say “third person auditory hallucinations”.
30. Running commentary voices
Patient hears voice(s) describing his actions, sensations or emotions as they occur. 
Score whether these are possible 'pseudo' hallucinations or definite ('true') 
hallucinations.
Voice must be in the third person. May be rated without an example if  a clear 
description is given that commentary occurs.
31. Abusive/accusatory/persecutory voices
Voices talking to the patient in an accusatory, abusive or persecutory manner.
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Voices must be in the second person. If voices are congruent with mood state also 
rate item 60.
32. Other (non affective) auditory hallucinations
Any other kind of auditory hallucination. Includes pleasant or neutral voices and non 
verbal hallucinations.
Note that this includes non-verbal auditory hallucinations. If hallucinations occur in 
the context of a mood episode and it is unclear whether they are congruent or 
incongruent, rate as congruent and rate’9’ for the equivalent incongruent item.
33* Non-affective visual hallucinations
Visual hallucinations in which the content has no apparent relationship to elation or 
depression.
If hallucinations occur in the context of a mood episode and it is unclear whether they 
are congruent or incongruent, rate as congruent and rate’9’ for the equivalent 
incongruent item.
34. Non-affective hallucination in any other modality
Hallucinations in which the content has no apparent relationship to elation or 
depression.
Rated positively if a clear description is given, even without a specific time period. If 
hallucinations occur in the context of a mood episode and it is unclear whether they 
are congruent or incongruent, rate as congruent and rate’9’ for the equivalent 
incongruent item.
NB. WHEN SCORING DELUSIONS PLEASE SCORE EACH SEPARATE 
DELUSION UNDER ONE AND ONLY ONE CATEGORY DESCRIBING THE 
SPECIFIC TYPE OF THE DELUSION i.e. AS EITHER; PERSECUTORY, 
GRANDIOSE, INFLUENCE/REFERENCE, BIZARRE, PASSIVITY, 
PRIMARY DEL PERCEPTION, OTHER PRIMARY DEL, THOUGHT 
WITHDRAWAL, THOUGHT BROADCAST, THOUGHT INSERTION, GUILT, 
POVERTY OR NIHILISTIC.
35. Thought echo
Score if patient experiences thoughts repeated or echoed in his or her head or by a 
voice outside the head.
As with the other thought interference items, this is rated conservatively. Repeated 
thoughts must not be under the patient’s control. Ruminative thoughts do not qualify. 
Note that this definition includes a voice repeating a person’s thoughts.
36. Thought insertion
Patient recognises that thoughts are being put into his head which are not his own 
and which have probably or definitely been inserted by some external agency.
Definition from SCAN. Example required for positive rating. In particular, ideas taken 
on by the patient from influential people in their lives are not rated positively.
37. Thought broadcast
Patient experiences thoughts diffusing out of his head so that they may be shared by 
others or even heard by others.
Definition from SCAN. Example required for a positive rating. A belief that other 
people know what the patient is thinking and an elaboration of this belief that they can 
therefore read his/her mind does not qualify. Note that this definition includes 
thoughts being heard by others (loud thoughts).
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38. Thought withdrawal
Patient experiences thoughts ceasing in his head which may be interpreted as 
thoughts being removed (or 'stolen') by some external agency.
Definition from SCAN. Example required for a positive rating.
39. Delusions of passivity
Include all 'made' sensations, emotions or actions. Includes all experiences of 
influence where patient knows that his own feelings, impulses, volitional acts or 
somatic sensations are controlled or imposed by an external agency.
The definition from SCAN is used. An example is required before a positive rating 
can be given. In particular, other people or hallucinatory voices telling the patient to 
perform a certain act and the patient acting under this pressure to do so is not rated 
positively.
40. Delusions of influence
Events, objects or other people in patient's immediate surroundings have a special 
significance, often of a persecutory nature. Include ideas of reference from the TV or 
radio, or newspapers, where patient believes that these are providing instructions or 
prescribing certain behaviour.
Require a definite delusion to rate this item. Delusion must refer to something 
outside of the body. Include delusional jealousy, delusional lover, and delusion of 
being spied upon.
41. Primary delusional perception
The patient perceives something in the outside world which triggers a special, 
significant relatively non understandable belief of which he is certain and which is in 
some way loosely linked to the triggering perception.
42. Persecutory delusions
Includes all delusions with persecutory ideation.
43. Bizarre delusions
Strange, absurd or fantastic delusions whose content may have a mystical, magical 
or 'science fiction' quality.
A particularly troublesome item. To be rated here, the delusion must be totally 
implausible in DSMIV terminology. The RDC definition adds that it must be patently 
absurd or fantastic. Most simple delusions of reference or persecution are not 
included. Great caution should be applied before rating delusions of a religious or 
supernatural nature or delusions which involve extra-sensory perception. Note that 
Capgras syndrome and other delusions of misidentification are rated here. If a 
delusion is bizarre, but can be rated elsewhere, rate it as bizarre (except for first rank 
symptoms).
44. Other primary delusions
Includes delusional mood and delusional ideas. Delusional mood is a strange mood 
in which the environment appears changed in a threatening way but the significance 
of the change cannot be understood by the patient who is usually tense, anxious or 
bewildered. Can lead to a delusional belief. A delusional idea appears abruptly in 
the patient's mind fully developed and unheralded by any related thoughts.
Include other delusions not classified elsewhere which are not secondary to mood 
disturbance, alcohol, or any other phenomena, e.g., delusion of thoughts being read, 
dysmorphophobia, hypochondriacal delusions.
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45. Bizarre behaviour #
Behaviour that is strange and incomprehensible to others. Includes behaviour which 
could be interpreted as response to auditory hallucinations or thought interference.
Rated as present with low threshold including, e.g., an entry in case-notes saying that 
the patient’s behaviour was strange or bizarre for no apparent reason or possibly as a 
consequence of psychotic symptoms. Behaviour must not be explicable by affective 
change.
46. Catatonia #
Patient exhibits persistent mannerisms, stereotypies, posturing, catalepsy, stupor, 
command automatism or excitement which is not explicable by affective change.
Include automatic obedience.
47. Speech difficult to understand #
Speech which makes communication difficult because of lack of logical or 
understandable organisation. Does not include dysarthria or speech impediment.
May be rated ‘1’ if, e.g., a case-note entry says the patient’s speech was difficult to 
understand because it was disorganised, without a specific example of the nature of 
the disorganisation.
48. Incoherent #
Normal grammatical sentence construction has broken down. Includes "word salad" 
and should only be rated conservatively for extreme forms of formal thought disorder.
Note this is only rated in extreme cases in addition to items 47 & 49. Entry of 
‘incoherent’ in notes is not sufficient, normally rated at item 47 unless there is more 
specific information about the nature of the speech disturbance.
49. Positive formal thought disorder #
The patient has fluent speech but tends to communicate poorly due to neologisms, 
bizarre use of words, derailments, loosening of associations.
This definition is similar to item 47. This item may be rated as well as item 47 if, in 
addition to an observation or description of disorganised speech, an example is given 
which allows it to be defined as positive formal thought disorder in Andreasen’s 
terminology or a description of the nature of the disorganisation is given which 
similarly allows it to be classified as a form of positive formal thought disorder. Do not 
include circumstantiality or clanging. Care is required regarding the meaning of an 
entry of ‘thought disorder’ in case-notes, i.e., formal thought disorder must be 
differentiated from schizophrenic thought disorder (that is, thought 
insertion/broadcast/withdrawal/control).
50. Negative formal thought disorder #
Includes paucity of thought, frequent thought blocking, poverty of speech or poverty 
of content of speech.
Excludes occurrence during a depressive episode. Note that this definition includes 
frequent thought blocking. Poverty of content of speech should be rated under item 
49.
51. Restricted affect #
Patient's emotional responses are restricted in range and at interview there is an 
impression of bland indifference or 'lack of contact'.
Exclude flat affect during a depressive episode, i.e., care is required regarding the 
meaning of an entry of ‘flattened affect’ in case-notes. Care is required when flat 
affect is in the context of Parkinsonian side-effects.
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52. Blunted affect #
Where the patient's emotional responses are persistently flat and show a complete 
failure to 'resonate' to external change. (NB. Differences between restricted and 
blunted affect should be regarded as one of degree, with 'blunted' only being rated in 
extreme cases).
If this item is rated positively, then so must item 51. Exclude flat affect during a 
depressive episode, i.e., care is required regarding the meaning of an entry of 
‘flattened affect’ in case-notes. Care is required when flat affect is in the context of 
Parkinsonian side-effects.
53. Inappropriate affect #
Patient's emotional responses are inappropriate to the circumstance, e.g. laughter 
when discussing painful or sad occurrences, fatuous giggling without apparent 
reason.
This item includes fatuous giggling for no reason, as well as emotional responses 
inappropriate to the circumstances. Care is required if in the context of a manic 
episode.
54* Perplexity#
Severe or marked confusion, bewilderment, perplexity or puzzlement. Proband is 
unable to judge correctly events in their surroundings. The proband may no longer 
understand the connections in the events around them and everything appears 
peculiar. The patient may keep on speaking about things not relevant to the theme 
but this is due to a failure to comprehend their environment rather than an abundance 
of flight of ideas. Proband may express feeling of being in a dream like state, being 
on another planet, or being like a zombie. Does not result from a lack of interest in 
surroundings (c.f. negative symptoms and depression). Not merely speech that is 
difficult to understand due to severe flight of ideas or formal thought disorder. Not due 
a change in the quality of perception of external space (c.f. de-realisation). Not the 
situation in which an individual can not make sense of a delusional system. Do not 
rate if obviously due to the effects of drugs (illicit or prescribed) or alcohol intoxication. 
NOTE: Very difficult to distinguish from a number of other symptoms including flight of 
ideas, negative symptoms, depression, marked delusional system, de-personalisation 
and de-realisation. Rate making the best estimate of whether symptom present based 
on all the available evidence.
PSYCHOTIC A FFE C TIV E  S Y M P TO M S
Should be rated as present if present for at least a significant portion of time in a 1 month period or less 
if successfully treated
Items marked * are not in the original O PCRIT.
All items are rated 0 No
1 Yes
9 Unknown/Missing
55. Grandiose delusions
Patient has grossly exaggerated sense of own importance, has exceptional abilities 
or believes that he is rich or famous, titled or related to Royalty. Also included are 
delusions of identification with God, angels, the Messiah etc. (See also ‘increased 
self-esteem’).
Score as present if present for at least 4 days.
56. Delusions of guilt
Firm belief held by subject that they have committed some sin, crime or have caused 
harm to others despite absence of any evidence to support this.
Score as present if present for at least 2 weeks.
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57. Delusions of poverty
Firm belief held by subject that they have lost all or much of their money or property 
and have become impoverished despite absence of any evidence to support this. 
Score as present if present for at least 2 weeks.
58. Nihilistic delusions
Firmly held belief that some part of patient's body has disappeared or is rotting away 
or is affected by some devastating or malignant disorder despite a lack of any 
objective supporting evidence.
Score as present if present for at least 2 weeks. Include patient’s belief that he/she is 
dead.
59. * Mood congruent third person auditory hallucinations
Two or more voices discussing the patient in the third person or patient hears voice(s) 
describing his actions, sensations or emotions as they occur. The content of the 
hallucinations has a clear relationship to a depressed/manic mood. Score if either 
'true' or 'pseudo' hallucinations, i.e. differentiation of the source of the voices is 
unimportant.
May be rated without an example if  a clear description is given that these occur. Rate 
if the notes say “third person auditory hallucinations”. If hallucinations occur in the 
context of a mood episode and it is unclear whether they are congruent or 
incongruent, rate as congruent and rate’9’ for the equivalent incongruent item.
60. * Mood congruent second person auditory hallucinations
Second person auditory hallucinations, where the content of the voices has a clear 
relationship to a depressed/manic mood.
Include here mood congruent non-verbal auditory hallucinations. If voices are 
abusive/accusatory/persecutory also rate item 31. If hallucinations occur in the 
context of a mood episode and it is unclear whether they are congruent or 
incongruent, rate as congruent and rate’9’ for the equivalent incongruent item.
61* Mood congruent visual hallucinations
Visual hallucinations in which the content has a clear relationship to a 
depressed/manic mood.
If hallucinations occur in the context of a mood episode and it is unclear whether they 
are congruent or incongruent, rate as congruent and rate’9’ for the equivalent 
incongruent item.
62. * Mood congruent hallucinations in any other modality
Hallucinations in which the content has a clear relationship to a depressed/manic 
mood.
Rated positively if a clear description is given, even without a specific time period. If 
hallucinations occur in the context of a mood episode and it is unclear whether they 
are congruent or incongruent, rate as congruent and rate’9’ for the equivalent 
incongruent item.
63. * Other secondary delusions
Delusions not rated elsewhere in which there is a clear relationship to a 
depressed/manic mood.
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Appendix D
Reliability Ratings Sheet for Mood Disorder Research Study 
Subjects
STUDY ID ________  INITIALS   DOB
RATER ________  DATE _______
DSM-IV ICD-10 RDC PN CYCLOID
DIMENSION SCORES: M
D
P
I
GAS SCORES: LIFETIME WORST (IN DEP EPISODE)
LIFETIME WORST (IN MANIC EPISODE) _____
PAST WEEK _____
SECTION 2 (LE)  MOOD CONGRUENCE (LE)  NEAR SECTION 2 (LE)
PREDOMINANT MAN AFFECT (LE)  DYSPHORIC MAN (LE)____
NO. EPISODES: MANIA ____ DEPRESSION________ ____
LONGEST DURATION: MANIA ____ DEPRESSION________ ____
AGE ONSET:
SYMPTOM IMPAIRMENT CONTACT ADMISSION____
FIRST SYMPTOMS_______________MANIA_____  DEP
FIRST IMPAIRMENT_____________ MANIA_____  DEP
FIRST PSYCHIATRIC CONTACT ____________
FIRST ADMISSION_______________MANIA_____  DEP
MOST RECENT ADMISSION_______MANIA_____  DEP
NO. ADMISSIONS:____ _____
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AGE OF FIRST PSYCHOSIS (HALLUCINATION OR DELUSION): ____
FIRST EPISODE POSTPARTUM? Y I N I UK
PUERPERAL EPISODE ____ MENSTRUAL   RAPID CYCLING
SUICIDAL IDEATION (LE) ____
LITHIUM RESPONSE ____ ANTI-DEPRESSANT RESPONSE (inc ECT)
SWITCH OF POLARITY FOLLOWING ANTI-DEPRESSANTS
PSYCHIATRIC SEQUELAE ONSET (WKS AFTER 
DELIVERY)
FULL-TERM DELIVERY #1
FULL-TERM DELIVERY #2
FULL-TERM DELIVERY #3
FULL-TERM DELIVERY #4
FULL-TERM DELIVERY #5
FULL-TERM DELIVERY #6
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Appendix E
The Beck Depression Inventory (BDI)
(Beck and Steer, 1987)
On this questionnaire are groups of statements. Please read each group of statements 
carefully, circle the number (0, 1 ,2  or 3) next to the one statement in each group which best 
describes how you feel today. If several statements within a group seem to apply equally 
well, circle each one. Be sure to read all the statements in each group before making 
vour choice.
do not feel sad. 
feel sad.
am sad all the time and I can’t snap out of 
t.
am so sad or unhappy that I can’t stand it.
am not particularly discouraged about the 
future.
feel discouraged about the future, 
feel I have nothing to look forward to. 
feel that the future is hopeless and that 
things cannot improve.
do not feel like a failure, 
feel I have failed more than the average  
person.
As I look back on my life, all I can see is a 
ot of failures.
feel I am a complete failure as a person.
get as much satisfaction out of things as I 
used to.
don’t enjoy things the w ay I used to. 
don’t get real satisfaction out o f anything 
anymore.
am dissatisfied or bored with everything.
don’t feel particularly guilty, 
feel guilty a good part of the time, 
feel quite guilty most of the time, 
feel guilty all of the time.
don’t feel I am being punished, 
feel I may be punished, 
expect to be punished, 
feel I am being punished.
don’t feel disappointed in myself, 
am disappointed in myself, 
am disgusted with myself, 
hate myself.
9 0 
1
2
3
10 0
1
2
3
11
12 0
1
2
3
13 0 
1 
2 
3
don’t feel I am worse than anyone else, 
am critical of myself for my weaknesses  
or mistakes, 
blame myself all the time for my faults, 
blame myself for everything bad that 
happens.
don’t have any thoughts of killing myself, 
have thoughts of killing myself, but I 
would not carry them out. 
would like to kill myself, 
would kill myself if I had the chance.
don’t cry any more than usual, 
cry more now than I used to. 
cry all the time now.
used to be able to cry, but now I can’t cry 
even though I want to.
am no more irritated now than I ever am. 
get annoyed or irritated more easily than I 
used to.
feel irritated all the time now. 
don’t get irritated at all by the things that 
used to irritate me.
have not lost interest in other people, 
am  less interested in other people than I 
used to be.
have lost most of my interest in other 
people.
have lost all of my interest in other 
people.
make decisions about as well as I ever 
could.
put off making decisions more than I used 
to.
have greater difficulty in making 
decisions than before, 
can’t make decisions at all anymore.
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14 0 I don’t feel I look any worse than I used to.
1 I am worried that I am looking old or 
unattractive.
2 I feel that there are permanent changes in 
my appearance that make me look 
unattractive.
3 I believe that I look ugly.
15 0 I can work about as well as before.
1 It takes an extra effort to get started at 
doing something.
2 I have to push myself very hard to do 
anything.
3 I can’t do any work at all.
16 0 I can sleep as well as usual.
1 I don’t sleep as well as I used to.
2 I wake up 1-2 hours earlier than usual and 
find it hard to get back to sleep.
3 I wake up several hours earlier than I used 
to and cannot get back to sleep.
17 0 I don’t get more tired than usual.
1 I get tired more easily than I used to.
2 I get tired from doing almost anything.
3 I am too tired to do anything.
18 0 My appetite is no worse than usual.
1 My appetite is not as good as it used to be.
2 My appetite is much worse now.
3 I have no appetite at all anymore.
19 0  I haven’t lost much weight, if any, lately.
1 I have lost more than 5 pounds.
2 I have lost more than 10 pounds.
3 I have lost more than 15 pounds.
I am purposely trying to lose weight by 
eating less. Yes No (please circle)
20 0 I am no more worried about my health than
usual.
1 I am worried about physical problems 
such as aches and pains; or upset stomach; 
or constipation.
2 I am very worried about physical problems 
and it’s hard to think of much else.
3 I am so worried about my physical 
problems that I cannot think of anything 
else.
21 0 I have not noticed any recent change in my
interest in sex.
1 I am less interested in sex than I used to be.
2 I am much less interested in sex now.
3 I have lost interest in sex completely.
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Appendix F
The Altman Self-Rating Mania Scale (ASRM) 
(Altman et al., 1997)
1. On this questionnaire are groups of five statements. Please read each group of 
statements carefully.
2. Choose one statement in each group that best describes how you feel today.
3. Circle the number next to the statement you have picked.
4. Please not the word ‘occasionally1 when used here means once or twice. ‘Often' 
means several times or more. ‘Frequently1 means most of the time.___________
1 0 I do not feel happier or more cheerful than usual.
1 I occasionally feel happier or more cheerful than usual.
2 I often feel happier or more cheerful than usual.
3 I feel happier or more cheerful than usual most of the time.
4 I feel happier or more cheerful than usual all of the time.
2 0 I do not feel more self-confident than usual.
1 I occasionally feel more self-confident than usual.
2 I often feel more self-confident than usual.
3 I feel more self-confident than usual most of the time.
4 I feel more self-confident than usual all of the time.
3 0 I do not need less sleep than usual.
1 I occasionally need less sleep than usual.
2 I often need less sleep than usual.
3 I frequently need less sleep than usual.
4 I can go all day and night without any sleep and still do not feel tired.
4 0 I do not talk more than usual.
1 I occasionally talk more than usual.
2 I often talk more than usual.
3 I frequently talk more than usual.
4 I talk constantly and cannot be interrupted.
5 0 I have not been more active (either socially, sexually, at work, home or school) than
usual.
1 I have occasionally been more active than usual.
2 I have often been more active than usual.
3 I have frequently been more active than usual.
4 I am constantly active or on the go all the time.
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Appendix G
The Hypomania Checklist (HCL-32)
(Angst et al., 2005a)
At different times in their lives everyone experiences changes or swings in energy, activity and mood 
("highs and lows" or "ups and downs").
This questionnaire asks about any periods o f “high mood” or “elation” that you feel you may have 
experienced during your life. These periods may last for hours, days, weeks or months.
The aim o f this questionnaire is to assess the characteristics o f the “high” periods.
Q l. First of all, how are you feeling today compared to your usual state? (Please cross only ONE
of the following)
Much worse than usual □
Worse than usual □
A little worse than usual □
Neither better nor worse than usual □
A little better than usual □
Better than usual □
Much better than usual □
Q2. How are you usually compared to other people?
Independently o f how you feel today, please tell us how you are normally compared to other people, by 
crossing which o f the followings statements describes you best.
Compared to other people, my level o f activity energy and m ood...
(Please cross only ONE o f the following)
... .is always rather stable and even □
.... is generally higher □
.... is generally lower □
... .repeatedly shows periods o f ups and downs □
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No box for each of the statements below.
In such a state: Yes No
1. I need less sleep □ □
2. I feel more energetic and more active □ □
3. I am more self-confident □ □
4. I enjoy my work more □ □
5. I am more sociable (make more phone calls, go out more) □ □
6. I want to travel and/or do travel more □ □
7. I tend to drive faster or take more risks when driving □ □
8. I spend more money/too much money □ □
9. I take more risks in my daily life (in my work and/or other activities) □ □
10. I am physically more active (sport etc.) □ □
11. I plan more activities or projects. □ □
12. I have more ideas, I am more creative □ □
13. I am less shy or inhibited □ □
14. I wear more colourful and more extravagant clothes/make-up □ □
15. I want to meet or actually do meet more people □ □
16. I am more interested in sex, and/or have increased sexual desire □ □
17. I am more flirtatious and/or am more sexually active □ □
18. I talk more □ □
19. I think faster □ □
20. I make more jokes or puns when I am talking □ □
21. I am more easily distracted □ □
22. I engage in lots of new things □ □
23. My thoughts jump from topic to topic □ □
24. I do things more quickly and/or more easily □ □
25. I am more impatient and/or get irritable more easily □ □
26. I can be exhausting or irritating for others □ □
27. I get into more quarrels □ □
28. My mood is higher, more optimistic □ □
29. I drink more coffee □ □
30. I smoke more cigarettes □ □
31. I drink more alcohol □ □
32. I take more drugs (sedatives, anti-anxiety pills, stimulants...) □ □
Q4. Did the questions (Q 3 ,1-32) above, which characterise a “high”, describe how yo 
are.... (Please cross only ONE of the following)
..sometimes (if you cross this box please answer all questions, 5-9 below) □
..most of the time (if you cross this box please answer only questions, 5 and 6 below)
□
..I have never experienced such a “high” (if you cross this box this questionnaire is now 
complete) □
Q5. Impact of your “highs” on various aspects of your life: (Please cross only ONE box 
for each aspect)
Positive Positive Negative No Impact
& Negative
1. Family Life □ □ □ □
2. Social Life □ □ □ □
3. Work □ □ □ □
4. Leisure □ □ □ □
Q6. Other people’s reactions and comments to your “highs”.
How did people close to you react to or comment on tour “highs”? 
(Please cross only ONE of the following)
Positively (encouraging and supportive) □
Neutral □
Negatively (concerned, annoyed, irritated, critical) □
Positively & Negatively □
No reactions □
Q7. Length of your “highs” as a rule (on average): (Please cross only ONE of the
following)
1 day □
2-3 days □
4-7 days □
Longer than 1 week □
Longer than 1 month □
I can’t judge/ don’t know □
Q8. Have you experienced such “highs” in the past twelve months?
Yes □
No □
Q9. If yes, please estimate how many days you spent in “highs” during the last twelve 
months:
 days
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Appendix H
Panic Attacks Questionnaire
[Questions taken from the Patient Health Questionnaire (PHQ) (questions 2a to 2e and 
question 3 of the PHQ) (Spitzer et al., 1999)].
Q1. Have you ever had an anxiety attack- suddenly feeling fear or panic?
Yes □ No □
If no, this questionnaire is now complete.
If yes, please complete Q2-6 below.
Q2. Has this happened on more than one occasion?
Yes □ No □
Q3. Do some of these attacks come out of the blue-that is, in situations where you do not 
expect to be nervous or uncomfortable?
Yes □ No □
Q4. Do these attacks bother you a lot or are you worried about having another attack?
Yes □ No □
Q5. During these attacks do you have symptoms like shortness of breath, sweating, your 
heart racing or pounding, dizziness, tingling or numbness, or nausea or upset stomach?
Yes □ No □
Q6. If you answered yes to any of the five questions above, how difficult do these problems 
make it for you to do your work, take care of things at home, or get along with other people?
Not difficult at all □
Somewhat difficult □
Very difficult □
Extremely difficult □
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Appendix I
The Brief Life Events Questionnaire (BLEQ)
(Brugha et al., 1985)
We have established that your first episode of FEELING DEPRESSED began on /  /
 . I would like to ask you about events or problems which may have happened to you
during the 6-months prior to that date.
[For the worst ever episode of depression, “first” was replaced with “worst”]
1. In the 6 months prior to your first episode 
of depression, did you suffer from a serious 
illness, injury or an assault?
If yes, at the time, how bad was that for you?
2. In the 6 months prior to your first episode 
of depression, did a serious illness, injury 
or assault happen to a close relative?
If yes, at the time, how bad was that for you?
3. In the 6 months prior to your first episode 
of depression, did a parent, spouse (or partner),
child, brother or sister of yours die? Yes No
If yes, at the time, how bad was that for you? Very bad Moderately bad Not too bad
4. In the 6 months prior to your first episode 
of depression, did a close family friend or 
relative die, such as an aunt, cousin or
grandparent? Yes No
If yes, at the time, how bad was that for you? Very bad Moderately bad Not too bad
5. In the 6 months prior to your first episode 
of depression, did you have a separation due to 
marital difficulties or break off a steady
relationship? Yes No
If yes, at the time, how bad was that for you? Very bad Moderately bad Not too bad
Yes No
Very bad Moderately bad Not too bad
Yes No
Very bad Moderately bad Not too bad
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6. In the 6 months prior to your first episode 
of depression, did you have a serious problem 
with a close friend, neighbour or relatives? Yes No
If yes, at the time, how bad was that for you?
7. In the 6 months prior to your first episode 
of depression, were you made redundant or 
sacked from your job?
If yes, at the time, how bad was that for you?
8. In the 6 months prior to your first episode 
of depression, were you seeking work without 
success for more than one month?
If yes, at the time, how bad was that for you?
9. In the 6 months prior to your first episode 
of depression, did you have a major financial 
crisis such as losing the equivalent of three 
months income?
If yes, at the time, how bad was that for you?
10. In the 6 months prior to your first episode 
of depression, did you have problems with 
the police involving a court appearance?
If yes, at the time, how bad was that for you?
11. In the 6 months prior to your first episode 
of depression, was something you valued lost 
or stolen?
If yes, at the time, how bad was that for you?
12. In the 6 months prior to your first episode 
of depression, did you/ your wife or partner 
give birth to a child?
If yes, do you think this contributed to your 
becoming depressed?
Very bad Moderately bad Not too bad
Yes No
Very bad Moderately bad Not too bad
Yes No
Very bad Moderately bad Not too bad
Yes No
Very bad Moderately bad Not too bad
Yes No
Very bad Moderately bad Not too bad
Yes No
Very bad Moderately bad Not too bad
Yes No
Probably not Perhaps yes Probably yes
213
Appendix J
Histograms showing the distributions of scores in the unipolar and 
bipolar samples for the scales used throughout the thesis.
UP: Unipolar Sample 
BP: Bipolar Sample
i) BADDS (Bipolar Affective Disorder Dimension Scale)
Depression Dimension (UP & BP), Mania Dimension (UP & BP), 
Psychosis Dimension (UP & BP), Congruence Dimension (BP)
ii) GAS (Global Assessment Scale)
Life Time Worse in Depressive Episode (UP & BP)
Life Time Worse in Manic Episode (BP)
iii) BDI (Beck Depression Inventory) (UP & BP)
iv) ASRM (Altman Self-Rating Mania Scale) (UP & BP)
v) BLEQ (Brief Life Events Questionnaire) (UP sibling pairs)
Six months prior to worst ever episode of depression 
Six months prior to first ever (onset) episode of depression
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